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Abstract 
According to recent studies PRGs (primary response genes) that are expressed rapidly 
after providing the activating stimulus are characterized by the initial presence of 
paused polymerases and high levels of H3K4me3 at their promoter. In contrast, SRGs 
(secondary response genes) are regulated by the active recruitment of RNA Pol II (RNA 
polymerase II), requiring the interplay of transcription factors and co-factors to induce 
transcription, and are therefore delayed in their expression, compared to PRGs. To 
examine the mechanisms driving the expression of SRGs, we focused on the regulation 
of STAT-regulated genes, stimulated by IFNγ (Interferon) or IFNβ. Effects of the latter 
were studied in macrophages infected with the Gram+, facultative intracellular 
bacterium Listeria monocytogenes. Infected cells produce IFNβ to synergize with 
additional pathways in the upregulation of host-defense genes. 
To examine the role of STAT1 (signal transducer and activator of transcription) in the 
regulation of IFNγ-induced SRGs, we focused on the regulation of the Gbp2 (guanylate 
binding protein) gene. Previous work in the lab had shown that Gbp2 belongs to a 
subgroup of genes that require both STAT1 and IRF1 (interferon regulatory factor) for 
transcriptional induction upon IFNγ treatment and that recruitment of HDACs (histone 
deacetylase) and CBP/p300 (CREB – cyclic AMP response element binding protein – 
binding protein) to the Gbp2 promoter directly depends on the presence of STAT1 and 
its phosphorylation on Ser727. We could further demonstrate that IRF1 binding was 
needed for the recruitment of RNA Pol II. Moreover, IRF7 was  involved in the 
regulation of Gbp2 and other ISRE (interferon stimulated response element)-driven 
genes after IFNγ treatment.  
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This finding is novel, since IRF7 was not known to be expressed upon IFNγ treatment 
and to participate in the regulation of interferon-induced genes. Contrasting IRF1, IRF7 
function in this context relied on the presence and constitutive activity of the S/T kinase 
TBK1 (TANK - TRAF family member associated NFκB – nuclear factor of kappa light 
polypeptide gene enhancer in B-cells -  activator - binding kinase). TBK1-mediated 
IRF7 phosophorylation was required for GBP2 expression, but did not alter IRF7 
binding to the Gbp2 promoter. Expression of the Socs1 gene did require the presence of 
IRF7, but not its phosphorylation by TBK1. In contrast to TBK1, the related S/T kinase 
IKKε (IκB – inhibitor of NFκB - kinase) repressed IRF7 activity to induce GBP2 
expression. These findings indicate that phosphorylated, aswell as unphosphorylated 
IRF7 participates in the regulation of ISRE-driven gene expression after IFNγ treatment. 
A distinct subset of SRGs requires the cooperation of signals derived from IFNs as well 
as additional signals derived from the infecting pathogen to acquire full-fledged 
transcriptional activity. Paradigmatic for this group is the Nos2 gene, encoding iNOS 
(inducible nitric oxide synthase), which is highly upregulated in macrophages during 
infections with various pathogens. In this study we show that the transcription factors 
NFκB and ISGF3 (interferon stimulated gene factor - a complex of STAT1, STAT2, 
and IRF9 which is formed and activated in response to type I IFNs, like IFNβ) 
cooperate in the induction of iNOS and iNOS like genes in macrophages, infected with 
Listeria monocytogenes.  
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We were able to demonstrate that, NFκB preceded ISGF3 at the Nos2 promoter and 
generated a transcriptional memory effect by depositing basal transcription factor TFIIH 
with the associated CDK7 (cyclin dependent kinase) kinase for serine 5 phosphorylation 
of the RNA Pol II - CTD (carboxyterminal domain). Moreover, p-TEFb (positive 
transcription elongation factor), a complex containing the kinase CDK9, which is 
required to release the Pol II enzyme from the NELF (negative elongation factor) 
dependent elongation block, was similarly deposited in an NFκB dependent manner. 
Deposition of CDK7-TFIIH at the proximal Nos2 promoter, was followed by TBP 
(TATA binding protein) and RNA Pol II binding, which were found to be recruited in 
an ISGF3 dependent manner. Hence, the two transcription factors cooperate in our 
infection model by assembling different components of the PIC (pre-initiation complex), 
and the RNA-Pol II enzyme itself, in order to induce iNOS transcription. Taken together 
our results indicate that at least for some SRGs not only the recruitment of RNA Pol II 
is a limiting step to induce gene expression, but also the recruitment of co-factors 
follows strict rules and results from the division of labor between different transcription 
factors. According to our findings this hypothesis is valid for  transcription factors that 
are activated within a single pathway, such as STAT1 and IRF1, but also those activated 
through different signaling pathways, like NFκB and ISGF3. Collectively these proteins 
converge at the promoters of a subset of infection-induced genes to assemble the PIC – 
Pol II complex, and engage the Pol II enzyme in active transcription. 
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Einleitung 
Auf der Basis existierender Publikationen, werden zwei große Gruppen von Genen, 
nach dem Prinzip ihrer Regulation, voneinander unterschieden. Eine spezielle 
Kathegorie von Genen wird im Zuge einer ersten/primären Antwort auf einen Stimulus 
gebildet und kann als PRGs (primary response genes) zusammengefasst werden. Als 
Unterscheidungskriterium von jenen Genen die zur Gruppe der sekundär exprimierten 
Gene (SRGs – secondary response genes) gerechnet werden, wird das Vorhandensein 
der RNA Polymerase II und die Histonmodifikation H3K4me3 am Promoter der 
betreffenden Gene, bereits vor dem Eintreffen des Stimulus, herangezogen. PRGs 
zeichnen sich durch einen sehr hohen Anteil, sowohl von RNA Pol II als auch 
H3K4me3 aus, wohingegen SRGs erst durch einen aktiven Prozeß im Verlauf des 
Stimulierens, das Binden der RNA Pol II am Promoter des zu regulierenden Gens 
gewährleisten müßen, einhergehend mit gesteigerter H3K4me3. Dieser zusätzliche 
Aufwand und das hierfür benötigte Vorhandensein von mehreren aktiven 
Transkriptionsfaktoren, ist in weiterer Folge, für die späte Expression dieser Gruppe 
von Genen, im Vergleich zu der Gruppe der PRGs, verantwortlich. Um die 
Mechanismen der Regulation dieser spät-exprimierten Gene zu analysieren 
konzentrierten wir uns auf jene Gene, die als Antwort auf Interferone exprimiert werden, 
und somit unter der Kontrolle der STAT (Signal transducers and activators of 
transcription) Familie von Transkriptionsfaktoren liegen. Zum Einen behandelten wir 
Zellen in unseren Untersuchungen mit IFNγ (Interferon), zum anderen analysierten wir 
die Effekte einer weiteren Klasse von Interferonen, der Typ I Interferone am Beispiel 
IFNβ, im Zuge der Infektion von Makrophagen mit dem Gram+, fakultativ 
intrazellulärem Bakterium Listeria monocytogenes. Makrophagen produzieren als 
Antwort auf eine Infektion mit Listerien große Mengen IFNβ, welches wiederum, im 
Zusammenwirken mit anderen Signalen, für die Regulation von Genen benötigt wird, 
die an der Abwehr der Infektion beteiligt sind.  
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Als Paradebeispiel für die große Gruppe der IFNγ regulierten Gene betrachteten wir die 
Regulation von Gbp2 (guanylate binding protein). Aufbauend auf bereits bestehende 
Arbeiten im Labor, welche STAT1 und IRF1 (interferon regulatory factor) als die 
wichtigsten Transkriptionsfaktoren identifizierten, und darüber hinaus die Bedeutung 
der Ser 727 Phosphorilierung von STAT1, für die Rekrutierung von HDACs (histone 
deacetylases) und CPB/p300 (CREB – cyclic AMP response element binding protein – 
binding protein) an den Gbp2 promoter beschrieben, entdeckten wir die Abhängigkeit 
der RNA Pol II Rekrutierung von der Anwesenheit von IRF1 am Promoter. Zusätzlich 
zu IRF1 identifizierten wir IRF7 als noch nicht beschriebenen Schlüßelfaktor für die 
Regulation von Gbp2, wie auch andere über einen ISRE (interferon stimulated response 
element) Konsensus regulierte Gene, im Zuge der IFNγ Antwort. Im Gegensatz zu IRF1, 
benötigt IRF7 für seine Aktivierung, auch im Kontext der IFNγ Antwort, die Aktivität 
der S/T Kinase TBK1 (TANK - TRAF family member associated NFκB – nuclear 
factor of kappa light polypeptide gene enhancer in B-cells -  activator - binding kinase). 
IRF7 Phosphorylierung durch TBK1 zeigte sich als notwendig für die Regulation von 
Gbp2 und anderen Genen, deren Abwesenheit führte jedoch nicht zu einem Verlust der 
IRF7 Promoterbindung. SOCS1 Expression zeigte sich im Gegensatz zu GBP2, 
unabhängig von der IRF7 Phosphorylierung durch TBK1. Die verwandte S/T Kinase 
IKKε (IκB – inhibitor of NFκB - kinase) hatte im Gegensatz zu TBK1, einen 
reprimierenden Effekt auf die GBP2 Expression. Zusammengenommen zeigen diese 
Daten, dass phosphoryliertes wie unphosphoryliertes IRF7 an der Genregulation von 
ISRE regulierten Genen, nach Behandlung mit IFNγ, beteiligt ist. 
Eine weitere Gruppe von Genen innerhalb der SRGs benötigt zusätzlich zu den 
Faktoren, welche über Interferone aktiviert werden, noch die Aktivierung von 
Transkriptionsfaktoren über andere Signaltransduktionswege, und deren 
Zusammenspiel um eine effiziente Expression zu erfahren. Ein Beispiel für diese 
speziell regulierten Gene ist das Nos2 Gen, welches für die Bildung der iNOS 
(inducible nitric oxide synthase) verantwortlich ist und nach Infektion durch 
verschiedenste intrazelluläre Pathogene, wie Listerien, gebildet wird. Es benötigt die 
Aktivierung von NFκB im selben Ausmaß wie die IFN abhängige Aktivierung von 
ISGF3 (interferon stimulated gene factor – ein Komplex aus STAT1, STAT2, und IRF9 
welcher im Zuge der Typ I IFN Signaltransduktion aktiviert wird, zum Beispiel IFNβ).  
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Im Zuge der detailierten Analyse des Mechanismus der iNOS Regulation, konnten wir 
zeigen, dass die Bindung von NFκB an den Nos2 Promoter jener von ISGF3 vorangeht. 
NFκB zeichnet dafür verantwortlich, dass der basale Transkriptionsfaktor TFIIH mit der 
assoziierten Kinase CDK7 (cyclin dependent kinase), welcher die RNA Pol II am Ser5 
des CTD (C-terminal domain) phosphoriliert, an den Promoter rekrutiert, und dort 
verankert wird. Dies erzeugt einen transkriptionellen Gedächtniszustand, der bestehen 
bleibt, auch wenn NFκB den Promoter wieder verlassen hat. Neben CDK7-TFIIH 
konnte auch das Rekrutieren von CDK9 p-TEFb (positive transcription elongation 
factor) als NFκB abhängig gezeigt werden. CDK9 aktivität ist notwendig um die NELF 
(negative elongation factor) abhängigen Blockade der Polymerase am Übergang zur 
Elongation aufzuheben. Dem Binden von CDK7 an den Promoter folgt die Bindung von 
TBP (TATA binding protein), und der Polymerase selbst, welche beide auf das 
Interferonsignal und die daraus resultierende Aktivierung von ISGF3 angewiesen sind. 
Die so geschaffene RNA Pol II Bindung kann schließlich die iNOS Transkription 
auslösen. Die beiden Transkriptionsfaktoren kooperieren in der Regulation des Nos2 
Gens durch das kombinierte Rekrutieren von verschiedenen Faktoren des PIC (pre 
initiation complex) und der RNA Pol II selbst.  
Zusammenfassend zeigen unsere Ergebnisse, dass nicht nur das Rekrutieren der 
Polymerase selbst ein limitierender Schritt zur Transkription ist, sondern auch das 
Rekrutieren von Kofaktoren einer strengen Kontrolle unterliegt, und von verschiedenen 
Transkriptionsfaktoren gesteuert wird. Diese Hypothese findet, anhand unserer Daten, 
nicht nur Anwendung bei Genen die im Zuge eines einzigen Stimulus exprimiert 
werden, wie im Fall von IFNγ aktiviertem STAT1 und IRF1, sondern gilt im selben 
Maße auch für Gene deren Expression die Zusammenarbeit mehrerer 
Signaltransduktionswege bedingt, wie am Beispiel der iNOS für NFκB und ISGF3 
gezeigt. Die getesteten Transkriptionsfaktoren vermitteln die Bindung von Faktoren des 
PIC und der Polymerase selbst um diese dann zur Expression zu veranlassen 
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INTRODUCTION 
Transcription and RNA-Pol II function 
Every transcriptional process leading to the expression of protein coding genes needs 
the activity of RNA-Pol II enzyme. In prokaryotes, one DNA dependent RNA 
polymerase is sufficient to transcribe all genes into RNA molecules. The labor of 
transcription in eukaryotes, however, is divided between three distinct multi-subunit 
enzymes. Each one of these three is dedicated to specific gene types: Pol I (polymerase I) 
transcribes exclusively genes encoding 18S and 28S rRNA; Pol III transcribes short 
genes including tRNA and 5S rRNA genes; and Pol II is the one responsible for the 
transcription of protein coding genes and snRNAs (small nucleolar RNAs). How the 
activity of mainly Pol II is regulated and what factors are involved in the different steps 
of transcription will be the focus of the following chapter. 
The Pol II - CTD (carboxy terminal domain) 
Pol II is made up of 12 different subunits named Rbp1-12 that together comprise a ~0,5 
MDa functional machinery. The different subunits are structurally and functionally 
conserved from yeast to humans. It was first noted in 1985 that the largest subunit of 
yeast Pol II, Rbp1, has a very unusual domain at the C-terminus which comprises 
tandem repeats of the heptapeptide sequence Y1S2P3T4S5P6S7, flanked by a linker 
sequence at the more N-terminal end of the CTD and a divergent C-terminal sequence 
(Allison et al., 1985; Chapman et al., 2008). The increased number of repeats 
corresponds to a larger complexity in its regulation and varies from 26 in yeast, 32 in 
nematodes, 45 in Drosophila to 52 in mammals.  
The repeats in yeast Pol II are perfectly conserved throughout the CTD. The heptads of 
mammalian CTDs can be further divided into a domain containing identical heptads 
(proximal domain) and heterogeneous heptads (distal domain), which contain a lysine 
instead of the serine at position 7 of the consensus repeat (Chapman et al., 2008). 
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Possible modifications at the Pol II CTD 
Phosphorylation has been detected on tyrosine, threonine and all three serines of the 
CTD repeat in vivo. Rbp1 exists in two forms that migrate differently in SDS PAGE: in 
the form designated IIa, the CTD is hypophosphorylated, whereas the form designated 
IIo has a hyperphosphorylated CTD. IIa preferentially associates with the PIC 
(preinitiation complex) at the promoter, and any phosphorylation of the CTD at this 
point prevents recruitment and initiation. For that reason early experiments revealed a 
role for glycosylation of the serines, as well as the threonine residues, which prevents 
CTD phosphorylation before onset of transcription. The glycosylation has to be 
removed from the residues in order to become phosphorylated (Kelly et al., 1993). In 
addition, peptidyl-prolyl bonds, which exist in either cis or trans conformation, can be 
converted to all-trans by PPIases (peptidyl-prolyl cis/trans isomerases). The function of 
CTD modifications, especially phosphorylation of the serine residues, is to provide a 
binding platform for factors, engaged in mRNA processing and in mediating or directly 
inducing chromatin modifications. Each serine is phosphorylated in different steps of 
the transcription cycle and can be used as a read-out for transcriptional progress (Figure 
1).  
DNA-Binding, Initiation, Elongation and Termination 
Transcription can be subdivided into 4 steps that are categorized based on the progress 
the RNA-Pol II enzyme has made in transcribing the mRNA (Figure1). Each step can be 
monitored by the presence or absence of signals that are generated during transcription 
on the Pol II CTD itself, at the promoter-chromatin, or on chromatin within the coding 
region of the transcribed gene (see below).  
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Figure 1: Poised, Paused and elongated Polymerases. a) Pol II can be poised for 
activation after recruitment and awaits phosphorylation of its CTD on S5 to initiate 
transcription. b) After CTD Ser5 phosphorylation by the TFIIH kinase CDK7 Pol II 
initiates transcription and pauses after the nascent transcript reaches a length of 30-50bp. 
The SET1 methyltransferase is recruited to the Pol II CTD via interactions with the PAF 
complex in a P-S5 dependent manner. SET1 methyltransferase interacts with capping 
enzymes and tri-methylates histone H3K4. c/d) Upon recruitment of P-TEFb, CDK9 
(CTK1 in yeast) phosphorylates Ser2 of the CTD, which leads to PAF mediated SET2 
binding and release from the NELF dependent elongation block (Hampsey and 
Reinberg, 2003). 
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DNA-Binding and the establishment of Pol II in a poised state 
In prokaryotes, promoter binding of the polymerase is mediated by the binding of σ-
factors to the target promoters. Different σ-factors control the expression of different 
subsets of genes. In eukaryotes the σ-factor has evolved to become a multisubunit 
complex, called PIC (pre-initiation complex), comprised of the so called basal 
transcription factors, which facilitates binding of RNA-Pol II (including all 12 subunits). 
Direct contact to DNA in case of TATA-driven genes is mediated by TBP (TATA-
binding protein), whereas in case of TATA-less genes DNA-binding is mediated via 
TAF (TBP associated factor), TBP like subunits of the basal transcription factor TFIID. 
TFIID binds to the minor groove of the DNA. TAF-proteins share close structural 
homology to histone proteins, that build up the nucleosomes forming a histone octamer 
(see below) (Maldonado and Reinberg, 1995). Nearly all of the TBP population is 
highly mobile in vivo, displaying FRAP-recovery rates of <15s for inducible genes 
(Sprouse et al., 2008). In contrast, turnover rates of TBP at constitutively expressed 
genes range between 10-20 minutes (Tora and Timmers, 2010).   
Two models have been discussed in the last years, for the binding of Pol II to the 
promoter of a protein coding gene. One model suggested Pol II to be recruited as a 
holoenzyme complex together with all the factors of the PIC and its release from the 
PIC after initiation of transcription. The second model describes Pol II binding 
subsequent to an ordered recruitment of the PIC factors starting with the TFIID complex 
as described above, closely followed by, TFIIA, TFIIB and TFIIF enabling Pol II 
binding (Figure1). TFIIE, TFIIH and TFIIJ thereafter join the bound Pol II enzyme and 
provide helicase and kinase activity to generate the transcription initiation bubble and 
initiate transcription (see below). In vitro binding studies to promoter DNA revealed 
that the second model is more likely to reflect the in vivo situation.  
However, in the last years both models have been proven to be partially right, since Pol 
II has been found to be stably associated with both TFIIF and TFIIB before recruitment 
in vivo (Elsby et al., 2006; Liu et al., 2010). Nevertheless, with the notable exception of 
TFIIF and TFIIB, the ordered recruitment of PIC factors is still the general accepted 
model for Pol II recruitment (Roeder, 1996).  
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Following promoter binding Pol II remains bound to the promoter in a poised state and 
awaits initiation to occur. Some genes are generally poised for transcription even in the 
absence of activating stimuli, by a promoter bound but not yet initiated Pol II. Upon 
signaling and subsequent transcription factor binding to the promoter or to enhancer 
sequences, Pol II is permitted to initiate transcription. Gene expression of poised genes 
is faster than expression of genes containing no polymerase at all or are even actively 
repressed by various mechanisms. In this regard, poised polymerases very often mark 
the promoters of PRGs (primary response genes) as described below (Saunders et al., 
2006).  
Initiation of transcription 
As soon as Pol II and TFIIH are bound together to the promoter, Pol II CTD undergoes 
phosphorylation at serine 5 of the conserved heptameric repeats. TFIIH is comprised of 
several core proteins providing ATP’ase and helicase activity, of CDK7 (cyclin 
dependent kinase 7) and its regulatory subunit cyclin H. CDK7 is responsible for Pol II 
S5 phosphorylation, predominantly in the distal domain of Pol II CTD, clearly favoring 
a YSPTSPK motif (Pinhero et al., 2004). Ser5 phosphorylation is greatest near the 5’-
end of genes, where initiation takes place (Sims et al., 2004). Moreover, CDK7 was 
recently found to be able to provide kinase function for the phosphorylation of Ser7 in 
addition to Ser5 (Akhtar et al., 2009; Glover-Cutter et al., 2009).  
Phosphorylation of Ser7 by DNA-PK is known to be important in the integrator 
dependent 3’-end processing of mammalian snRNA genes (Egloff et al., 2007). 
Whether or not CDK7 driven Ser7 phosphorylation plays a different role than Ser5 
phosphorylation still remains enigmatic. CDK7 dependent Ser7 phosphorylation leading 
to integrator binding at the 3’end of genes would rely on CDK7 activity at the 3’end of 
the nascent transcript where integrator complexes should form. Since CDK7 activity is 
restricted to the 5’end of genes a possible explanation of how this might happen is 
provided by Nick Proudfood and colleagues showing that many genes depend on DNA-
bendind of the 3’end towards the promoter for fast expression upon reactivation (Tan-
Wong et al., 2009). Thereby CDK7 would be able to contact Pol II at the 3’end of genes, 
enabling faster integrator formation and mRNA processing. Dephosphorylation of Pol II 
at Ser5, for example, is mediated in mammals by the phosphatase SCP1 which is crucial 
for Pol II recycling (Meinhart et al., 2005).   
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Recent findings by Graziano Lolli revealed the mechanism of Pol II retention in the 
unphosphorylated state and its release after Ser5 phosphorylation. Early studies showed 
that heptad repeats in the CTD can directly contact and intercalate into DNA (Suzuki, 
1990). Lolli now demonstrated that the unphosphorylated Pol II which is linked to DNA 
via CTD-DNA intercalation, is released after Ser5 phosphorylation. Phosphorylation 
introduces negative charges that disturb the CTD interaction with the negatively 
charged DNA backbone. Moreover, he concluded, that DNA-CTD interaction is needed 
to prevent Ser2 phosphorylation, which would permit Pol II to enter the phase of 
productive elongation (see below) (Lolli, 2009). 
An additional function for CTD Ser5 phosphorylation has been described in yeast very 
early on. The modified Ser5 serves to bind, enzymes that add a methylguanosine cap to 
the 5’ end of nascent RNAs, enzymes of the splicing machinery, and the histone 
methyltransferase SET1 containing complex (Orphanides and Reinberg, 2002; Hampsey 
and Reinberg, 2003). To ensure that Pol II only proceeds to productive elongation after 
the successful addition of the 5’cap, nature has installed a checkpoint at the transition 
from initiation to elongation where Pol II pauses after transcription of the first 30-50bp 
(Rasmussen and Lis, 1993). This checkpoint is controlled by the factors NELF 
(negative elongation factor) and DSIF. NELF recruitment depends on the presence of 
CDK7 (Glover-Cutter et al., 2009). 
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Transcriptional elongation 
To proceed to productive elongation Pol II has to be released from the NELF mediated 
elongation block. This is achieved by the katalytic activity of the P-TEFb (positive 
transcription elongation factor b) subunit CDK9. Ser2 of the Pol II CTD as well as 
NELF and DSIF themselves are substrates for CDK9. Negative effects of NELF and 
DSIF on transcription are relieved by P-TEFb-mediated phosphorylation of NELF. 
However NELF can also support transcription when it is associated with GAGA factor 
(a trx – trithorax - family member)(Lee et al., 2008). 
Phosphorylation of Ser2 increases towards the 3’-end of genes. Interestingly, expression 
of genes containing no intronic sequences, like genes encoding histone proteins or 
mammalian snRNA genes, does not rely on Ser2 phosphorylation, indicating that this 
mark is involved in targeting the spliceosome to the nascent mRNA transcript (Medlin 
et al., 2005). Indeed it was shown in vitro and in vivo that recruitment of splicing 
factors depends on the presence of S2– phosphorylation (Hirose et al., 1999; Misteli and 
Spector, 1999). CDK9 predominantly phosphorylates the proximal domain of 
mammalian Pol II CTD. Recent observations show that phosphorylation of Ser2 by 
CDK9 was greatest after initial phosphorylation of Ser5 in the distal CTD-domain by 
CDK7, thereby reflecting the basic principal of sequential transcriptional activation 
(Pinhero et al., 2004). 
Pol II can be transcriptionally arrested right after recruitment or at the transition from 
initiation to elongation, by the lack of CDK7 or CDK9 activity, respectively (Margaritis 
and Holstege, 2008). A third form of arrested polymerase can occur within the coding 
region of the gene leading to polymerase stalling. Sequences next to alternative splice 
sites have been proven to slow down the elongation rate and processivity of Pol II, 
which leads to possible stalling of the polymerase. This in turn ensures the formation of 
alternative exons (Kornblihtt et al., 2004).  
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Thus Pol II stalling can occur at regions where stalling is required for subsequent RNA 
processing events, or it takes place accidently. To ensure that a defective polymerase 
does not block the transcription of a gene, defective Pol II is ubiqutinated and 
proteasomally degraded (Leung et al., 2008; Daulny et al., 2008). Nature has installed a 
unique mechanism to distinguish a defective Pol II from a stalled Pol II enzyme. A 
classically stalled Pol II that awaits the recruitment of factors required for alternative 
splicing, is unable to be reengaged in the transcriptional process unless the transcription 
factor TFIIS is recruited (Reines et al., 1989). Very recent findings of Adelman and 
colleagues indicate that Pol II backtracks on the nascent transcript and generates an 3’ 
overhang of 8-12 bp in length, which needs to be cleaved by TFIIS in order to reengage 
the Pol II enzyme in transcription (Adelman et al., 2005). 
Pol II CTD and transcriptional termination 
Pol II CTD has lost most of the Ser5 phosphorylation by the time it reaches the 
polyadenylation signal. Ser2 and Ser7 (in case of snRNA genes) phosphorylation 
increases towards the 3’-end of the mRNA (Hirose and Ohkuma, 2007). Egloff and 
colleagues demonstrated in case of snRNA genes, that both residues need to be 
phosphorylated to enable binding of integrator complexes (Egloff et al., 2010). Whether 
both marks are required for the binding of CPSF (cleavage and polyadenylation 
specificity factor) to the mRNA of protein coding genes remains to be determined. 
However the role of CTD modifications in transcriptional termination is not yet fully 
understood. 
Where the CTD code meets the histone code 
Like the CTD code, the histone code comprises reversible modifications of the histone 
tails, that form binding platforms for factors associated with both active and repressed 
transcription. Phosphorylation, acetylation, ubiquitination and methylation of histone 
tails play fundamental roles in orchestrating transcription (see below). Interestingly, the 
chromatin state of the transcribed DNA template is closely related to the 
phosphorylation state of RNA Pol II CTD (Hampsey and Reinberg, 2003; Berger, 2007).  
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Figure 2: Role of Histone Lysine Methylation by HKMTs (histone lysine 
methyltransferase) in Tanscription Elongation. 
The yeast SET1/Compass methyltransferase complex is recruited to the Pol II CTD in a 
P-Ser5 dependent manner. SET1 introduces the H3K4me3 mark, which peaks in line 
with the P-Ser5 pattern, at the 5’-end of genes (Figure2). SET1 contacts the CTD via 
interaction with the PAF1 complex. SET2 on the other hand is responsible for 
H3K36me3 which peaks at the 3’-end of transcribed genes and directly binds the Ser2 
and Ser5 phosphorylated CTD (Kizer et al., 2005).  
In addition, two histone acetyltransferases, p300 and PCAF, have been found to 
associate with the IIa form and the IIo form of the polymerase, respectively. p300 is 
thereby recruited directly to the TSS to maintain the chromatin/DNA template in a loose 
and accessible state, and PCAF is travelling along with the elongation competent 
polymerase to facilitate effective transcription (Cho et al., 1998). 
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Chromatin and Transcription 
Chromatin is the physiological template of all eukaryotic genetic information, and 
undergoes a series of PTMs (posttranslational modifications) that largely impinge on 
histone amino termini to regulate access to the underlying DNA template. Recently an 
ancient role for a chromatin-like structure was identified in Mycobacteria (Colangeli et 
al., 2009). However, chromatin is still a feature of eukaryotic cells. Chromatin 
modifications have emerged to become highly dynamic binding platforms for an 
increasing number of chromatin associated factors. These factors themselves are 
“writers” and/or “readers” of chromatin modifications, in other words they can de novo 
introduce modifications and/or are capable of binding chromatin modifications to 
regulate the onset or repression of transcription. All steps of transcription including the 
binding of transcription factors, are subject to the chromatin-state at the promoter or 
within the coding region of genes. Large and defined regions of chromatin have been 
found initially in liverwort mosses to be either highly condensed and transcriptionally 
silent, termed heterochromatic regions, or have an open chromatin structure and are 
transcriptionally active, termed euchromatic regions. The initial hypothesis, called the 
“Histone code hypothesis”, of Strahl and Allis implies that not a single chromatin mark 
facilitates activation or repression, but a combination of marks is needed to regulate 
gene-expression, and one established mark can stimulate the introduction of other marks 
(Strahl and Allis, 2000). 
The identification and exploration of chromatin modifications accelerated the research 
field of epigenetics. The findings that these marks can be transmitted to daughter cells 
upon cell divison, leading both to the formation of transcriptional active or repressive 
chromatin and also to the maintenance of the chromatin-state through cell-generations, 
provided new insight into the maintenance of cell identity. In line with this, chromatin 
marks, and factors responsible for introducing these marks, have been identified to be 
responsible for cell differentiation and lineage commitment by the regulation of cell 
type specific gene expression. The following chapter will not deal with the epigenetic 
consequences of chromatin modifications in the context of ES-cell differentiation or 
lineage specific gene expression, but will focus on the direct influence of mainly 
activating chromatin marks on the regulation of the different steps of transcription. 
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The Nucleosome 
In eukaryotic cells, genes are complexed with core histones and other chromosomal 
proteins in the form of chromatin. The basic repeating unit of chromatin, the 
nucleosome, includes two copies of each of the four core histones H2A, H2B, H3 and 
H4 wrapped by 146 bp of DNA. The connection from one nucleosome to the other by 
the DNA template is called “spacer” and generates a ~20bp long part of DNA that is 
accessible to DNA binding factors. With the aid of additional proteins including histone 
H1 the nucleosomes are further packaged into 30nm fibers with six nucleosomes in a 
spiral or solenoid arrangement (Zhang and Reinberg, 2001). To become 
transcriptionally active the 30nm fiber has to unfold into a 11nm structure also called 
“beads-on-a-string”. Still the 11nm structure is not permissive for transcription. 
Remodelling of nucleosomes has to take place to enable access to DNA.  
Chromatin remodeling and histone variant exchange 
Pol II activity on target genes frequently requires the ATP-dependent multi-subunit 
chromatin remodeling complex Swi/Snf or histone acetyltransferases such as SAGA 
(Spt-Ada-Gcn5-acetyltransferase). It was long questioned whether the binding of 
transcription factors to the promoter DNA leads to promoter proximal chromatin 
remodelling, or whether the action of chromatin remodelling complexes is required to 
facilitate binding of transcription factors to DNA. Evidence for the latter hypothesis was 
provided in 1999 by Kim Nasmyth and colleagues who demonstrated that the action of 
chromatin remodelling complexes is needed for sequential binding of transcription 
factors in yeast (Cosma et al., 1999).  
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With some exceptions this dogma has been strenghened by numerous studies during 
recent years (Drobic et al., 2010). Relevant for this thesis, recent work of Rod Bremners 
group also supports this model for STAT (signal tranducers and activators of 
transcription) transcription factors by showing that STAT1 dependent activation of the 
CIITA promoter requires the activity of BRG1 (Brahma-related gene 1), the ATP’ase 
subunit of Swi/Snf (or BAF complex in humans)(Ni et al., 2008). Moreover they could 
show that chromatin remodeling at the CIITA promoter is not restricted to defined 
regions at the proximal promoter but can spread over 100kb (Ni et al., 2005). These 
events in turn link BRG1 to the phenomenon of DNA bending, since long range 
interactions are very often required for transcription factors to get in contact with the 
Polymerase to affect transcription. At the CIITA promoter DNA bending is required for 
factors bound to different distal enhancers to communicate with the promoter bound 
RNA Pol II (Ni et al., 2008).  
ATP dependent chromatin remodeling can result in the deposition of nucleosomes on 
the DNA to make DNA-binding elements accessible, or it leads to the eviction of some 
or all components of the histone octamer. H3 and H4 are mainly depleted from 
nucleosomes during remodeling. Since the interaction of the two H3 molecules is 
critical for nucleosomal stability this disturbs the nucleosomal structure, whereas H2A 
and H2B can remain bound to the DNA (Talbert and Henikoff, 2010). In yeast, NDR 
(nucleosome depleted region) formation for most promoters is dependent on the RSC 
remodelling complex, which displaces nucleosomes from the NDR (Hartley and 
Madhani, 2009).  
Interestingly eviction is limited to the nucleosomes upstream of the TSS. The first 
nucleosome downstream of the TSS, the +1 nucleosome, has proven to be crucial in the 
process of transcriptional initiation. It is found to be the most highly positioned 
nucleosome and very often contains a histone variant of H2A, H2A.Z. A role for the 
displacement of H2A to H2A.Z in Pol II pausing, has been shown recently in 
Drosophila (Mavrich et al., 2008). In human cells positioning of H2A.Z by the ATP 
dependent factor Swr1, in upstream promoter elements contributes to both activation 
and repression (Gévry et al., 2007; Gévry et al., 2009). 
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FACT (facilitates chromatin transcription) mediated exchange of H2A-H2B dimers by 
the H2A.Z-H2B dimer-variant during transcriptional elongation can reveal cryptic 
promoters within the coding region of the transcribed gene (Talbert and Henikoff, 2010). 
FACT recruitment and activity depend on H3K4 mono-methylation and is ATP 
independent in in-vitro experiments, but it associates with CHD1 in vivo, a protein that 
hydrolizes ATP and binds H3K4me to remodel nucleosomes (Reinberg and Sims, 2006). 
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Figure 3: Models for the Involvement of Chromatin Remodeling and Histone Exchange 
in Transcriptional Processes 
Moreover, canonical histones can be exchanged by histone variants during certain 
processes in the cell that require the subsequent recruitment of specialized factors. One 
well studied example is the exchange of histone H3 by the variant H3.3 during DNA-
DSB (double strand break) – repair. The hallmark of variant histones is that they contain 
additional and modified residues on their amino-terminal tail, prior to incorporation, 
that provide binding platforms for proteins involved for example in DNA-DSB repair, 
as shown in case of H3.3 (Talbert and Henikoff, 2010). 
In addition to repositioning and eviction of nucleosomes from chromatin, covalent 
modifications of aminoacid-residues in the histone amino-termini are crucial for 
chromatin reorganisation and transcription. Known HPTMs (histone post transcriptional 
modification) are: acetylation, ubiquitination, methylation and phosphorylation. 
Histone acetylation 
The first HAT (histone acetyl transferase) that has been identified as an homolog of the 
yeast transcriptional co-activator GCN5, immediately linked histone acetylation to gene 
activation (Brownell et al., 1996). Several transcriptional co-activators contain intrinsic 
HAT activity: GCN5, p300/CBP, PCAF, TAF250 (TFIID subunit) and the p160 family 
of nuclear receptor coactivators. On the other hand transcriptional repressors like SIN3 
or NcoR/SMRT are associated with HDACs leading to the removal of the mark. 
Introduction 
  Page 22
 
Figure 4: Characterized Sites of Histone Acetylation 
The mechanisms linking histone acetylation to transcriptional activation are divergent. 
Acetylation takes place on lysine residues predominantly described at the N-terminal 
tails of H3 and H4 and leads in the first place to changes in structure and charge. In the 
case of acetylation, the neutralization of positively charged lysines reduces the strength 
of binding of the strongly basic histones or histone tails to negatively charged DNA, 
thus opens DNA binding sites (Vettese-Dadey et al., 1996). This is also relevant to open 
up higher chromatin order structures, like the 30nm fiber.  
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Several HPTMs in combination can form binding surfaces for DNA/Chromatin binding 
factors that associate with chromatin compaction or are engaged in the transcriptional 
process. This mode of action for HPTMs was first shown for acetylation. Proteins that 
contain a bromodomain can bind to acetylated lysines (Dhalluin et al., 1999). Examples 
for proteins containing a bromodomain are GCN5 and CBP/p300, which are themselves 
HATs (“writer” and “reader” in one molecule) and can therefore initiate the spreading 
of an existing acetylation mark (Figure 3). Further examples are TAF1, BDF1 of the 
TFIID complex, RSC4 in the RSC remodeling complex, and BRD2, member of a large 
family of bromodomain proteins. Whereas chromatin remodeling can affect large 
regions as in the case of the CIITA enhancers, hyperacetylation of histones frequently 
occurs on very defined regions in proximity to the binding sites of the transcription 
factors responsible for HAT recruitment (Parekh and Maniatis, 1999).  
Histone phosphorylation and phospho-acetylation 
Phosphorylation of histones was discovered very early on. PRGs, in former times also 
called “immediate-early genes”, showed increased expression in correlation with the 
phosphorylation of H3 (Mahadevan et al., 1991). H3S10 has been identified as a very 
important residue in all eukaryotic species, and is closely associated with active 
transcription. Moreover, H3S28 and H3T11 have been identified to become 
phosphorylated (Figure 4). Many kinases have been described that target these sites: 
SNF1 in S. cerevisiae, MSK1/2 and the related RSK2, and IKKα (IkB - Inhibitor of 
NFkB – Nuclear factor of kappa light polypeptide gene enhancer in B Cells - kinase) in 
mammals (Sassone-Corsi et al., 1999; Lo et al., 2001; Soloaga et al., 2003; Yamamoto 
et al., 2003; Anest et al., 2003). Phosphorylation, like acetylation, causes a change in the 
charge of the phosphorylated residues, resulting in lose affinity of the histone tails to the 
underlying DNA.  
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In vitro experiments for several acetylating enzymes show a strong binding preference 
for histone H3 phosphorylated at Ser10. Indeed, recent studies identified a 
phosphorylation- acetylation link, where both marks cooperate in the recruitment of 
proteins of the 14-3-3 family, ζ and ε. The binding preference for H3S10 
phosphorylation of 14-3-3 proteins was greatest with the nearby presence of H3K9ac. In 
case of H3S28p the nearby H3K27ac mark was not required, although it shares the 
sequence motif with H3S10 (Macdonald et al., 2005; Winter et al., 2008). Recent work 
of Kristian Helin and colleagues shows that MSK mediated H3S28p induces the 
displacement of PcG (Polycomb group) proteins from the neighbouring H3K27me3 
mark, thereby inducing gene expression (Gehani et al., 2010).  
 
Figure 5: Examples for recently identified histone modification crosstalk. (A) Histone 
H3S10 phosphorylation leads to the binding of 14-3-3 protein family members which in 
turn serve to recruit BRD1 or MOF. MOF mediates the subsequent binding of Brd4 by 
acetylation of H4K16. Brd4 was found to be able to recruit P-TEFb to induce gene 
expression of PRGs. (B) The simultaneous presence of H3K4me3 and H4K16ac, when 
the latter is induced by the repression of HDAC activity, is not always associated with 
transcriptional activation, pointing towards a more complex role of modification 
crosstalk (Lee et al., 2010).  
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Recent findings point out at a series of functions for P-Ac (phosphoacetylation), serving 
as a binding platform for 14-3-3 proteins. Studying PRG promoters, James Davie and 
colleagues revealed the dependency of BRG1 recruitment to 14-3-3 proteins on MSK1 
mediated P-Ac (Figure 5A). Transcription factors Elk-1 or NF-κB serve to recruit 
BRG1 via this mechanism, in turn enabling subsequent chromatin remodelling and 
binding of transcription factors like c-Jun that initiate transcription (Drobic et al., 2010). 
Findings of Oliviero and colleagues add another level of complexity to the issue of 
histone cross-talk, in favor of the histone code hypothesis. Based on the observation that 
H3S10ph enhances the recruitment of GCN5, which in turn acetylates H3K14 (Figure 
7A) (Cheung et al., 2000; Agalioti et al., 2002), this study demonstrated that H3S10 
phosphorylation by the kinase PIM1 on a serum responsive gene, recruits 14-3-3 
proteins, thereby providing a binding platform for the HAT MOF. MOF induces 
acetylation of H4K16 which forms a recognition site for the bromodomain containing 
BRD4 protein. BRD4 subsequently recruits P-TEFb leading to the release of the 
promoter proximal paused Pol II (Figure 5A) (Zippo et al., 2009). 
Histone ubiquitination 
Ubiquitination can occur on Histone H2A and H2B and increase the size of the histone 
by approximately two-thirds. In contrast to K48-linked ubiquitylation, which leads to 
degradation of the protein via the 26S proteasomal pathway, histones undergo K63-
linked ubiquitylation. This adds just one ubiquitin molecule to a lysine residue of the 
histone tail of H2A and H2B at residues K119 and K120, respectively. In yeast residue 
K123 in H2B is homologous to vertebrate H2BK120. In contrast to other histone 
modifications, which are localized in unstructured C-termini of the respective histones, 
these residues are located in the highly structured C-terminus of H2A and H2B, thereby 
enabling limited access of binding factors (Weake and Workman, 2008).  
H2Aub is associated with transcriptional repression via Polycomb group 
BMI1/RING1A proteins. However there is no evidence for evolutionary conservation of 
H2Aub in yeast (Wang et al., 2004).  
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Figure 6: Sites of Histone Ubiquitylation and Their Consequence for Transcriptional 
Regulation 
H2Bub has been extensively studied in the last years and was found to provide a direct 
link between histone modifications and the transcriptional activity of RNA-Pol II. In 
yeast the ubiquitin E2 ligase RAD6 was shown to be recruited in an activator and BRE-
1 dependent manner. BRE-1 acts as the ubiquitin conjugating E3 ligase. Consistently, 
H2Bub colocalizes with RNA-Pol II in dependence on BRE-1 and the PAF complex. 
Importantly, requirements of the PAF complex and the Pol II C-terminal domain (CTD) 
serine 5 kinase Kin28/CDK7 for H2B ubiquitylation, have implicated H2B 
ubiquitylation in transcription elongation (Ng et al., 2003a; Wood et al., 2003; Xiao et 
al., 2005). Moreover, H2Bub has been identified in yeast as the critical determinant for 
H3K4 and H3K79 trimethylation (see below) by COMPASS and Dot1 
methyltransferases (Figure 7B) (Nakanishi et al., 2009).  
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Figure 7: Examples of histone crosstalk. Phosphoacetylation mediated by GCN5 
binding to H3S10-Ph (A). H2Bub mediates H3K4me3 by the recruitment of 
SET1/COMPASS (B) (Lee et al., 2010). 
A histone H3 trimethylation independent function of H2Bub has been reported recently 
by showing that it directly facilitates FACT dependent chromatin transcription in vitro. 
Furthermore, FACT activity and H2Bub are connected during transcription elongation 
in vivo, and the modification has a selective role in regulating FACT mediated 
chromatin reassembly following RNA-Pol II transcription (Fleming et al., 2008). These 
findings are supported in the recent publication of Roeder and colleagues reporting the 
afore mentioned RAD6/BRE-1/PAF connection and the role of H2Bub in FACT-
mediated chromatin reassambly in the wake of elongating Pol II in human cells (Kim et 
al., 2009). A contrasting result was published showing in budding yeast that H2B 
deubiquitination by Ubp8 is crucial to allow Ctk1/CDK9 to phosphorylate Pol II at Ser2 
(Wyce et al., 2007). These conflicting data may result from the use of different genetic 
model systems.  
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Histone methylation 
Methylation of histones is the most intensively studied HPTM. It occurs on either 
lysines or arginines and is therefore mediated by two distinct classes of enzymes. 
Lysines can become mono-, di-, or tri-methylated. The number of identified HKMTs 
(histone lysine methyltransferases) has increased and they have all been linked to the 
methylation of several known lysine residues (Martin and Zhang, 2005). Six of these 
residues have been well characterized to date: five on H3 (K4, K9, K27, K36, K79) and 
one on H4 (K20). Methylation at H3K4, H3K36, and H3K79 has in general been linked 
to transcriptional activation, and the rest to transcriptional repression (Figure 8). H3K79 
and H4K20 methylation have been found to play a key role in DNA repair processes 
(Martin and Zhang, 2005). In contrast to acetylation or phosphorylation, methylation 
does not significantly change the charge of the N-terminal histone tail. Therefore the 
main regulatory function of methylation is to directly recruit effector proteins, or 
adaptors, that regulate transcription or other cellular processes. Proteins that contact 
methylated lysines have to contain either a tudor, chromo or PHD repeat domain.  
 
Figure 8: Sites of Histone Lysine Methylation, Their Protein Binders, and Functional 
Role 
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H3K4 methylation has been extensively studied, since it has been found to closely 
correlate with active transcription (see above). H3K4me3 appears at transcriptionally 
active genes as defined islands located at the 5’end of genes. The first H3K4 methylase 
complex to be identified, COMPASS, was purified from yeast and contains SET1 and 
seven other polypeptides (Miller et al., 2001). SET1 belongs to the trithorax group of 
transcriptional regulators and comprises a SET-domain, which is responsible for 
catalyzing mono-, di-, and trimethylation of H3K4. SET1/COMPASS in yeast has six 
mammalian homologs, MLL1 to MLL4 (mixed-lineage leukemia gene), SET1a and 
SET1b. The last two are responsible for methylating the bulk of H3K4 methylation 
marks in mammals (Wu et al., 2008). The MLL family of SET containing methylases is 
responsible for methylating only a small proportion of H3K4 residues. MLL1/MLL2 
activity has recently been found to act together and rely on the binding partner Menin, 
that mediates MLL1/MLL2 by binding both of the molecules (Caslini et al., 2007). 
MLL1/MLL2 regulated H3K4 methylation was found to be present in only 3% of genes 
in MEFs within a gene transcriptional profiling array. Most of these genes lack the 
TATA-Box and are responsible for developmental regulation and differentiation, like 
part of the genes encoded within the hox-gene cluster (Wang et al., 2009).  
The primary function of H3K4me3 is thought to be exerted after Pol II recruitment and 
depends on Ser5 phosphorylation of Pol II CTD (Ng et al., 2003b). SET1/COMPASS in 
yeast and also the SET1 homolog in mammals were found to be recruited to genes by 
the ubiquitination of histone H2B, requiring prior recruitment of Pol II and the PAF1 
complex (Krogan et al., 2003; Shilatifard, 2006; Kim et al., 2009). However, recent 
findings also indicate a role for H3K4me3 prior to Pol II recruitment at least for the 
MLL family of SET domain-containing proteins in mammals (Wang et al., 2009). This 
result is strengthened by the findings that H3K4me3 can serve to recruit CHD1 protein 
and the NURF complex, known to mobilize nucleosomes at active genes in Drosophila. 
The domains that mediate association with H3K4 are a tandem set of chromodomains in 
CHD1 and a PHD finger within NURF (Sims et al., 2005; Li et al., 2006). In addition, 
the PIC subunit TFIID was recently found to directly recognize the H3K4me3 mark via 
the PHD finger of TAF3. In the same study binding of the TAF3 - PHD finger was 
shown to be further enhanced by the additional presence of acetylation at H3K9 and 
H3K14, providing a link between methylation and (phospho-) acetylation in the 
activation of transcription (Vermeulen et al., 2007). 
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However, introduction of H3K4me3 is closely followed by the di-methylation of H3K4 
on the neighbouring nucleosome close to the transcription initiation site, by SET1 or its 
mammalian homologs. Stephen Buratowski recently showed that H3K4me2 is bound by 
the PHD finger of SET3C in yeast. SET3 contains a SET domain, but no 
methyltransferase activity has yet been reported. SET3C interacts physically with two 
HDACs, HOS2, and HST1, leading to the subsequent deacetylation of nucleosomes 
downstream of the promoter. This may in turn be necessary to prevent transcription 
initiation from cryptic promoters next to the TSS. Supportive evidence was provided by 
the finding that yeast mutants for the SET1 – SET3 complex pathway affect Pol II 
association with a target gene (Kim and Buratowski, 2009). 
H3K4 mono-methylation by i.e. human SET9 is highly dispersed throughout genes. It 
appears to be predominantly localized at enhancer regions (Ghisletti et al., 2010). For as 
yet unknown reasons some enhancers contain both H3K4me and H3K4me3 marks at 
the same time (Robertson et al., 2008; Wilson et al., 2009).  
In the elongation phase of transcription, phosphorylation of CTD serine 2 by CDK9, 
together with the phosphorylated Ser 5, creates a binding site for SET2, resulting in 
H3K36me2 and H3K36me3. Both marks can be detected throughout transcribed regions 
but clearly peak towards the 3’end of genes. SET2 has been shown to interact directly 
with the PAF complex and CHD1 that can in turn bind to H3K36me2. CHD1 plays a 
role in transcriptional termination. Like in the case of H3K4me2, H3K36me2 recruits 
the Rpd3S HDAC complex which removes the acetylation of histones in the wake of 
Pol II transcription in order to block transcription initiation from cryptic promoters 
(Carrozza et al., 2005). 
Methylation at H3K79 is very unusual because it is located within the core of the 
histone rather than in the tail, like all the other known modifications. The only 
methylase capable of introducing this mark known so far, is the human hDOT1L which 
has been linked to leukemogenesis. Since there is no protein to date that binds this mark, 
the link to transcriptional regulation is still enigmatic. The only described function links 
it to DNA repair processes (Martin and Zhang, 2005). 
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H3K9, H3K27, and H4K20 methylation, are linked to transcriptional repression. For 
example, H3K9me3 is a target for the protein HP1, which induces and maintains the 
formation of pericentric heterochromatin thereby participating in gene silencing. 
H3K9me2 and phosphorylation on the nearby H3S10 counteract each other and result in 
the demethylation of H3K9 once H3S10 is phosphorylated. The methyltransferase 
SUV39H1 was first described to be able to methylate H3K9. H3K27-methylation has 
largely the same function. It binds Polycomb proteins and is predominantly located near 
PREs (Polycomb responsive elements). H4K20 methylation appears to be dependent on 
H3K9 methylation. The exact function is still unclear, but it was linked to DNA – repair 
processes via the binding of DNA damage check point protein CrB2 in budding yeast 
(Martin and Zhang, 2005). 
Arginine methylation has been implicated in both active and repressive chromatin. 
PRMT1 (protein arginine methyltransferase) and PRMT4/CARM1 have both been 
linked to transcriptional activation. PRMT1 targets the residue H4R3, whereas PRMT4 
is known to target the methylation of residues on histone H3, H3R2, H3R17, and 
H3R26. Both were shown to be specifically recruited by transcription factors like p53 
and NFκB, and closely correlate with the appearance of RNA-Pol II at target genes. 
Moreover, arginine methylation is linked to histone acetylation by CBP (Strahl et al., 
2001; Bauer et al., 2002; Daujat et al., 2002; Cuthbert et al., 2004). PRMT1 was found 
to participate in negative regulation of type I IFN signaling, thereby linking known 
histone modifyers to modification events in the cytoplasm (Weber et al., 2009). 
Class I, II and III transcription factors 
The rate at which mammalian protein-encoding genes are transcribed depends on the 
frequency at which RNA polymerase II is recruited into an initiation complex and 
subsequently rendered competent for transcriptional elongation. These processes require 
the binding of transcription factors and are intimately linked with the structure and 
modification of the surrounding chromatin.  
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DNA binding transcription factors like STATs (signaltransducers and activators of 
transcription) can recruit a variety of proteins that enable gene expression, including Pol 
II (RNA polymerase II) and chromatin modifiers (Kadonaga, 2004). Recruitment of 
CRCs (chromatin-remodeling complexes) results in the remodeling of the 
nucleosome:DNA template in order to reveal critical regulatory regions, including 
transcription factor-binding sites or the TSS (transcription start site) (Chi, 2004). 
Transcription factors in general can be divided into three different categories on the 
basis of their mode of activation and function (Figure 9). 
 
Figure 9: Model of Class I, II and III transcription factor relationship. Class I 
transcription factors are constitutively expressed and, when activated, regulate the 
expression of PRGs (primary response genes) within 2hrs after treatment, STATs, 
NFκB or IRF3 belong to this group. Class II transcription factors like IRF1 or IRF7, are 
synthesized de novo, within two to eight hours after treatment, and therefore PRGs. 
They control the expression of SRGs (secondary response genes), either on their own or 
in conjunction with Class I transcription factors. Class III transcription factors are 
defined as lineage specific factors expressed upon differentiation. In the case of 
macrophages PU.1, C/EBPβ, or IRF8 belong to this group.  
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Class I transcription factors 
The first category consists of transcription factors that are constitutively expressed. This 
kind of transcription factors are mostly retained in the cytoplasm in an inactive state and 
translocate to the nucleus subsequent to their signal-dependent activation. Activation is 
achieved by either modifying enzymes (e.g. by phosphorylation, K63-linked 
ubiquitination, methylation, acetylation, …) as in the case of STATs, or by 
sequestration/ degradation of an inhibitory molecule. The best studied example of this 
latter possibility is the canonical pathway of NFκB activation (nuclear factor for kappa 
light chain enhancement in B-cells) causing the degradation of IκBα (inhibitor of NFκB 
alpha). This class of transcription factors is the best characterized of the three in the 
literature and contains a significant amount of the key players relevant for inducing an 
immune-response. Relevant for immne responses this group contains some but not all 
IRF family members, like IRF3 and IRF9, in addition to STATs and NFκB. A hallmark 
of this class of transcription factors is their ability to be rapidly (within minutes) 
activated upon stimulation and to be therefore responsible for regulating the 
transcriptional induction of PRGs.  
PRGs (primary response genes) 
The classical PRG is actively transcribed within a time frame of 2 hours after 
stimulation and contains conserved binding sites for class I transcription factors. 
Medzhitov and colleagues recently sub-divided this group of genes according to their 
GC-content in the promoter proximal region into PRG-I and PRG-II genes, with high or 
low GC-content, respectively. PRG-I genes can, based on their findings, be 
distinguished from PRG-II genes by the initial presence of activating chromatin marks, 
like H3K4me3 and H3K9Ac, and the presence of a paused polymerase at their 
promoters. Recruitment of the paused polymerase at these promoters is dependent on 
the constitutive factor SP1 that has the ability to bind GC-rich sequences. Some PRGs 
(i.e. Nfkbia, Irf1) are basally expressed but further induced upon treatment (Hargreaves 
et al., 2009). PRG-II genes lack these activating marks and are very often occupied by a 
polymease in a poised state. PRG-II genes are therefore only expressed after the 
recruitment of histone and polymerase modifying co-factors (see below), subsequent to 
class-I transcription factor binding. Additionally the promoters of PRGs are in most 
cases depleted of histones at the transcription factor binding sites and the TSS, thereby 
enabeling the fast access to DNA by DNA binding factors. 
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Pol II can be preloaded on the promoters of many genes that are not actively transcribed 
(Guenther et al., 2007; Muse et al., 2007; Zeitlinger et al., 2007). This was further 
demonstrated in regard to immediate mediators of the inflammatory response, i.e. TNFα 
gene expression (Adelman et al., 2009). Medzhitov and colleagues recently added 
another line of understanding to the observed phenomenon of NELF dependent 
polymerase stalling (see below), demonstrating that PRGs are very often occupied by 
paused polymerases waiting for the release of the elongation block. Moreover they 
could show that several PRGs do produce full-length but unmature and therefore 
unstable, transcripts even in the absence of an activating signal, due to the lack of Ser2 
phosphorylation (Hargreaves et al., 2009). 
As a consequence of their capability to induce rapid target gene expression, negative 
regulation of class I transcription factors is an important step to terminate expression of 
PRGs. Interestingly, most class I transcription factors downregulate their own activity 
by creating a negative “feedback loop” on the basis of their own PRGs. For example, 
STAT activity is antagonized by the expression of SOCS (suppressor of cytokine 
signaling) proteins, which are under the control of STAT itself (Alexander and Hilton, 
2004). NFκB activity is antagonized by the NFκB driven expression of IκBα, which 
binds and exports NFκB from the nucleus and or facilitates its removal from the 
promoters of target genes (Hayden and Ghosh, 2008). STAT activation can, for example, 
occur downstream of IFN (interferon) signaling which leads to the binding of STAT1 
homodimers or ISGF3 (interferon stimulated gene factor 3), a heterotrimeric factor 
comprised of STAT1, STAT2, and IRF9, to GAS (γ-IFN activated sequence) or ISRE 
(IFN stimulated response element), respectively (see below for detailed description). In 
particular STATs, IRFs and NFκB are relevant factors in the context of the work below.  
Additional examples for PRGs relevant in the context of inflammation and anti-viral 
responses are: Mx1/2 and Irf7 genes, as examples for ISRE only driven genes 
downstream of IFN-I signaling (signaling initiated by binding of IFNα species or IFNβ 
to the IFNAR – IFNα receptor); or Irf1 which is like SOCS genes, a GAS driven gene. 
The Hif1α (hypoxia induced factor) gene, which is an NFκB responsive gene and was 
shown to be expressed after TLR4 (Toll like receptor) stimulation (Ramanathan et al., 
2009).  
Introduction 
  Page 35
Class II transcription factors 
Transcription factors of this category are synthesized de novo after a given stimulus and 
depend on the function of class I transcription factors. Therefore they all belong to the 
group of PRGs described above. These factors control the expression of SRGs 
(secondary response genes) subsequent to PRG expression over a prolonged period of 
time. Some class II transcription factors act, once expressed, on their own accord to 
drive target gene expression and some act in concert with Class-I transcription factors 
leading to transcriptional autoregulation and amplification of the response (Medzhitov 
and Horng, 2009). Examples of class II transcription factors in the context of an 
interferon mediated response after infection are: IRF1 which is expressed after 
activation of STAT1 homodimers in response to IFNγ and to a minor extent in response 
to IFN-I; IRF7, the master regulator of IFN-I responses, has proven to be crucial for the 
expression of all IFN-I genes, leading to the amplification of IFN-I signaling during 
sustained infections (Honda et al., 2005). Moreover HIF1α was shown to assist NFκB 
to drive the expression of a subset of NFκB target genes (Ramanathan et al., 2009). 
SRGs (secondary response genes)   
This sub-group of genes is expressed within 2-8 hours after treatment, according to the 
categorization of Medzhitov and colleagues. Most genes that participate in the 
generation of an antiviral-state belong to the group of SRGs. Prime examples for well 
known SRGs in the context of immunity against pathogens are: Gbp1/2, Nos2 and Ifnβ.  
Gbp1/2 (IFNγ inducible members of the p65 GTPase gene family with putative roles in 
the resistance to intracellular pathogens) are genes controlled via both GAS and ISREs. 
In the context of an IFNγ response  STAT1 homodimers, as class I transcription factor, 
and IRF1, as class II transcription factor interact to induce their expression (Lew et al., 
1991; Briken et al., 1995).  
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Nos2 encodes the protein iNOS (inducible nitric oxide synthase), an enzyme responsible 
for the production of NO (nitric oxide) radicals and their derivatives that directly lead to 
killing or reduced replication of infectious agents by mutation of DNA and inhibition of 
DNA repair and protein synthesis (MacMicking et al., 1997). Expression of the Nos2 
gene depends on signals emanating from IFN-receptors and on the activation of NFκB 
(i.e. by TNFα - tumor necrosis factor alpha - or TLR ligands). iNOS regulation has been 
extensively studied in the context of IFNγ and the TLR4 ligand LPS, leading to the 
conclusion that Nos2 expression follows the same rules as any other IFN-II target gene, 
including the dependency on IRF1 (Kamijo et al., 1994; Meraz et al., 1996). 
During bacterial infection, iNOS expression requires synthesis of IFN-β and signalling 
through the type I IFN receptor (IFNAR). IFN-β can itself be categorised as a SRG 
because its transcription depends on the formation of an enhanceosome complex (see 
below) comprised of class I and class II transcription factors, namely AP1 (activator 
protein1), NFκB, IRF3 and IRF7 (Panne et al., 2007). In keeping with this notion,  IFN-
β mRNA is not strongly expressed before 4hrs after treatment.  
In contrast to PRGs, SRGs harbor no poised or paused polymerase, nor any activating 
marks on the core-histone tails (see below). The delayed expression of SRGs compared 
to PRGs is due to their dependence on de novo gene expression of class II transcription 
factors and the active recruitment of chromatin remodellers, histone modifying enzymes 
and Pol II complexes. 
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Class III transcription factors 
This category of transcription factors consists of lineage specific factors that are 
upregulated during cell differentiation. In the case of macrophages PU.1 (also known as 
SPI1) and C/EBPβ (CCAAT/enhancer-binding-protein-β), as well as RUNX1 (runt-
related transcription factor 1) and IRF8 are prime examples. They play important roles 
in maintaining the constitutive expression of genes, the preparatory chromatin-
remodeling at inducible genes and the silencing of genes associated with alternative 
cell-fates (Medzhitov and Horng, 2009). RUNX1 for example has been shown to 
‘anchor’ specific genomic loci to the nuclear matrix (the architectural scaffold of the 
nucleus) to assemble domains of active or inactive chromatin (Zeng et al., 1997).  
Furthermore, Ghisletti and colleagues have generated new insight in the macrophage 
specific regulation of inducible genes. They monitored PU.1 binding at gene enhancers 
which was found to be colocalized with H3K4me1. Enhancers containing both PU.1 
and H3K4me1 were primed to become activated by subsequent binding of stimulus 
dependent factors like NFkB, IRFs or AP.1 (activator protein1). This study, for the first 
time, showed a mechanism how tissue specific factors together with stimulus dependent 
factors together orchestrate the onset of macrophage specific gene-expression (Ghisletti 
et al., 2010). 
Interferons and STATs 
Since their discovery more than 50 years ago by Isaacs and Lindenmann (ISAACS and 
LINDENMANN, 1957), interferons (IFNs) have been subject to numerous studies 
leading to the identification of various IFN types, their receptors and the proteins 
involved in transmitting the signal from the receptor to the nucleus. Over 50 members 
of four-helix bundle cytokines like IFNs have been characterized so far resulting in an 
increased number of proteins involved in IFN and IFN-like signaling. The key-players 
of these signaling pathways are the members of the JAK (Janus kinase) family of 
protein tyrosine kinases and the STAT (signal transducers and activators of transcription) 
transcription factors. The following chapters will deal with the molecular principles of 
the JAK-STAT signaling and give an overview on STAT function as transcription 
factor. 
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Events leading to STAT activation  
Subsequent to dimerization of the respective receptor, JAKs are activated. Contrasting 
RTK (receptor tyrosine kinases) the receptors recognizing IFNs (IFNAR, interferon 
alpha receptor, IFNGR, interferon gamma receptor or IFNλR, interferon λ receptor, for 
the recognition of type I IFNs, IFNγ or IFNλ, respectively) are not capable of 
autophosphorylation. Therefore they rely on the kinase function of the permanently 
associated JAKs to guarantee signal transduction to STATs. Four members of JAKs 
have been identified, namely TYK2 and JAK1/2/3.  
The role and function of JAKs 
JAKs range in size from 120 to 140 kDa and bear two critical C-terminal domains, one 
kinase (Ki) and one pseudokinase domain (ΨKi). Critical for JAK activation is the 
phosphorylation of two tyrosine residues in the activation loop that results in 
accessibility of the substrate binding site. Association with receptors is mediated by the 
N-terminal FERM (four point one, ezrin, radixin, moesin) domain that faciliates contact 
to proline-rich, membrane-proximal box1/box2 domains on cytokine receptors. In 
addition, JAKs contain a conserved SH2- related domain with unknown function 
(Decker et al., 2005; Schindler et al., 2007).  
TYK2 was found to be involved in signaling downstream of IFN-I (type I IFNs), IL-6 
(interleukin 6), IL-10, IL12 and IL23, thereby participating in allergic and antimicrobial 
responses. JAK1 is engaged in signaling downstream of IFN-I and IFN-II (IFNγ), IL-
2/4, IL10 and IL6. JAK2 associates  with single-chain receptors (i.e. Epo-R, GH-R, Prl-
R) but also with IL-3R, IL-5R, GM-CSFR and IFNGR. JAK3 is expressed mainly in 
leukocytes. It exclusively associates with the common γ chain and therefore mediates 
signaling in response to IL-2 and additionally to IL-4, IL-7, IL-9, IL-15, and IL-21. All 
respective receptors share  the common γ-chain for signaling (Schindler et al., 2007). 
Upon receptor dimerization subsequent to ligand binding, JAKs become activated by 
transphosphorylation, as shown initially for JAK2 (Remy et al., 1999). This leads to the 
phosphorylation of the receptor on tyrosines that in turn can be recognized by the SH2 
domain of STATs. Receptor bound STATs are thereby brought in close proximity to the 
JAKs leading to STAT phosphorylation. Thus, JAK kinase function is essential for 
signal transduction by the receptor as well as the STAT.  
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The STAT dimer 
In mammals 7 STATs are known to receive the signal from the upstream JAKs as 
described above (STATs 1, 2, 3, 4, 5a, 5b and 6). The nature of STAT activation has 
remained enigmatic for a long time. Initial experiments focused mainly on STAT-
effector function, clarifying their role as transcription factors thereby identifying STAT 
binding sites on promoters of hundreds of target genes.  
Little was known about the physiological principal of STAT activation until Darnell and 
colleagues critically questioned whether the current model of STAT dimer formation 
only  upon phosphorylation, reflected the situation in cells (Mertens et al., 2006). 
Becker and colleagues and Chen and colleagues (Mao et al., 2005; Neculai et al., 2005), 
who first crystalized STATs in the inactive /unphosphorylated form, demonstrated an 
anti-parallel structure of the inactive dimer. Based on these findings, Darnell and 
colleagues provided a novel model for STAT activation and their recycling after 
dephosphorylation in the cell nucleus (Mertens et al., 2006) (Figure 8).  
Accordingly, STATs reside in the cytoplasm as preformed homo- or heterodimers 
(Braunstein et al., 2003) in an anti-parallel confirmation, where the N-terminus of one 
dimer partner lies next to the C-terminus of the other. STATs in general comprise 
several conserved domains: a CC (Coiled-Coil) domain is located next to the short N-
terminal domain followed by a conserved DBD (DNA binding domain). The so called 
linker-domain connects the DBD with the SH2 domain. At the C-terminus transcription 
activation competent STATs contain the TAD (trans-activation – domain). The 
antiparallel STAT dimer is held together in the inactive state via direct contact of the N-
terminal domains and reciprocal interactions of the CC domains with the DBDs (Figure 
8).  
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Figure 10: Model for STAT1 activation and recycling. Upon ligand binding and 
subsequent  phosphorylation by JAKs, preformed STAT dimers undergo a 
conformational change from an anti-parallel to a parallel structure. The NDs (N-
terminal domain), CC (coiled-coil) and DBDs (DNA-binding-domain) associate only in 
the anti-parallel and inactive dimer. Upon activation and rotation the SH2 domains, 
located at the C-terminal end, reciprocally bind the phosphotyrosine 701 of the dimer-
partner. The active dimer translocates into the nucleus and binds at promoters of ISGs 
(interferon stimulated genes) to drive their expression. Inactivation of the STAT dimer 
is initiated by de novo interaction of NDs which might contact the body of the pSTAT. 
This in turn leads to rotation and CC-DBD interactions can occur. Dephosphorylation of 
Y701 by phosphatases takes place in the nucleus leading to subsequent nuclear export 
(Mertens et al., 2006). 
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Essential modifications for STAT function 
Two amino acid residues were proven to be crucial for dimerization and activation of 
STAT proteins, residue F172 located in the CC-domain and a conserved tyrosine next to 
the SH2 domain (Y701 in case of STAT1). Phophorylation at the tyrosine residue by 
JAKs upon ligand binding is needed for the reciprocal pY-SH2 (tyrosine-SH2) 
interaction that initiates the rotation of the dimer into a parallel and transcriptionally 
active form. According to Darnell and colleagues this rotation enables the STATs to 
form a structure capable of binding DNA and at the same time hiding the tyrosine 
residue from becoming dephopshorylated by phosphatases. The N-terminal interaction 
between the two dimer partners is lost upon rotation into the active form. In addition, 
this event is crucial for liberating the NLS (nuclear localization sequence) for 
subsequent nuclear import by importin α, thereby shifting the balance for continuous 
nuclear export/import toward nuclear accumulation (Schindler et al., 2007). 
Nevertheless, the N-terminal domain has been shown to be essential also in the process 
of inactivating the STAT dimer (Mertens et al., 2006). De novo interaction of the STAT 
N-terminus in the parallel conformation induces rotation into the antiparallel state 
resulting in the protrusion of the SH2 domains out of both ends of the now anti-parallel 
dimer. This in turn results in the dephosphorylation of the tyrosine residue, which is in 
this conformation no longer protected from phosphatases, and in the nuclear export of 
the now inactive STAT dimer (Figure 1).  
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Besides tyrosine phophorylation, STATs in general undergo further modifications 
including serine phosphorylation, acetylation and O-glycosylation. Serine 
phosphorylation takes place in the TAD of all STATs with STAT2 as notable exception 
(Decker and Kovarik, 2000). For STAT1 the phosphorylation occurs within a conserved 
PMS*P motif at position 727. STAT1 and STAT5, at least, contain a second serine-
residue in the TAD at position 708 and 779, respectively, which can be phosphorylated 
(Tenoever et al., 2007). The phosphorylation of serine residues in the TAD domain of 
STATs has been shown to be needed for transcriptional activity (Varinou et al., 2003). 
The kinase responsible for STAT1 serine phosphorylation is still unknown though 
recent data suggest that in the context of IFN responses STAT1 has to be localized in 
the nucleus to become S727 phosphorylated (Sadzak et al., 2008). Furthermore, recent 
findings indicate a role for non-tyrosine phosphorylated STATs in regulating 
transcription following stimulation with TLR- (toll like receptor), IL1R- or TNFR 
(tumor necrosis factor) ligands, or in the context of IFN responses (Decker and Kovarik, 
2000; Yang et al., 2005; Cheon and Stark, 2009).  
The role of STAT lysine-acetylation has been subject to numerous studies. Reportedly, 
acetylation of STAT3 positively regulates transcriptional activity and homodimer 
stability (Yuan et al., 2005). STAT1 acetylation at lysines K410 and K413 was 
suggested to regulate dephosphorylation. Because dephosphorylation is essential for 
STAT1 recycling this finding may explain the repression of STAT1 target genes 
following pretreatment with the HDAC (histone deacetylase) inhibitor TSA (trichostatin 
A) (Zupkovitz et al., 2006; Krämer et al., 2009; Krämer and Heinzel, 2010).  
O-glycosylation has been shown to be essential for STAT5 interaction with its co-
activator CBP (cAMP responsive element binding protein – CREB binding protein). 
The glycosylated residue of STAT5 is conserved also in STAT1, STAT3 and STAT6 
(Gewinner et al., 2004).   
The biological role of STAT-family members 
The seven members of the STAT family of transcription factors are embedded in a 
series of signaling events ranging from signal transduction downstream of hormone 
receptors (prolactin, growth hormone), hematopoietin receptors (e.g. GM-CSFR 
(granulocyte/macrophage – colony stimulating factor receptor, IL-3, 5, 7-R, EpoR 
(erythropoietin receptor), or receptors for various interleukines and IFN that regulate 
immune responses. 
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STAT1 as the first STAT described in literature, is activated subsequent to IFN-II (Type 
II IFN - IFNγ) stimulation, thereby initiating the formation of STAT1 homodimers, also 
called GAF (GAS – γ-IFN activated site - binding transcription factor), the key factor 
for IFNGR signaling. The GAS consensus binding sequence for STAT1 homodimers is 
a palendromic sequence: TTCNNNGAA (N = any base). STAT1 target genes promote 
inflammation and antagonize proliferation thereby antagonizing the effects of STAT3 
target genes. Studies in gene targeted mice and humans expressing STAT1 mutants 
underline the importance of STAT1 in the immune response against viral and bacterial 
infections. Many genes stimulated by STAT1, in context of an IFN-γ response, require 
cooperative effects by other transcription factors like IRF1, SP1, USF-1 or 
C/EBPβ (Decker and Kovarik, 1999). 
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STAT1 like STAT2 was originally identified as part of the ISGF3 (interferon stimulated 
gene factor 3) complex downstream of IFN-I signaling, which is comprised of a 
STAT1/2 heterodimer in complex with IRF9 (interferon regulatory factor 9). This 
heterotrimeric factor binds to ISREs (interferon stimulated response elements) 
following the consensus sequence: PuPuTTTCNNTTTPyPy (Pu=Purine; N=any base; 
Py=Pyrimidine). Recent data indicate that ISGF3 is also activated downstream of the 
IFN-III (IFNλ) receptor. In the context of an IFNγ response the ISRE mediates 
transcriptional effects of IRF1 and non-canonical STAT1 complexes e.g., STAT1 
homodimer associated with IRF9 (Bluyssen et al., 1995; Kimura et al., 1996). Many 
ISGs (interferon stimulated genes) can be expressed after treatment with both IFN-I or 
IFN-II, pointing towards a similar role of IFN-I and IFN-II in inducing an anti-viral  
response. Still the two IFN classes play different roles in immunity to infection. IFNγ, is 
produced by NK- or NKT-cells very early after infection in a STAT4 dependent manner 
or by  TH-1 or CD8+ T-cells of the adaptive immune-system at a later stage of the 
immune response. IFNγ is the main macrophage activating cytokine, thus participating 
in the defence against invading bacterial pathogens (see below) (Schroder et al., 2004). 
Studies in STAT1 deficient mice confirm the essential role of STAT1 for both ISGF3 
complex-mediated IFN-I responses and for STAT1 homodimer-mediated antibacterial 
responses. Such animals are exceedingly sensitive to both viral and bacterial pathogens 
(Durbin et al.1996 Meraz et al.1996) Despite the predominant role of IFN-I and IFN-γ 
in antiviral and antibacterial immune responses, respectively, there are significant 
contributions of both IFN types to immune responses against all classes of pathogens 
(Decker et al., 2002; Decker et al., 2005).  
The main role of STAT3 is to mediate signalling by cytokines of the IL-6 family. 
However, this family member is engaged also downstream of the receptors for IL-10 as 
well as for (G)-CSF, leptin, IL-21 and IL-27. STAT3 often counteracts the 
proinflammatory role of STAT1. Tissue specific knock-out in mice confirmed the anti-
inflammatory role of STAT3 (Kisseleva et al., 2002; Levy and Darnell, 2002). Finally, 
STAT3 was found to promote tumor growth through non-canonical mechanisms, i.e. in 
the absence of tyrosine phosphorylation and/or DNA binding (Yang et al., 2005; 
Schindler et al., 2007). 
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STAT4 and STAT6 are non-redundant antagonistic players, essential for the 
development of either a type-I or type-II immune-responses. Both were extensively 
studied in the field of T-Cell development. STAT4 directs the IL-12 dependent lineage 
commitment of CD4+ T-cells to TH-1 cells (Lee et al., 2006; Wilson et al., 2009). As 
mentioned above STAT4 induces IFNγ production by TH1 as well as NK- or NKT-cells 
and is involved in the IL-23 dependent expansion of TH-17 cells (Hunter, 2005). In 
contrast, STAT6 mediates TH2 differentiation and the production of TH2 signiture 
cytokines IL-4, IL-5 and IL-13. In line with this, STAT4 is essential for the clearence of 
infection with viral, intracellular bacterial or protozoan pathogens via cellular 
mechanisms, whereas STAT6 enhances IL-4 mediated isotype switching in B-Cells, 
predominatly leading to IgE production. Therefore STAT6 mainly contributes to mast-
cell activation dependent immunity against helminths, such as gastrointestinal 
nematodes (Finkelman et al., 2004). The molecular principles how these two STATs 
orchestrate differential gene expression will be further highlighted (see below). 
Two tandem genes encode STAT5a and STAT5b which share extremely high sequence 
identity (~ 96% aa). STAT5a/b are activated downstream of IL-3 (IL-3, IL-5, and GM-
CSF), single chain and γc receptor families. The main function of STAT5a/b was 
revealed by recent gene targeting studies demonstrating a role for STAT5(s), among 
others, in erythropoiesis and lymphopoiesis (Yao et al., 2006).   
STATs and chromatin 
STATs, upon activation and binding to their consensus binding sites at promoter or 
enhancer regions, make contact to co-factors needed to remodel and modify histones at 
the promoter as a pre-requisite for Pol II binding and/or transcriptional initiation. To 
date, a limited set of experiments provide an idea how STATs interact with co-factors to 
induce transcription of both PRGs and SRGs. With the development of ChIP (chromatin 
immune precipitation) -sequencing, as a method to analyze ChIP data quantitatively on 
a genome wide basis, it was possible to compare histone modification patterns with sites 
of STAT recruitment to find correlations and interdependencies (Robertson et al., 2007). 
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STATs and chromatin remodeling 
The STAT1 driven expression of the transcription factor CIITA upon IFNγ treatment 
dependens on BRG1. Interestingly, detailed analyses of the CIITA enhancers conferred 
only partial dependency on BRG1 (Ni et al., 2008). In line with the reports by the 
Nasmyth laboratory (see above), STAT1 binding itself relies on BRG1-dependent 
chromatin remodeling at the CIITA promoter and a series of other STAT1 and ISGF3 
target genes, like Gbp1/2. Constitutive BRG1 association to IFN-γ target genes is 
STAT1 independent (Ni et al., 2005). Nevertheless, BRG1 specificity and effects on the 
promoters of different STAT target genes can be highly divergent, as  illustrated by the 
requirement for BRG1 activity at the Irf1 promoter for the recruitment of STAT3 but 
not for STAT1 homodimers (Ni and Bremner, 2007). In contrast, BRG1 recruitment to 
the Ifnγ promoter in TH1-cells is STAT4 dependent (Zhang and Boothby, 2006).  
STATs and histone modifications 
Recent data demonstrate that chromatin modification and remodeling events have to 
precede STAT1 binding to the promoters of IFNγ driven genes (Robertson et al., 2007; 
Robertson et al., 2008). To date the Ifnγ promoter itself is one of the most intensively 
studied promoters, in the context of  STAT-orchestrated chromatin dynamics. STAT5 
was shown to be responsible not only for inducing remodelling at the Ifnγ promoter but 
also for increased histone acetylation (Shi et al., 2008). STAT4 binds to the Ifnγ 
promoter and and enhancer regions leading to the induction of permissive genetic 
modifications and the activation of gene expression. The Ifnγ locus comprises bivalent 
chromatin modifications, a combination of the activating H3K4me3 and the repressive 
H3K27me3 mark, which makes it poised for either activation or silencing. Upon 
activation H3K4 methylation is enhanced and H3K27 methylation is reduced (Wilson et 
al., 2009).  
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Recently, Lei Wei and colleagues studied the chromatin status of Ifnγ, Il4 and Il17 gene 
loci in TH1, TH2, iTreg and nTreg cells. STAT4- and STAT5-dependent increases of 
H3K4me3 marks were found in TH1 and iTreg cells, respectively. Observed H3K27me3 
patterns in these cells support the notion that, once differenciated, STATs and other 
transcription factors regulate the cell fait of these cells by the introduction of active or 
repressive chromatin marks (Wei et al., 2009). In a different approach, Lei Wei and 
colleagues monitored the distribution of H3K4me3, H3K27me3, and H3K36me3 along 
with STAT4 and STAT6 binding to reveal the interdependency of the chromatin 
modifications with either of the STATs in the context of TH1/TH2 – differential gene 
regulation. Only a small proportion of STAT dependent genes showed also STAT 
dependent changes in histone modifications. STAT4 was in this regard found to mainly 
promote accessible marks (H3K4me3), whereas STAT6 had a prominent role in 
antagonizing repressive marks (H3K27me3), to induce transcription. Genes whose 
transcriptional and epigenetic regulation depend on STATs in TH1/TH2-cells, include 
phenotype-defining cytokines (Ifnγ, Il4 and Il24), receptors (Il18rap, Il18r1, Lag3, and 
Il4ra), transcription factores (Gata3, Tbx21), transcriptional repressors (Id2 and Zbtb32), 
and to date unrecognized STAT dependent genes, upregulated in TH1/TH2 –cells. These 
included Hipk2, Plcd1, Skap2, and Gbp2 (Wei et al., 2010).  
STAT cooperation with Class I transcription factors 
As described above STAT-mediated gene expression very often relies on the concerted 
interplay of STATs with other factors. In context of STAT1 during an IFNγ response it 
is very well established that IRF1 is required for gene induction of SRGs (Decker and 
Kovarik, 1999). Interestingly, STATs can also share labor with partners of their own 
family, for example when STAT1 and STAT2 are combined in the ISGF3 complex 
downstream of IFNAR signaling. A very recent and surprising relationship is the 
interdependent action of STAT4 and STAT6 to ensure differential expression of 
lineage-specifying genes, like Il-18r1-l18rap. Both STATs can bind the promoter to 
either suppress or activate transcription (Wei et al., 2010). 
The mechanism of STAT3 and NFκB co-requirement for the induction of the Il1rn (IL1 
receptor antagonist) gene has recently been clarified. In case of the human Il1rn 
promoter STAT3, upon IL-10 and LPS cotreatment, precedes NFκB recruitment, and 
leads to chromatin rearrangements in order for NFκB to get access to its promoter 
binding site, and to initiate transcription (Tamassia et al., 2010).  
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NFκB and STAT interactions have been subject to numerous studies in recent years, 
since both factors are crucial mediators of an immunological response to pathogens. 
Paradigmatic for the group of genes, induced after pathogen exposure, that requires both 
STAT and NFκB to get expressed, is the Nos2 gene, encoding iNOS. 
iNOS as a prime example for STAT-NFκB convergence 
Upon innate immune responses iNOS is expressed and produces NO (nitric oxide) 
radicals, which exert direct antimicrobial activity and regulate cell survival (Bogdan, 
2001; Zwaferink et al., 2008). The regulation of iNOS expression was mainly studied 
using, on the one hand, LPS (lipopolysaccharid) as TLR4 ligand to activate NFκB, and 
IFNγ for active STAT1 homodimer formation, on the other hand. Activation of the 
NFκB, p65/p50 heterodimer, is induced downstream of the canonical NFκB pathway 
involving the activation of the IKK-complex, leading to the subsequent phosphorylation, 
and thereafter ubiquitination of IκBα (Hayden and Ghosh, 2008). 
The Nos2 promoter contains among others, GAS, ISRE and NFκB-BS (NFκB- binding 
sites). It was shown to require NFκB, STAT1 and, like other ISGs, IRF1 for full 
expression, after LPS and IFNγ treatment (Kamijo et al., 1994; Meraz et al., 1996). 
However, to date little effort was made in understanding the molecular events leading to 
iNOS regulation in response to infections with intracellular pathogens. A well-known 
example of these is the Gram-positive, facultatively intracellular bacterium Listeria 
monocytogenes. Following uptake, this pathogen escapes to and replicates in the host 
cell cytoplasm, owing to its ability to disrupt endosomal or phagosomal compartments 
with the help of its encoded hemolysin, listeriolysin O (LLO). In murine BMDMs (bone 
marrow derived macrophages) a hitherto unknown cytoplasmic receptor senses 
infection and induces signaling to the IFN-I genes. The first IFN-I to be produced by 
infected cells is IFN-β. Formation of an enhancosome at the IFN-β promoter and 
subsequent transcription requires members of the IRF family, particularly IRF3 (Panne 
et al., 2007).  
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The activation of IRF3 was shown to depend on the two kinases TBK1 (TANK - TRAF 
family member associated NFκB activator - binding kinase) and IKKε, but not on the 
adaptor protein MAVS (mitochondrial anti-viral signaling protein) (Stockinger et al., 
2004; Stetson and Medzhitov, 2006; Soulat et al., 2006). Importantly, both IRF3, IFN-β 
and the IFNAR were essential for iNOS expression in macrophages infected with L. 
monocytogenes (Stockinger 2004), suggesting iNOS to belong with the large category 
of antimicrobial SRG that are co-regulated by primary infection-derived signals such as 
NFκB and by IFN-I (Figure 11). The molecular mechanism or biological significance 
underlying this two-signal requirement for iNOS expression have not been explored. 
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Figure 11: Pathways activated after infection with LL (living Listeria) ot treatment 
with hkL (heat killed Listeria) or LLO – Listeria (Listeria deficient for the poreforming 
protein Listeriolysin O). Among other factors, LL induce early after their recognition by 
host cells, the activation of the heterodimers p65/p50, forming the transcription factor 
NFκB, and the MAPK p38 via TLR mediated signaltransduction. In addition, a hitherto 
unknown receptor senses Listeria as soon as they escape, in an LLO dependent manner, 
from the phagolysosome to the cytoplasm. Once recognized in the cytoplasm the 
signaltransduction in turn activates the two kinases TBK1 and IKKε, which are required 
for the activation of the class I transcription factor IRF3 and the class II transcription 
factor IRF7. Activation of both lead, together with acticated NFκB and AP1, to the 
production of type I IFNs, in particular IFNβ and IFNα4, in a first wave of type I IFN 
production. IFNβ production and subsequent signaling leads to the activation of ISGF3 
and to the expression of ISGs. Notably, signaling cascades emanating from the 
treatment with hkL or LLO- Listeria, activate the TLR dependent extracellular 
signaltransduction but fail to induce endogenous IFNβ production, due to their inability 
to reach the host cell cytoplasm. 
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Aims 
In recent publications STATs have been found to cooperate with many other factors to 
induce gene expression of ISGs. The major goal of this study was to identify and 
characterize the role of STAT1, in cooperation with IRF1 or NFκB, in the processes 
leading to active gene expression. For this purpose two different situations were chosen: 
first, the interdependency of STAT1 and IRF1 in the regulation of genes after treatment 
with IFNγ represented an example of transcription factor cooperation within the same 
signalling pathway. Second, the cooperation of STAT1 and NFκB in the regulation of 
genes after infection with Listeria monocytogenes represented the cooperation of 
transcription factors activated by distinct signalling pathways. The main focus of these 
studies was  to examine the requirement of transcription factors for co-factor 
recruitment and for induced changes in chromatin structure and/or composition, which 
in turn enables the binding of factors of the PIC and Pol II. 
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Results 
Distinct modes of action applied by transcription 
factors STAT1 and IRF1 to initiate transcription of the 
IFN-g inducible Gbp2 gene 
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A subgroup of genes induced by IFN- requires both STAT1 and IRF1
for transcriptional activation. Using WT, stat1/, or irf1/ cells, we
analyzed the changes induced by IFN- in gbp2 promoter chromatin.
STAT1 associated with the promoter independently of IRF1 and
played an essential role in the ordered recruitment of the coactivator/
histone acetyl transferaseCREB-bindingprotein (CBP) and thehistone
deacetylase HDAC1. Hyperacetylation of histone 4 also required
STAT1. Phosphorylation at S727 in the transactivating domain in-
creased transcriptional activity of STAT1. In cells expressing a
STAT1S727A-mutantCBP recruitment, histone4hyperacetylationand
RNApolymerase II associationwith the gbp2 promoterwere strongly
reduced. IRF1 association with the gbp2 promoter followed that of
STAT1, but STAT1 association with DNA or histone hyperacetylation
were not necessary for IRF1 binding. RNA polymerase II association
with the gbp2 promoter required both STAT1 and IRF1, suggesting
that both proteins mediate essential steps in transcriptional activa-
tion. IRF1, but not STAT1, was found to coimmunoprecipitate with
RNA polymerase II. Together, the data support the assumption that
the main role of STAT1 in activating gbp2 transcription is to provide
transcriptionally competent chromatin, whereas the function of IRF1
may lie in directly contacting RNA polymerase II-containing transcrip-
tional complexes.
chromatin  interferon  signal transduction  interferon regulatory factor
IFN- enhances cell-mediated immunity against both nonviralpathogens and viruses (1). STAT1, the central mediator of
IFN--induced gene expression is phosphorylated at Y701 by the
IFN- receptor-associated Janus kinases Jak1 and Jak2, an essential
prerequisite for dimerization and nuclear translocation (2). In
addition, a serine/threonine kinase phosphorylates the STAT1
transactivating domain at S727 and increases transcriptional com-
petence (3–5). Promoter sequences found in IFN response regions
are the -IFN activated site (6) recognized by STAT1 dimers and
the IFN-stimulated response element (ISRE) (7). ISRE sequences
bind STATcomplexes and also IFN regulatory factors (IRFs) (8, 9).
In the context of the IFN- response, the ISREmediates transcrip-
tional effects of IRF1 and noncanonical STAT1 complexes, e.g.,
STAT1 dimers associated with IRF9 (10–12).
STAT1 has been linked predominantly to positive gene reg-
ulation, but some genes are repressed by STAT1 (13–15). Many
genes stimulated by STAT1 in the context of an IFN- response
require cooperative effects with other transcription factors, such
as IRF-1, USF-1, SP1, or C/EBP (16). In most cases both
STAT1 and the cooperating transcription factor bind to their
cognate promoter sequences, although the cooperation with
C/EBP is mediated by a sequence designated GATE, which
binds C/EBP but not STAT1 (17).
The gbp1 and gbp2 genes are IFN--inducible members of the
p65 GTPase gene family with putative roles in the resistance to
intracellular pathogens (18). gbp2 transcription in both humans and
mice requires promoter binding sites for both STAT1 dimers and
IRF transcription factors (6, 19). Guanylate-binding protein (GBP)
expression in response to IFN- is virtually absent in cells from irf1
knockout mice (10, 11), The promoter of the irf1 gene contains a
binding site for STAT1 dimers. Therefore, IRF1 accumulates in
cells treated with IFN- (20).
Transcriptional activation of the gbp genes is accompanied by
promoter acetylation (5). Consistently, STAT1 interacts with the
coactivator/histone acetyl transferase (HAT) CREB-binding pro-
tein (CBP) that is required for STAT1-dependent transcription of
chromatin templates in vitro (5, 21, 22). Moreover, microarray
analysis of HDAC1-deficient cells identified gbp genes as belonging
within a group of genes requiring histone deacetylase 1 (HDAC1)
for IFN--induced expression (23). STAT1 also directly binds a
complex of MCM proteins that enhance gbp transcription most
likely by providing helicase activity for strand separation in the
initiation and elongation steps (24). BRG1, an ATPase subunit of
the SWI/SNF chromatin remodeling complex, binds the human gbp
promoter as a prerequisite for the association of STAT1 (25, 26).
Serving as a paradigm for the group of genes coregulated by
STAT1 and IRF1, the gbp2 gene allows us to address two important
open questions. (i) What is the relative importance of STAT1 for
IFN--induced gbp2 transcription as a transcriptional activator of
the irf1 gene on the one hand and as a cognate binding factor of the
gbp2promoter on the other? (ii)What is the nature of themolecular
mechanismsmediating cooperative stimulation of gbp transcription
by STAT1 and IRF1?Our studies show that both STAT1 and IRF1
are required at the gbp2 promoter to recruit RNA polymerase II
(RNA pol II) to the transcription initiation site. STAT1 and its
phosphorylation at S727 are essential for CBP recruitment, and
STAT1alsomediates the association of the promoterwithHDAC1.
By contrast, the binding of IRF1 to the gbp2 promoter occurs
independently of STAT1 binding and histone acetylation, but it
cooperates with STAT1’s activities in recruiting RNA pol II.
Results
Organization of the Murine gbp1/gbp2 Promoters and Regulation of
Their Activity by STAT1 and IRF1. A cluster of five GBP genes maps
to mouse chromosome 3 (www.ensembl.org). Previously, three
groups described murine GBP promoters. The first report assigned
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the cloned promoter to the gbp1 gene (27). Two further groups
subsequently cloned the same stretch of DNA and a further one
differing by only a few base pairs but with an identical IFN response
region (19, 28). Those two groups concurred in their interpretation
that the cloned DNAs contained highly homologous promoters of
the gbp1 and gbp2 genes. The ensembl database shows the gbp1 and
gbp2 genes juxtaposed and in the same orientation, spaced by a
short intergenic region of 1,466 bp. The previously described
promoters are all highly homologous to the intergenic region
containing the gbp2 promoter, but none shows significant homology
to the region upstreamof gbp1, suggesting that all of them represent
allelic variations of the gbp2 promoter (see Fig. 2A). Quantitative
real-time PCR analysis showed that the gbp1 and gbp2 genes are
strictly coregulated, as would be expected from the use of common
promoter elements (Fig. 1A). Both showed an identical require-
ment for the presence of STAT1 and IRF1, with the need for
STAT1 being more stringent than that for IRF1. Inspection of the
gbp1 upstream sequence revealed the presence of bona fide IFN-
-activated site (GAS) and ISRE sequences at positions 253/
245 (TTCATAGAA) and 139/127 (AATTTCACTTTCT),
respectively. These gbp1 upstream sequences most likely constitute
an IFN- response region, but functional analysis will be required
to ascertain this assumption.
The IFN-response region of the gbp2 promoter is divided into an
ISRE proximal to the cap site and more distal GAS and ISRE
sequences (Fig. 2A). Our recent ChIP experiments showed that the
proximal gbp2 promoter ISRE associates with a noncanonical,
IFN--activated STAT1 complex (5). The distal GAS element is a
canonical, although imperfect, binding site for STAT1 dimers (19).
To determine the temporal sequence of IRF1 accumulation and
gbp2 expression, we determined IFN--induced accumulation of
irf1 nuclear RNA (hnRNA), mRNA (Fig. 1B), and protein (Fig.
1C). Unspliced irf1 hnRNA was already 50%maximal 30 min after
addition of cytokine. The accumulation of cytoplasmic mRNA was
delayed by 15 min and protein synthesis by yet another 15 min.
Nuclear gbp2 mRNA closely correlated with amounts of IRF1
protein, and the delay between hnRNA synthesis and cytoplasmic
mRNAaccumulationwas similar as in the case of irf1. The data thus
confirm that gbp2 mRNA transcription is mostly a secondary
response to IFN- and that in the presence of STAT1 dimers, IRF1
availability limits the rate of gbp2 nuclear RNA synthesis.
Recruitment of Transcriptional Regulators to the gbp2 Promoter. To
address the changes of gbp2 promoter chromatin after IFN-
stimulation, we performed antibody (Ab)-mediated ChIP. Consis-
tent with our previous results (5), STAT1 was recruited rapidly to
the proximal and distal response elements (Fig. 2B). Recruitment
of the HAT CBP and histone 4 hyperacetylation closely paralleled
STAT1 binding. Recruitment of HDAC1 also paralleled that of
Fig. 1. Regulation of the gbp1 and gbp2 genes by IFN- dependence on the presence of STAT1 and IRF1. (A) gbp1 (Upper) and gbp2 (Lower) expression in irf1-
and stat1-deficient fibroblasts. Immortalized WT, irf1/, and stat1/ fibroblasts were treated with 10 ng/ml (240 units/ml) IFN- for the indicated times and
analyzed for expression of gbp1 and gbp2 by real-time PCR. Inducibility was calculated after normalizing to GAPDH mRNA levels. (B) Kinetics of irf1 and gbp2
expression. Primary BMDMs were treated with 10 ng/ml (240 units/ml) IFN- for the indicated times. Nuclear RNA (hnRNA), isolated from purified nuclei, and
mRNA from whole-cell extracts were isolated and reverse transcribed. Inducibility of irf1 and gbp2 hnRNA (Upper) and mRNA (Lower) expression were analyzed
by real-time PCR and normalized to endogenous GAPDH. (C) Western blot analysis of IRF1 protein expression was performed with lysates from WT BMDM treated
with 10 ng/ml (240 units/ml) IFN- for the indicated time. Equal loading was determined by probing the membrane with anti-panERK Abs.
Fig. 2. Recruitment of transcriptional regulators to the gbp2 promoter
chromatin. (A) Graphic representation of the murine gbp2 promoter region.
gbp1 and gbp2 are located on chromosome 3 and are separated by 1.466 bp
of intergenic region. This region contains the regulatory GAS and ISRE ele-
ments. Primer pairs used for ChIP assays are depicted. (B) Recruitment of STAT1
(S1C), IRF1 (IRF1), RNA pol II (Pol II), CBP (CBP), and HDAC1 (HDAC1) to
the distal (DIS) and proximal (PROX) regions of the gbp2 promoter, and
hyperacetylation of histone 4 (acH4) of the respective promoter regions, as
analyzed by ChIP. Primary BMDM were treated with 10 ng/ml (240 units/ml)
IFN- for the indicated time points (minIFN-), and formaldehyde-cross-linked
chromatin was isolated and subjected to IP with the indicated Abs. The
promoter elements were analyzed by amplification of the distal and proximal
gbp2 promoter regions by PCR. The specificity for the IP was determined by
using preimmune serum (C) as negative control and amplification of input
DNA (IN) by PCR.
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STAT1. This finding is consistent with earlier reports showing
that STAT1 interacts with these proteins when coimmunoprecipi-
tated from cell extracts or in pull-down assays (29). IRF1 also bound
both the proximal and distal promoter regions (Fig. 2B). Promoter
binding was delayed by 20 min compared with STAT1. The
kinetics of RNA pol II recruitment were similar to those of IRF1
binding, which in turn closely paralleled the accumulation of IRF1
protein and nuclear gbp2 mRNA (Fig. 1).
Further investigation of the gbp2 promoter was performed in
gene-disrupted fibroblasts. The kinetics of gbp2 expression and
transcription factor recruitment in this cell type were not signifi-
cantly different from those observed in macrophages (data not
shown). IFN--induced STAT1 binding was virtually unaffected by
the absence of IRF1 (Fig. 3A). Slightly reduced association partic-
ularly with the proximal site reflects reduced STAT1 expression in
irf1/ cells (Fig. 3G), which is most likely due to the role of IRF1
in maintaining STAT1 expression through autocrine type I IFN
production (30). IRF1 binding to the gbp2 promoter was completely
abolished in stat1/ cells (data not shown) because of the complete
lack of IFN--induced IRF1 synthesis (Fig. 3G).
STAT1 deficiency caused an almost complete absence of CBP
andHDAC1 recruitment, histone 4 hyperacetylation, andRNApol
II binding (Fig. 3 B–F). By contrast, IRF1 deficiency had little
impact on the association of HDAC1. CBP recruitment or the
hyperacetylation of H4 particularly at the proximal promoter were
reduced, but an IFN--stimulated increase was clearly detectable.
Strikingly, however,RNApol II recruitment to the gbp2 cap sitewas
highly dependent on the presence of IRF1. To demonstrate spec-
ificity of these findings, IFN--dependent factor recruitment to the
irf1 promoter was examined. Consistent with the lack of an IRF1-
binding site in its IFN--response region, CBP and, importantly,
RNA pol II association were found to be unaffected by the absence
of IRF1 protein (Fig. 3F). In contrast, neither protein was found to
be associated with the irf1 promoter in absence of STAT1.
Effect of Mutating the S727 Phosphorylation Site in the STAT1
Transactivating Domain. STAT1 S727 phosphorylation is essential
for IFN--induced, gbp2 promoter histone 4 hyperacetylation.
Moreover, CBP does not efficiently bind STAT1S727A in IFN--
treated cells (5). Consistent with these earlier findings, the recruit-
ment of CBP to gbp2 promoter chromatin was virtually absent in
cells expressing a STAT1S727A phosphorylation site mutant, and
absence of CBP coincided with strongly reduced H4 acetylation
(Fig. 4 A and B). Accumulation of IRF1 protein in response to
IFN- is reduced by 50% in cells expressing STAT1S727A (Fig.
4E). Despite this reduction and the lack of histone acetylation,
particularly at the proximal gbp2 promoter, IRF1 association with
the IFN response region was not very different from that found in
cells expressing wild-type (WT) STAT1 (Fig. 4C). The specificity of
IRF1 binding was confirmed by the lack of amplification of the irf1
promoter in the same ChIP DNA samples (Fig. 4C). The binding
of RNA pol II was significantly decreased in IFN--treated cells
expressing STAT1S727A (Fig. 4D), which is in line with the strong
effect of the STAT1S727A mutation on gbp transcription (5, 31).
Analysis of gbp2 Expression and gbp2 Promoter Chromatin in Cells
Expressing IRF1 in Absence of Stat1 Activity. Irf1 being a STAT1-
regulated gene, STAT1-independent effects of IRF1 on IFN--
regulated genes cannot be studied in stat1/ cells. Therefore, we
resorted to two different strategies to study IRF1 in the absence of
STAT1 activity. First, a doxycyclin (dox)-repressed IRF1 gene was
introduced into STAT1-deficient fibroblasts. ChIP analysis of IRF1
showed a strong increase of chromatin-associated IRF1 in trans-
fected cells after dox withdrawal (Fig. 5A) and a concomitant
expression of endogenous gbp2 mRNA. gbp2 expression caused by
IRF1 alone was much lower than that noted in IFN--treated WT
cells (Fig. 5B). These results are consistent with previous reports
(32) showing transcriptional effects of IRF1 overexpression. They
demonstrate that IRF1 alone is able to bind gbp2 chromatin and
stimulate target gene transcription but that expression is low
compared with cytokine-treated cells. Therefore, the data also
stress the important role of STAT1 dimer association with chro-
matin for gbp2 promoter activity. Similar conclusions could be
drawn from experiments with a recently established line of murine
Fig. 3. Impact of irf1 or stat1 deficiency on the IFN--induced alterations of gbp2 promoter chromatin. (A–E) ChIP assays were performed with immortalized
WT, stat1 (stat1/)-, and irf1 (irf1/)-deficient fibroblasts for binding of STAT1 (S1C) (A), hyperacetylation of histone 4 (acH4) (B), recruitment of CBP (CBP)
(C), RNA pol II (Pol II) (D), and HDAC1 (HDAC1) (E) to the proximal (PROX) and distal (DIS) regions of the gbp2 promoter. The cells were treated for 30 or 60
min with 10 ng/ml (240 units/ml) IFN-, and formaldehyde-cross-linked chromatin was immunoprecipitated with the indicated Abs. (F) IFN--dependent factor
recruitment to the irf1 promoter. DNA isolated from A–E was subjected to PCR by using primers recognizing the irf1 promoter. (G) Western blot analysis of
whole-cell extracts from WT, irf1-, and stat1-deficient fibroblast for protein expression of STAT1 and IRF1. The cells were treated for 60 min with 10 ng/ml (240
units/ml) IFN- or left untreated. The membrane was probed with a STAT1 C-terminal Ab, -IRF1 Ab, and with anti-panERK Abs for equal loading.









fibroblasts expressing a fusion protein between IRF1 and the
ligand-binding domain of the human estrogen receptor (IRF1-
hER) (33, 34). In this cell line, IRF1 is constitutively expressed, but
its transcription factor activity is strictly controlled by estrogen [see
supporting information (SI) Fig. 7]. IRF1-ER bound the gbp2
promoter in absence of exogenous stimuli and binding was in-
creased after treatment with estrogen, IFN-, or both. Induction of
gbp2 expression by estrogen alone was low compared with that
by IFN-.
IRF1, but Not STAT1, Is Found in Complexes with RNA Pol II in
IFN--Treated Cells. STAT1 being the major player in gbp2 pro-
moter histone hyperacetylation, we tested whether the role of
IRF1 might be to directly contact protein complexes containing
RNA pol II. Extracts from IFN--treated macrophages were
precipitated with Abs to either IRF1 or STAT1, and the
precipitates were analyzed by Western blot for the presence of
RNA pol II. Fig. 6 shows that RNA pol II was associated with
IRF1 60 min after IFN- treatment. By contrast, association of
RNA pol II with STAT1 was not detected at this or earlier time
points. Control blots demonstrated the expected increase in
STAT1 tyrosine phosphorylation and IRF1 protein expression.
Discussion
The STAT and IRF protein families contribute in numerous
ways to the development and regulation of innate and adaptive
immune responses. As an example, STATs and IRFs interact
functionally both in the synthesis of and response to type I IFN
(35, 36). For the subgroup of genes represented by gbp2, the
functional interaction does not appear to require tight associa-
tion or cooperative binding of the two proteins, but rather results
from a requirement for both STAT1 and IRF1 in the process of
transcriptional activation. The main goal of this study was to gain
insight into the IFN--induced chromatin changes requiring, or
resulting from, the STAT1–IRF1 interaction.
Both the distal and proximal IFN- response regions of the gbp2
promoter contain a canonical IRF binding site. Our data as well as
Fig. 4. Role of STAT1 S727 phosphorylation in the activation of the gbp2
promoter by IFN-. BMDM, obtained from WT and STAT1 S727A mice, were
treated with 10 ng/ml (240 units/ml) IFN- for the indicated time points, and
formaldehyde-cross-linked chromatin was isolated. (A–D) IP of sonicated frag-
ments was performed overnight with polyclonal Abs against CBP (A), hyper-
acetylated histone 4 (acH4) (B), IRF1 (C), and RNA Pol II (D). (E) Western blot
analysis of whole-cell extracts from WT and S727A macrophages. The cells
were treated with IFN- and analyzed for IRF1 protein levels. Equal loading
was determined by reprobing the membrane with anti-panERK Abs.
Fig. 5. Analysis ofgbp2promoter chromatin and ofgbp2 in Stat1/ cells. (A)
STAT1-deficient fibroblasts were pretreated with dox for 6 h and then tran-
siently transfected with pRETRO-tet-OFF-FLAG-IRF1. Twenty-four hours after
transfection, dox was removed from the cells () or left on the cells (dox) for
an additional 24 h. Control cells were treated with 10 ng/ml (240 units/ml)
IFN- for 1 h. Formaldehyde-cross-linked chromatin was isolated and sub-
jected to IP with IRF1 Abs. The proximal gbp2 promoter was analyzed by PCR.
The specificity for the IP was determined by using preimmune serum (C) as
negative control, and amplification of input DNA (IN) by PCR. (B) RNA was
isolated, reverse-transcribed, and analyzed for endogenous gbp2 expression
by real-time PCR.
Fig. 6. IRF1 associates with RNA pol II complexes in IFN--treated cells.
BMDM obtained from WT mice were treated with 10 ng/ml (240 units/ml) IFN-
for 30 or 60 min. Nuclei were isolated, and IP with the indicated Abs was
performed. Western blot membranes were probed with an Ab to RNA pol II.
Aliquots from the lysates were recovered before the IP (WCE) and analyzed by
Western blot for the input of RNA pol II, Y701-phosphorylated STAT1 (pY701),
and IRF1.
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those from previous studies (11, 19) show that these sites are
occupied by IRF1 during an IFN- response. Residual gbp2 tran-
scription still occurred in absence of IRF1 andmay reflect exclusive
STAT1 action or result from the activity of a different IRF family
member. Distinguishing these possibilities requires further investi-
gation. STAT1 binds the distal part of the IFN- response region
using an imperfect GAS, whereas the proximal site represents one
of the rather rare cases (15) where STAT1 binds a different
promoter sequence as a consequence of IFN- signaling. In an
analogous situation, the human 9/27 gene is rendered IFN--
inducible by a STAT1/IRF9 complex associatingwith an ISRE (12).
The presence of IRF9 at the gbp2 promoter in IFN--treated cells
has not been tested.
Consistent with recently reported immunoprecipitation (IP)
experiments (5, 29), our study demonstrates that CBP andHDAC1
are recruited to promoter chromatin in a STAT1-dependent man-
ner. The almost identical kinetics of recruitment after IFN-
treatment suggest that complexes of STAT1 dimers with CBP
and/orHDAC1 are either formed before binding to gbp2 chromatin
or that their assembly at the promoter is extremely rapid. Both the
HAT function of CBP and HDAC1 activity are needed to effi-
ciently activate gbp2 transcription (5, 23). CBP function closely
correlates with promoter histone hyperacetylation, but the target of
HDAC1 is still unknown. The concomitant recruitment of CBP and
HDAC1 favors the assumption that their target proteins are
different. Alternatively, they might be regulated to act on the same
targets in different phases of the transcriptional cycle. The highly
transient nature of histone 4 hyperacetylation at the gbp2 promoter
is in good agreement with the assumption that deacetylase activity
must closely follow that of the HAT.
Absence of IRF1 reduced, but did not abrogate CBP recruit-
ment and gbp2 promoter hyperacetylation. The rather small
decrease was closely correlated with, and most likely due to, the
reduced association of the promoter with STAT1 dimers in
irf1/ cells. Reduced levels of STAT1 in gene-targeted cells
result from IRF1’s role in regulating constitutive STAT1 expres-
sion downstream of autocrine type I IFN activity (30). This IRF1
activity and its delayed binding to gbp2 promoter chromatin with
respect to that of STAT1 binding argue against a helper function
of IRF1 for Stat1 association. More likely the reduction of CBP
recruitment and histone acetylation in irf1-deficient cells results
from a combination of low STAT1 amounts and low affinity of
the protein for the gbp2 IFN response region.
Using cells expressing IRF1 in absence of STAT1 dimers, we
were able to show that IRF1 associates with the gbp2 promoter in
the absence of prebound STAT1. Hence, STAT1 must neither
directly contact IRF1 nor modify chromatin as a prerequisite for
IRF1 binding. Furthermore, IRF1 association with the gbp2 pro-
moter chromatin was unaffected by the absence of STAT1 TAD
phosphorylation at S727 and the concomitant decrease in CBP
association to STAT1 dimers and histone 4 hyperacetylation (5).
Unperturbed association of IRF1 with the gbp2 promoter under
these conditions shows that the reduction of IFN--induced gbp2
expression in cells expressing STAT1S727A is correlated with an
absence of histone hyperacetylation, not a lack of IRF1 binding.
Our findings also suggest a very limited potential of IRF1 to recruit
HATs to the gbp2 promoter. Otherwise, defective histone acety-
lation in STAT1S727A cells should be rescued by IRF1. gbp2
belongs with a group of IFN--induced genes that strongly require
STAT1 serine phosphorylation. It is tempting to speculate that
IFN--induced genes that are less dependent on the STAT1 serine
phosphorylation require STAT1 interaction with transcriptional
proteins that either reduce the need for histone hyperacetylation, or
that, unlike IRF1, significantly contribute to HAT recruitment.
RNA pol II binding shows a virtually complete dependence on
IRF1. Gain-of-function analysis in cells expressing IRF1 in
absence of active STAT1 shows its limited intrinsic ability to
stimulate gene expression, and IPs demonstrate that IRF1 and
RNA pol II are parts of the same transcriptional complex.
Therefore, our data are consistent with a division of labor
between STAT1 and IRF1 in stimulating gbp2 expression. IRF1
plays an essential role in directing RNA pol II to the CAP site
through its ability to contact either the enzyme itself or associ-
ated proteins, one of which might be TFIIB (37). The important
role of IRF1 in RNA pol II recruitment is suggested not only by
the coimmunoprecipitation experiment, but also by the nearly
identical kinetics of IRF1 and RNA pol II association with gbp2
chromatin and the onset of nuclear gbp2RNA accumulation. For
STAT1, our findings support (at least) two different tasks in
activating gbp2 gene transcription. First, it must stimulate irf1
mRNA transcription. Second, it must directly contribute to gbp2
promoter activation by creating a more permissive chromatin
environment for RNA pol II through the recruitment of CBP
and possibly other HATs. STAT1 is also essentially required for
HDAC1 association with the gbp2 promoter chromatin, and
HDAC1 is important for gbp2 expression (23). Identifying the
relevant targets for this enzyme and determining whether they
are identical to those associated with type I IFN-induced tran-
scription (29, 38, 39) will be an important future task. Besides
CBP STAT1 is instrumental in directing MCM proteins and
possibly also other chromatin remodeling factors to target
promoters (24). The question of whether IRF1 additionally
contributes to the remodeling of promoter chromatin and struc-
ture will need to be answered. Several events appear to be
parallel between the gbp2 promoter and the pIV promoter of the
cIIta gene, encoding the master regulator of MHC II genes. Both
promoters recruit STAT1 and IRF1 with similar kinetics and
mediate a secondary, delayed response to IFN- (this work and
refs. 26 and 40). Both employ the HAT activity of P300/CBP and
the chromatin remodeling activity of the SWI/SNF subunit
BRG1 (25, 26, 41). On the other hand, HDAC1 has so far not
been implicated in CIITA regulation, and, conversely, the E box
binding protein USF1, which is needed for cIIta gene stimulation
(42), has not been linked to gbp2 mRNA expression. It will be
interesting to see whether these differences really distinguish the
two promoters or whether they reflect incomplete knowledge of
their regulation. In the latter situation, the identical mechanisms
of induction may represent a molecular paradigm for secondary
response promoters stimulated by IFN-.
Materials and Methods
Antibodies. Antiserum to the STAT1 C terminus used for
Western blot analysis and ChIP assays was as described (43).
STAT1 phospho-Y701 Ab was purchased from New England
Biolabs (Beverly, MA). Monoclonal panERK Abs were pur-
chased from Transduction Laboratories (Lexington, KY). Abs
for IRF1 (M-20) and RNA Pol II (N-20) and a polyclonal
antiserum to the N terminus of CBP were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Ab against
acetylated H4 was purchased from Upstate Biotechnology
(Lake Placid, NY). Affinity-purified rabbit Abs were used to
analyze HDAC1 by ChIP (23).
Cytokines and Reagents. Recombinant mouse IFN- was used at
a final concentration of 10 ng/ml (240 units/ml). Dox was
purchased from Sigma–Aldrich (St. Louis, MO) and used at a
final concentration of 1 g/ml.
Cells. Bone marrow-derived macrophages (BMDM) were obtained
by culture of bonemarrow inL-cell derivedCSF-1 as described (44).
Immortalized fibroblasts from WT, stat1/ (45), and irf1/ mice
(46) (kindly provided by J. Pavlovic, University of Zurich, Zurich,
Switzerland) were cultured in DMEM containing 10% FCS.
Plasmids and Transfections. irf1 cDNA was generated by using
RNA from IFN--treated macrophages and inserted into









pRetro-Off (Clontech, Palo Alto, CA). STAT1-deficient cells
were pretreated with dox for 6 h before transfection by using
ExGen (Fermentas) reagent according to the manufacturer’s
instructions. Cells were analyzed 48 h after transfection. Expres-
sion of IRF1 from the transfected plasmid was induced by
removal of dox for 24 h.
ChIP. A total of 107 cells (primary macrophages or fibroblasts with
identical results) were used per time point. ChIP assays were
performed as recently described (23) with the following Abs:
STAT1-C (1:100), IRF1 (3 g), RNA Pol II (3 g), CBP (3
g), acH4 (4 g), and HDAC1 (1:100). Primers used for the
analysis of the proximal (PROX) and distal (DIS) gbp2 promoter
were as described (5). For the irf1 promoter the following primers
were used: forward, 5-AGCACAGCTGCCTTGTACTTCC-3,
and reverse, 5-CTTAGACTGTGAAAGCACGTCC-3. All ChIP
data presented in this work represent a minimum of three inde-
pendent experiments.
RNA Preparation, cDNA Synthesis, and Quantitative RT-PCR. Total
RNAwas isolated from 1 106macrophages or fibroblasts by using
the NucleoSpin RNA II kit (Macherey &Nagel, Du¨ren, Germany)
as described (47). Nuclear RNAwas isolated from nuclear extracts,
prepared as described (48). The cDNAs were reverse-transcribed
from 5 g of total or nuclear RNA. Real-time PCR experiments
were normalized to the GAPDH housekeeping gene. Primers for
real-time PCR of the GAPDH, gbp2, and irf1 genes were used as
described (31, 47). Unspliced hnRNA was analyzed by real-time
PCR using primer pairs recognizing exon–intron borders. hn-irf1:
forward, 5-ACATCGATGGCAAGGGATAC-3, and reverse, 5-
GCATGCTGGGATGCTTTAAT-3; hn-gbp2: forward, 5-
TCCAAGGCAGATGTTGTT-3, and reverse, 5-CTCCACAAC
TGAGGACTCCA-3.
Coimmunoprecipitation. A total of 107 cells were harvested in PBS
and resuspended in 300l of sucrose buffer (0.32M sucrose/10mM
TrisHCl, pH 8/3 mM CaCl2/2 mM MgOAc/0.1 mM EDTA/0.5%
Nonidet P-40/1 mM DTT/0.5 M PMSF). The nuclei were pelleted
and washed twice in sucrose buffer (without Nonidet P-40) and
resuspended in 100 l of low-salt buffer (20 mM Hepes/1.5 mM
MgCl2/20 mM KCl/0.2 mM EDTA/25% glycerol/0.5 mM DTT/0.5
mM PMSF). Then, 100 l of high-salt buffer (20 mM Hepes/1.5
mMMgCl2/800mMKCl/0.2mMEDTA/25% glycerol/1%Nonidet
P-40/0.5 mM DTT/0.5 mM PMSF) was added slowly to the
suspension. The lysates were incubated for 45 min at 4°C on a
rotating wheel and centrifuged for 15 min at 14,000 g. One-tenth
of the supernatant was used as IP-input control and boiled with
Laemmli buffer for 10 min. Binding of STAT1 C-terminal Ab
(1:100 dilution) or with 3 g of IRF1 Ab was performed overnight
at 4°C. Protein A beads were added for 2 h, and the immunocom-
plexes were washed three times in low-salt buffer. The beads were
boiled in 50 l of Laemmli buffer and subjected to SDS gel
electrophoresis.
Western Blot. A protocol for this procedure was recently de-
scribed (31).
We thank Manuela Baccarini for critical reading of our manuscript. This
work was supported by Austrian Research Foundation Grant SFB
F28-B13, Subproject 2803 (to T.D.). G.Z. and C.S. were supported by the
Austrian Federal Ministry for Education, Science, and Culture
(GEN-AU Project ‘‘Epigenetic Plasticity of the Mammalian Genome’’)
and Austrian Research Foundation Project P16443 (to C.S.).
1. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) J Leukoc Biol 75:163–189.
2. Levy DE, Darnell JE, Jr (2002) Nat Rev Mol Cell Biol 3:651–662.
3. Wen Z, Zhong Z, Darnell JE, Jr (1995) Cell 82:241–250.
4. Decker T, Kovarik P (2000) Oncogene 19:2628–2637.
5. Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, Muller M, Decker T
(2003) Immunity 19:793–802.
6. Lew DJ, Decker T, Strehlow I, Darnell JE (1991) Mol Cell Biol 11:182–191.
7. Levy DE, Kessler DS, Pine R, Reich N, Darnell JE, Jr (1988) Genes Dev 2:383–393.
8. Pine R, Decker T, Kessler DS, Levy DE, Darnell JE, Jr (1990) Mol Cell Biol
10:2448–2457.
9. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N (2001) Annu Rev Immunol
19:623–655.
10. Kimura T, Nakayama K, Penninger JM, Kitagawa M, Harada H, Matsuyama T,
Tanaka N, Kamijo R, Vilcek J, Mak TW, Taniguchi T (1994) Science 264:1921–1924.
11. Kimura T, Kadokawa Y, Harada H,MatsumotoM, SatoM, Kashiwazaki Y, Tarutani
M, Tan RS, Takasugi T, Matsuyama T, et al. (1996) Genes Cells 1:115–124.
12. Bluyssen HA, Muzaffar R, Vlieststra RJ, van der Made AC, Leung S, Stark GR, Kerr
IM, Trapman J, Levy DE (1995) Proc Natl Acad Sci USA 92:5645–5649.
13. Ramana CV, Grammatikakis N, ChernovM, NguyenH, Goh KC,Williams BR, Stark
GR (2000) EMBO J 19:263–272.
14. Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, Stark GR (2001) Proc
Natl Acad Sci USA 98:6674–6679.
15. Hartman SE, Bertone P, Nath AK, Royce TE, Gerstein M, Weissman S, Snyder M
(2005) Genes Dev 19:2953–2968.
16. Decker T, Kovarik P (1999) Cell Mol Life Sci 55:1535–1546.
17. Weihua X, Kolla V, Kalvakolanu DV (1997) Proc Natl Acad Sci USA 94:103–108.
18. MacMicking JD (2004) Trends Immunol 25:601–609.
19. Briken V, Ruffner H, Schultz U, Schwarz A, Reis LF, Strehlow I, Decker T, Staeheli
P (1995) Mol Cell Biol 15:975–982.
20. Pine R, Canova A, Schindler C (1994) EMBO J 13:158–167.
21. Zhang JJ, Vinkemeyer U, Gu W, Chakravarti D, Horvath CM, Darnell JE, Jr (1996)
Proc Natl Acad Sci USA 93:15092–15096.
22. Zakharova N, Lymar ES, Yang E, Malik S, Zhang JJ, Roeder RG, Darnell JE, Jr
(2003) J Biol Chem 278:43067–43073.
23. Zupkovitz G, Tischler J, Posch M, Sadzak I, Ramsauer K, Egger G, Grausenburger
R, Schweifer N, Chiocca S, Decker T, Seiser C (2006) Mol Cell Biol 26:7913–7928.
24. Snyder M, He W, Zhang JJ (2005) Proc Natl Acad Sci USA 102:14539–14544.
25. Pattenden SG, Klose R, Karaskov E, Bremner R (2002) EMBO J 21:1978–1986.
26. Ni Z, Karaskov E, Yu T, Callaghan SM, Der S, Park DS, Xu Z, Pattenden SG,
Bremner R (2005) Proc Natl Acad Sci USA 102:14611–14616.
27. Nicolet CM, Paulnock DM (1994) J Immunol 152:153–162.
28. Anderson SL, Carton JM, Zhang X, Rubin BY (1999) J Interferon Cytokine Res
19:487–494.
29. Nusinzon I, Horvath CM (2003) Proc Natl Acad Sci USA 100:14742–14747.
30. Taniguchi T, Takaoka A (2001) Nat Rev Mol Cell Biol 2:378–386.
31. Kovarik P, Mangold M, Ramsauer K, Heidari H, Steinborn R, Zotter A, Levy DE,
Muller M, Decker T (2001) EMBO J 20:91–100.
32. Pine R (1992) J Virol 66:4470–4478.
33. Kirchhoff S, Schaper F, Hauser H (1993) Nucleic Acids Res 21:2881–2889.
34. Kroger A, Dallugge A, Kirchhoff S, Hauser H (2003) Oncogene 22:1045–1056.
35. Levy DE, Marie I, Prakash A (2003) Curr Opin Immunol 15:52–58.
36. Honda K, Yanai H, Takaoka A, Taniguchi T (2005) Int Immunol 17:1367–1378.
37. Wang IM, Blanco JC, Tsai SY, Tsai MJ, Ozato K (1996) Mol Cell Biol 16:6313–
6324.
38. Chang HM, Paulson M, Holko M, Rice CM, Williams BR, Marie I, Levy DE (2004)
Proc Natl Acad Sci USA 101:9578–9583.
39. Sakamoto S, Potla R, Larner AC (2004) J Biol Chem 279:40362–40367.
40. Morris AC, Beresford GW,MooneyMR, Boss JM (2002)Mol Cell Biol 22:4781–4791.
41. Kretsovali A, Agalioti T, Spilianakis C, Tzortzakaki E, Merika M, Papamatheakis J
(1998) Mol Cell Biol 18:6777–6783.
42. Muhlethaler-Mottet A, Di Berardino W, Otten LA, Mach B (1998) Immunity
8:157–166.
43. Kovarik P, Stoiber D, Novy M, Decker T (1998) EMBO J 17:3660–3668.
44. Baccarini M, Bistoni F, Lohmann Matthes ML (1985) J Immunol 134:2658–2665.
45. Durbin JE, Hackenmiller R, Simon MC, Levy DE (1996) Cell 84:443–450.
46. Reis LF, Ruffner H, Stark G, Aguet M, Weissmann C (1994) EMBO J 13:4798–4806.
47. Stockinger S, Reutterer B, Schaljo B, Schellack C, Brunner S, Materna T, Yamamoto
M, Akira S, Taniguchi T, Murray PJ, et al. (2004) J Immunol 173:7416–7425.
48. Solan NJ, Miyoshi H, Carmona EM, Bren GD, Paya CV (2002) J Biol Chem
277:1405–1418.
2854  www.pnas.orgcgidoi10.1073pnas.0610944104 Ramsauer et al.
Results 
  Page 53
A Role for IRF7 and TBK1 in the Regulation of IFN-γ 
Induced Genes 
IFNγ driven IRF7 expression is mediated via GAS and/or ISRE 
bound STAT1  
As discussed in Ramsauer et al., GBP2 expression is absent in Stat1 -/- MEFs whereas 
Irf1 -/- MEFs still show residual expression of GBP2 mRNA after treatment with 
IFNγ (Ramsauer et al., 2007). Residual GBP2 transcription may reflect exclusive 
STAT1 action or result from the activity of a different IRF family member, like IRF8 
(ICSBP), which has been shown to contribute to IFNγ mediated gene expression under 
various conditions. Additional IRF family members that have been linked to contribute 
in the regulation of ISGs are IRF3 and IRF7 (Savitsky et al., 2010). IRF3 belongs to the 
Class I family of transcription factors and is therefore constitutively expressed. In 
contrast, IRF7 is a Class II transcription factor. Binding of  ISGF3 to two defined ISREs 
in the 5’UTR of the gene, confers IRF7 gene responsiveness exclusively to type I IFNs. 
IRF3 and IRF7 have both been shown to be crucial regulators of responses to viral or 
bacterial infections, since gene expression of IFNβ and IFNα4 strictly depends on the 
activation of IRF3 and IRF7 (Honda et al., 2005; Panne et al., 2007). Moreover, IRF7 
expression and activation is needed for the second wave of type I IFN production during 
prolonged infections by upregulating the expression of all IFNα genes, independently of 
IRF3, with IFNα4 as notable exception (Marié et al., 1998; Honda et al., 2005; Caillaud 
et al., 2005; Génin et al., 2009).  
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To study a possible contribution of IRF7 in the regulation of IFNγ driven gene 
expression, we tested whether IRF7 is expressed after treatment of WT MEFs with IFNγ. 
Indeed we could show an increase of IRF7 mRNA after IFNγ treatment (Figure 12B). 
Since IFNγ signaling in most situations occurs not through the formation of an active 
ISGF3 complex, which can bind to the two known ISRE sites, this finding suggests two 
possible explanations. First, IRF7 expression after IFNγ treatment can be mediated by 
the presence of a GAS in the promoter or an enhancer region of the Irf7 gene. Or, 
second, it may indicate a contribution of a STAT1-IRF9 complex. Such complexes are 
known to form in vitro (Bluyssen et al., 1995) and previous studies addressing the 
regulation of the Gbp2 gene by IFNγ suggest they may play a role in this situation 
(Varinou et al., 2003).  
Sequence analysis of the murine Irf7 gene promoter and upstream sequences revealed a 
GAS, which follows the perfect consensus sequence TTCTCTGAA, located in an 
enhancer region 1117bp upstream of the TSS (Figure 12A). Moreover, the human Irf7 
gene promoter, contains a GAS directly at the promoter ranging from 35bp to 27bp 
upstream of the TSS and confers IFNγ responsiveness in recent microarray experiments 
(Saha et al., 2010). To test whether the GAS of the murine Irf7 enhancer binds STAT1 
homodimers in response to IFNγ, we performed ChIP assay analysis for STAT1 and 
STAT2 binding in WT MEFs. STAT1 but not STAT2 was found to bind the GAS 
enhancer in response to IFNγ within 30 minutes after treatment. In addition, very little 
STAT1 but again no STAT2 was found at the GAS enhancer after IFNβ treatment. 
Interestingly, STAT1 was found to bind the ISRE containing promoter in addition to the 
enhancer after 30 minutes of treatment with IFNγ. As expected both STAT1 and STAT2 
bind the ISRE sites after treatment with IFNβ.  
Our data suggests that IRF7 mRNA expression in response to IFNγ is regulated via the 
binding of STAT1 to both the enhancer and promoter region. Promoter binding of 
STAT1 appears to be much more transient compared to the recruitment to the enhancer 
region, pointing at a stronger effect of STAT1 homodimers at the newly defined 
enhancer. Although STAT1 binding to both regions might be needed for full expression 
of IRF7 mRNA, the sustained IRF7 expression after 4hrs of IFNγ treatment (Figure 12B) 
might depend predominantly on the enhancer bound STATs. 
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Figure 12: Kinetics of IRF7 mRNA expression and STAT1 recruitment to the Irf7 
promoter, determined by qPCR and ChIP, respectively. (A) Schematic drawing of the 
promoter ISRE sites located in the 5’UTR of the Irf7 gene, and the newly defined GAS 
located in the enhancer region 1.1kb upstream of the TSS. (B) IRF7 mRNA expression 
after treatment of WT and Irf7 -/- MEFs with IFNγ for the indicated time points, was 
determined by qPCR. (C) WT MEFS were stimulated with IFNγ or IFNβ and processed 
for ChIP at the indicated time points. Antibodies for ChIP are shown on the left, P.I. 
indicates controls performed with preimmune sera. The precipitates were amplified by 
PCR with primers flanking the enhancer (GAS) or promoter (ISRE) region as indicated 
in (A) and analyzed by gel-electrophoresis.   
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ISGF3 driven gene-expression after IFNγ treatment depends on 
IRF7 
Next we asked whether IRF7 and/or IRF3 might contribute to IFNγ-induced target gene 
expression and in turn be responsible for the residual expression of GBP2 mRNA, 
observed in the previous section (Ramsauer et al. 2007). We monitored the mRNA 
expression profile of several ISGs by qPCR analysis. WT MEFs or MEFs deficient for 
IRF7 or IRF3 were analyzed after treatment with IFNγ. mRNA expression of ISRE-
driven genes, like Gbp2 or Tap1, depended on the presence of IRF7, which appeared to 
be strongest at later time points after treatment. Expression of SOCS1, was also found 
to be IRF7 dependent. Interestingly, the Socs1 5’ flanking region contains a bonafide 
IRF binding site in an enhancer at position -1772 to -1764, following the consensus 
TTTCTTTTT, which is conserved in humans (Schlüter et al., 2000). mRNA expression 
of Irf1, which contains only a GAS in its promoter, showed very little IRF7 dependency. 
ISG mRNA expression in Irf3 -/- MEFs was strongly diminished in all tested cases, 
including IRF1 (Figure 13A-D). This finding points to a more general and maybe 
indirect effect of IRF3 in the regulation of ISGs and is consistent with the reported role 
of IRF3 in maintaining STAT1 expression through autocrine type I IFN production 
(Taniguchi and Takaoka, 2001; Stockinger et al., 2004). To examine STAT1 levels in 
Irf3 -/- or Irf7 -/- MEFs we performed Western blot analysis using a STAT1 C-terminal 
antibody. The activation status of STAT1 was revealed by the use of a STAT1 
phosphotyrosine 701 specific antibody, since small differences in STAT1 levels might 
not alter STAT1 activation under the tested conditions. In line with the published work 
on IRF3-dependent autocrine type I IFN signaling, Irf3 -/- MEFs displayed severely 
reduced STAT1 levels compared to WT MEFs, which altered STAT1 activation 
capacity, leading to drastically reduced levels of tyrosine-phosphorylated STAT1. 
Reduced IRF1 mRNA expression in Irf3 -/- MEFs was supported by the finding of 
reduced IRF1 protein levels in these cells. In contrast, Irf7 -/- MEFs displayed normal 
levels of STAT1 and a normal STAT1 phosphotyrosine pattern upon IFNγ treatment, 
comparable with WT MEFs. In line with mRNA expression, IRF1 protein expression 
was,  not altered in Irf7 -/- MEFs (Figure 13E).  
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Taken together our results indicate a direct role for IRF7 in regulating ISG expression in 
response to IFNγ stimulation. However, the gene regulatory function of IRF7 in this 
context appears to be confined to ISRE-driven genes. IRFs in general have the 
capability to bind directly the core sequence within the ISRE consensus repeat, with 
little or no variation within the different IRF species (Savitsky et al., 2010). Moreover, 
the results monitoring the mRNA expression of identified IRF7-driven genes, including 
Gbp2, show that target gene expression is reduced, but not completely abrogated, in Irf7 
-/- MEFs. This in turn points to a role for IRF7 in enhancing target gene expression, to 
achieve more prolonged expression profiles.  
 
Figure 13: Kinetics of ISRE and GAS-driven genes, after IFNγ treatment, determined 
by qPCR and Western-blot. WT, Irf3-/- and Irf7 -/- MEFs were treated with IFNγ for 
the indicated time points. (A-D) GBP2, TAP1, SOCS1 and IRF1 mRNA expression was 
determined by q-PCR after normalization to GAPDH levels. (E) IRF1 protein 
expression and STAT1 tyrosine phosphorylation were detected in Western-blot analysis. 
Differences in STAT1 expression levels between WT MEFs and MEFs deficient for 
Irf3 or Irf7, were analyzed by reprobing the blot with an antibody against STAT1 C-
terminus. Pan ERK levels were analyzed as a normalization control. 
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IRF1 and IRF7 synergistically drive GBP2 expression; 
Differential requirement for TBK1 and IKKε for IRF7 mediated, 
IFNγ driven gene expression  
IRF7 is known to form either homo- or heterodimers with other IRF family members, 
mainly IRF3 in the context of IFNβ and IFNα4 gene expression after pathogen 
exposure (Lin et al., 2000; Au et al., 2001; Au and Pitha, 2001). IRF1 is so far known to 
physically and functionally interact with IRF8 among the IRF family (Laricchia-Robbio 
et al., 2005), and participates in the IRF3 and IRF7 mediated regulation of human 
IFNalpha genes (Au and Pitha, 2001). Since all of the IFNγ-inducible genes identified 
above as IRF7 target genes are known targets for IRF1, we wondered whether IRF7 has 
the capability to functionally interact with IRF1 to drive ISG expression. To test for a 
possible interplay of IRF7 with IRF1 in the regulation of GBP2 mRNA expression, we 
performed reporter gene assays with IRF7 and IRF1 expressing constructs. Transfection 
of equal copy numbers of Irf1 or Irf7 genes in the context of an otherwise identical 
expression plasmid demonstrated a nearly identical ability to stimulate the Gbp2 
promoter-luciferase reporte gene. Cotransfection of the same copy number of combined 
Irf1 and Irf7 genes produced a two-fold higher activity of the Gbp2 promoter (Figure 
14A). In this experiment, Stat1 -/- MEFs were transfected to avoid indirect stimulation 
of the Gbp2 reporter through IRF7-driven IFNα expression. 
IRF7, like IRF1, was able to induce the Gbp2 reporter on its own. In the context of 
infection, the transcriptional activity of IRF7 has been shown in numerous studies to 
rely on the activity of the kinases TBK1 and IKKε. The two enzymes were shown to act 
redundantly for the activation of IRF3 and IRF7 and the production of type I IFN in 
anti-viral responses (Perry et al., 2004)(Stockinger et al., 2004; Stetson and Medzhitov, 
2006; Soulat et al., 2006), although recent reports show differences at least in the mode 
of their activation (Honda et al., 2005; Chau et al., 2008). Challenging the view of 
functional redundany, antagonistic activity of TBK1 and IKKε, based on competition 
for a common adapter protein, was recently suggested by the group of John Hiscott (Paz 
et al., 2009).  
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To determine whether TBK1 and IKKε kinase function is needed for the transcriptional 
activity of IRF7 in connection with IFNγ induced genes, we performed qPCR analysis 
for the expression of IRF7 target genes after treatment of either WT or double-deficient 
Tbk1/Ikbke -/- MEFs with IFNγ. mRNA expression of the previousely identified IRF7 
targets, depended differentially on the presence of the two kinases. We observed the 
strongest effect on gene expression in Tbk1/Ikbke -/- MEFs for Gbp2 and Tap1, 
showing a decrease in mRNA expression levels by more than 50% (Figure 14B,C). 
Conversely, like the IRF7 independent Irf1 gene, SOCS1 mRNA expression did not 
display a significant reduction in Tbk1/Ikbke -/- MEFs (Figure 14D,E).  
To further examine the role of particularly TBK1 in the regulation of the transcriptional 
activity of IRF7 on the Gbp2 gene, we performed co-transfection experiments with 
IRF7 and TBK1 in Tbk1/Ikbke -/- MEFs. In contrast to the transfection of IRF7 in Stat1 
-/- MEFs (Figure 14A), which still express TBK1 and IKKε, IRF7 transfection into 
Tbk1/Ikbke -/- MEFs was not able to induce Gbp2 reporter gene expression (Figure 14F). 
By contrast, cotransfection of IRF7 and TBK1 strongly increased Gbp2 reporter gene 
expression. Addition of an antibody blocking the accessibility of the IFNAR for its 
ligands (Sheehan et al., 2006), was without effect on expression of the reporter gene in 
this experiment. Hence we can rule out a contribution of type I IFN signalling to the 
ability of transfected TBK1/IRF7 to activate the Gbp2 promoter under our experimental 
conditions. (Figure 14F).  
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Given the ability of IFNγ to induce IRF7 mRNA expression and the TBK1 requirement 
for IRF7 activity, we wondered whether IFNγ treatment causes activation of TBK1. To 
test this hypothesis, we performed cotransfection experiments introducing IRF7 and 
TBK1 in Stat1 -/- MEFs. The cells were subsequently treated with IFNγ or left without 
treatment. Stat1 -/- MEFs express the kinases TBK1 and IKKε, but are not able to 
stimulate the Gbp2 reporter via activation of STAT1. Treatment of IRF7-transfected 
Stat1 -/- MEFs with IFNγ did not significantly enhance the reporter gene activity. 
Moreover,  IRF7 synergized with TBK1 in these cells to enhance Gbp2 reporter gene 
expression in Stat1 -/- MEFs, irrespective of prior treatment with IFNγ (Figure 14G). 
The synergism suggests that TBK1 directly acts on the large amounts of IRF7 present in 
transfected cells. Unlike IRF7, IRF1’s transcriptional activity is thought to occur 
without phosphorylation-mediated activation (Savitsky et al., 2010). In keeping with 
this notion, IRF1 and TBK1 cotransfection resulted in a modest increase of Gbp2 
reporter gene expression. This increase is likely to reflect the activity of TBK1 on 
endogenous IRF7 substrates rather than on the cotransfected IRF1 (Figure 14H). 
The results from IRF7 and TBK1 cotransfection experiments in Tbk1/Ikbke -/- MEFs 
indicates that IRF7 must be phosphorylated to efficiently drive the expression of GBP2 
and that the phosphorylating activity is present in WT or Stat1-/-, but not in 
TBK1/IKKe-deficient fibroblasts (Figure 14F). To examine the IRF7 phosphorylation 
status we performed 2D gel electrophoresis with nuclear extracts of WT and Tbk1/Ikbke 
-/- MEFs after treatment with IFNγ for 4hrs to induce IRF7 expression, and probed the 
membrane with polyclonal IRF7 antibody (Caillaud et al., 2005). Preliminary results 
showed the formation of at least one TBK1/IKKε-dependent IRF7 phosphoisoform 
(Figure 14I).  
Thus, our results indicate, that IRF1 and IRF7 synergistically regulate the expression of 
ISRE- driven genes upon stimulation with IFNγ. IRF7 in this context appears to be 
phosphorylated in an TBK1/IKKε dependent manner. IRF7 is phosphorylated at least on 
one serine residue by constitutively active TBK1 and/or IKKε, since IFNγ treatment has 
no enhancing effect on Gbp2 reporter gene expression, and the expression levels of the 
Gbp2 reporter observed after transfection of only IRF7 in Stat1 -/- MEFs, is completely 
abrogated in Tbk1/Ikbke -/- MEFs. 
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Figure 14: Regulation of IFNg-induced genes by IRF1 and IRF7; requirement for 
TBK1-mediated phosphorylation. , (A) Stat1 -/- MEFs were transfected with either 
IRF1 or IRF7 and Gbp2 – luciferase reporter activity was measured. The values are 
expressed as -fold induction relative to cells transfected only with reporter construct 
after normalization to a co-transfected Renilla luciferase reporter. (B-E) Expression of 
GBP2, TAP1, SOCS1 and IRF1 mRNA in WT and Tbk1/Ikbke -/- MEFs after IFNγ 
treatment for the times indicated, was analyzed by qPCR and normalized to GAPDH 
mRNA levels. (F) Tbk1/Ikbke -/- MEFs were transfected with IRF7 or TBK1 alone, or a 
combination of both. MEFs were treated with IFNAR1 blocking antibody for the whole 
period of transfection or left untreated. (G) Stat1 -/- MEFs were transfected with IRF7 
or TBK1 alone or in combination. Trnafected cells were stimulated over night with 
IFNγ or left untreated. (H) Stat1 -/- MEFs were transfected with IRF1 or TBK1 alone or 
in combination .In panels F-H Gbp2 luciferase reporter activity was measured as 
decribed for (A). (I) Requirement for TBK1/IKKε mediated IRF7 phosphorylation 
determined by 2D gel electrophoresis. Nuclear extracts of WT or Tbk1/Ikbke -/- MEFs 
were subjected to 2D gel electrophoresis. IRF7 isoforms were analyzed by Western 
blotting using an antibody against IRF7. 
Critical role of serines (S425 - S426 and S437 - S438) of the IRF7 
regulation domain as phosphoacceptors for both the 
stimulation of IRF7 activity by TBK1 and its repression by IKKε.  
IRF7 can be activated by phosphorylation of several serine residues, located in the 
carboxy terminal regulatory domain (Marié et al., 2000; Caillaud et al., 2005). For in 
depth analyzes of the serine residues required for IRF7 transcriptional activity at the 
Gbp2 promoter we performed transfection experiments in Stat1 -/- MEFs and 
Tbk1/Ikbke -/- MEFs with a set of IRF7 phosphomutants, generated by Isabelle Marié 
and David Levy (Figure 15A; (Caillaud et al., 2005)).  
Transfection of WT IRF7 as well as the serine to alanine mutants M1 (S425A and 
S426A) and M5 (S437A and S438A) in Tbk1/Ikbke -/- MEFs failed to induce Gbp2 
reporter gene expression, whereas transfection of the serine to aspartate mutant M15 (all 
serines except S425 and Ser426 are mutated to aspartate), upregulated Gbp2 reporter 
gene activity very efficiently (Figure 15B). Co-transfection of TBK1, to reconstitute 
kinase activity, increased reporter gene activity drastically in the case of both WT IRF7 
and the M15 mutant. TBK1 co-transfection with M1 and M5 mutants led to a moderate 
increase of Gbp2 reporter gene expression.  
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Since the two pairs of serines (S425 - S426 and S437 - S438) mutated in the IRF7 M1 
and M5 mutants proved crucial in our experiments we next transfected the IRF7 M12 
and M18 mutant in our setup with Tbk1/Ikbke -/- MEFs, to further examine the effect of 
aspartate substitutions of the most N-terminal serines (S425 and S426) as well as serines  
in the middle (S429, S430, and S431) and at the C-terminal end (S441) of the regulatory 
region (Figure 15A). The IRF7 M18 mutant did not increase reporter gene expression 
when transfected alone into Tbk1/Ikbke -/- MEFs, but produced an enhanced reporter 
gene activity when co-transfected with TBK1. The M12 mutant exerted a similar pattern, 
but stimulation of reporter gene expression by this mutant in absence of  TBK1 was 
higher compared to M18. In spite of containing aspartates in all except the most C-
terminally located position, the IRF7 M12 mutant was not as efficient as the IRF7 M15 
mutant in inducing reporter gene expression, neither when transfected alone, nor 
together with TBK1 (Figure 15D).  
Compared with the results obtained in Tbk1/Ikbke -/- MEFs, all mutants behaved similar 
when transfected into Stat1-/- MEFs, with two notable exceptions: first, reporter gene 
expression stimulated by the M15 mutant did not exceed the levels obtained with WT 
IRF7;  second, the overall inducibility of the reporter gene by transfected IRF7 was 
much lower in Stat1 -/- MEFs than in Tbk1/Ikbke -/- MEFs (Figure 15C).  
Extending the setup in Stat1 -/- MEFs with the additional transfection of IRF7 M12 and 
M18 mutants revealed that in contrast to the picture seen in Tbk1/Ikbke -/- MEFs, IRF7 
M18 mutant was not able to drive reporter gene expression, neither when transfected 
alone nor when cotransfected with TBK1. Transfection of IRF7 M12 mutant still 
induced Gbp2 reporter gene expression in Stat1 -/- MEFs when transfected alone, but, 
unlike Tbk1/Ikbke -/- MEFs, co-transfection with TBK1 did not enhance the reporter 
gene expression (Figure 15E).  
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Transfection of the IRF7 M15 mutant, alone or together with TBK1 in Tbk1/Ikbke -/- 
MEFs, was more efficient in driving Gbp2 reporter gene expression than WT IRF7 
under the same conditions. In contrast, transfection of IRF7 M15 mutant in Stat1 -/- 
MEFs, alone or together with TBK1, never induced the Gbp2 reporter gene to the level, 
or even beyond the level seen after transfection of WT IRF7 (compare Figure 15D with 
15E). This finding prompted us to to examine whether the damped reporter gene 
expression levels in Stat1 -/- MEFs could be an effect of IKKε, the most prominent 
player in IRF regulation differing between Stat1-/- MEFs and  Tbk1/Ikbke -/- MEFs 
after reconstitution with TBK1. To directly assess whether effects of TBK1 and IKKε 
differ with regard to GBP2 promoter activation,  WT or mutant IRF7 was introduced to 
Tbk1/Ikbke -/- MEFs by transfection and  IKKε was co-introduced instead of TBK1. 
Interestingly, we found that unlike TBK1, IKKε did not activate either WT or mutant 
IRF7 for increased activity on the Gbp2-reporter gene. In addition, the phosphorylation-
independent activity of  the IRF7 M15 mutant was suppressed by IKKε. Importantly, 
the increase in reporter gene expression seen after cotransfection of TBK1 with either 
WT IRF7 or IRF7 M15 was strongly suppressed by the additional presence of  IKKε. 
(Figure 15F). 
Taken together our results indicate that a combination of phosphorylated serines is 
needed for full transcriptional activity of IRF7 to induce GBP2 expression. Compared to 
WT IRF7 the M15 mutant exhibited higher activity in Tbk1/Ikbke-/- MEFs, after 
cotransfection with TBK1. This suggests that not all of the phosphomimetic sites in the 
M15 mutant are phosphorylated by TBK1 on WT IRF7. In addition, the two most N-
terminal serines in the regulatory domain are crucial for IRF7 activity on the GBP2 
promoter. These residues are the only ones not mutated to aspartate in the M15 mutant 
and must, therefore, be responsible for further activation of this mutant after TBK1 
cotransfection. The reduced activation of the M1 mutant with the two N-terminal 
serines mutated to Ala corroborates this interpretation. Our findings are very much in 
line with the data generated by Marié and colleagues in previous studies (Caillaud et al., 
2005).  
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Co-transfection of IKKε instead of TBK1 resulted in decreased transcriptional activity 
of the M15 mutant, indicating that one of the two N-terminal serines is a target for IKKε 
and results in repression of IRF7 transcriptional activity. In line with our findings, 
Marié and colleagues identified in previous studies the first serine residue to be a 
possible IKKε target and assumed a role for IKKε in negative regulation of IRF7 
activity (Caillaud et al., 2005).  
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Figure 15: Transcriptional activity of IRF7 mutants. (B-G) Transactivation of the Gbp2 
promoter by different mutants of IRF7. Stat1 -/- MEFs (C,E) or Tbk1/Ikbke -/- MEFs 
(B,D,F) were transfected with WT IRF7 or the IRF7 mutants indicated in (A). 50ng of 
IRF7 constructs were transfected alone or co-transfected with either 1µg TBK1 
(B,D,E,F), 1µg IKKε (F) or the combination of 0,5µg TBK1 and 0,5µg IKKε (F) as 
indicated. Gbp2 reporter gene expression is indicated as -fold induction relative to cells 
transfected only with reporter construct after normalization to co-transfected, 
constitutively expressed and Renilla luciferase reporter. (G) Summerizing Table of the 
results with the transfected IRF7 mutants in Stat1-/- MEFs or Tbk1-Ikbke -/- MEFs, 
alone or together with TBK1 and/or IKKε. 
Simultaneous recruitment of both IRF1 and IRF7 to the Gbp2 
promoter of IFNγ-treated cells 
According to our findings, IRF1 and IRF7 interacted at least functionally to drive the 
expression of ISRE driven genes in the context of an IFNγ response. Next, we asked 
whether IRF1 and IRF7 colocalize on the promoter of the Gbp2 gene following 
treatment of cells with IFNγ. For this purpose we performed ChIP and reChIP assay 
analysis and monitored the binding of IRF1 and IRF7 by qPCR to the Gbp2 gene 
promoter. This protocol was chosen to reduce the background obtained in single-round 
ChIPs with our antibody to IRF7. The Gbp2 promoter can be devided into a distal and 
proximal region, containing either a GAS and ISRE site or only one ISRE site, 
respectively (Figure 16A). Both regions were shown to bind IRF1 efficiently after IFNγ 
treatment (Ramsauer et al., 2007). Repeatedly, we observed an increased binding of 
IRF1 to both promoter regions, with virtually indistinguishable kinetics (Figure 16B,E).  
ChIP-reChIP experiments with an IRF7 antibody recently  generated by our lab 
revealed IRF7 to be associated with both regions of the Gbp2 promoter. In contrast to 
IRF1 binding, kinetics of IRF7 association was different comparing the distal and the 
proximal region (Figure 16C,F). In general IRF7 occupancy of the Gbp2 promoter, 
followed the IRF7 mRNA expression profile (Figure 12). IRF7 association with the 
distal Gbp2 promoter region appeared to be more sustained and increased towards the 
end of the measurement period, whereas IRF7 binding to the proximal promoter clearly 
peaked after 3 hrs of IFNγ treatment. Sequential ChIP with antibody against IRF7 and 
re-ChIP with an IRF1 specific antibody, displayed a pattern for IRF1 and IRF7 co-
occupancy at both promoter regions similar to the one observed for IRF7 association, 
(Figure 16D,G). 
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To test whether phosphorylation of IRF7 is important for its association with the Gbp2 
promoter we assessed IRF7 and IRF1 recruitment to the proximal Gbp2 promoter in 
WT and Tbk1/Ikbke -/- MEFs by sequential ChIP assays. ChIP for IRF1 and reChIP for 
IRF1 revealed that IRF1 binding to the Gbp2 promoter is similar in both genotypes. 
IRF7 recruitment was unimpeded in Tbk1/Ikbke -/- MEFs, as revealed by ChIP of IRF1 
and reChIP of IRF7 (Figure 16H,I). 
To test the specificity of the newly generated IRF7 antibody, we performed ChIP-
reChIP analysis in WT and Irf7 -/- MEFs, stimulated with IFNγ. Our results show that, 
IRF7 does not bind to the Gbp2 promoter of Irf7 -/- MEFs. Furthermore, the 
background of IRF7 binding was similar between untreated WT MEFs and untreated 
Irf7 -/- MEFs, suggesting that  IRF7 is not constitutively associated with the Gbp2 
promoter (Figure 16J). 
Taken together our results indicate that IRF1 and IRF7 co-occupy the distal and 
proximal Gbp2 promoter, but binding of IRF1 precedes that of IRF7, since the IRF 
prototype binds to the Gbp2 promoter already 1 hour after IFNγ treatment (Ramsauer et 
al., 2007), reaching its maximum after 2 hrs. In contrast, little IRF7 binding was 
detected after 2 hours, followed by a peak of IRF7 binding after 3 hrs of treatment. 
IRF7 binding was not reduced in Tbk1/Ikbke -/- MEFs, indicating that phosphorylation 
of IRF7 by either kinase is not required for nuclear translocation and DNA binding. 
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Figure 16: IRF1 and IRF7 recruitment to the Gbp2 promoter after treatment with IFNγ. 
(A) Schematic drawing of the GAS located in the distal region and ISRE sites located in 
both, the distal and proximal promoter region of the Gbp2 gene. (B-J) WT MEFs (B-J), 
Tbk1/Ikbke -/- MEFs (H,I), or Irf7 -/- MEFs were treated with IFNγ for the times 
indicated. The cells were processed for ChIP (B,E) or ChIP-reChIP (C,D,F,G-J). 
Antibodies used are shown on top of the panels. The precipitates were amplified with 
primers flanking the distal (B-D) or proximal (E-J) Gbp2 promoter and analyzed by 
qPCR. Data are expressed as % of input DNA.  
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Transcriptional regulation of theNos2 gene encoding
inducible nitric oxide synthase (iNOS) requires type I
interferon (IFN-I) signaling and additional signals
emanating from pattern recognition receptors. Here
we showed sequential and cooperative contributions
of the transcription factors ISGF3 (a complex
containing STAT1, STAT2, and IRF9 subunits) and
NF-kB to the transcriptional induction of the Nos2
gene in macrophages infected with the intracellular
bacterial pathogen Listeria monocytogenes. NF-kB
preceded ISGF3 at theNos2 promoter and generated
a transcriptional memory effect by depositing basal
transcription factor TFIIH with the associated CDK7
kinase for serine 5 phosphorylation of the RNA poly-
merase II (pol II) carboxyterminal domain (CTD).
Subsequent to TFIIH deposition by NF-kB, ISGF3 at-
tracted the pol II enzyme and phosphorylation at CTD
S5 occurred. Thus, STATs and NF-kB cooperate
through pol II promoter recruitment and the phos-
phorylation of its CTD, respectively, as a prerequisite
for productive elongation of iNOS mRNA.
INTRODUCTION
The production of nitric oxide (NO) occurs during innate immune
responses to all classes of pathogens (Bogdan, 2001). The
molecule has direct antimicrobial activity, contributes to cell
signaling, and regulates cell survival (Bogdan, 2001; Zwaferink
et al., 2008). Inducible nitric oxide synthase (iNOS), the enzyme
encoded by the Nos2 gene and responsible for NO production
during infection, is synthesized de novo as a response to the
recognition of microbial molecular patterns. Studies with bacte-
rial lipopolysacharide (LPS) or with pathogen-infected murine
cells showed that full transcriptional induction of Nos2 and of
NO production occurs only after synthesis of type I interferons
(IFN-I) and signaling through the Janus kinase (JAK)-STATpathway (Bogdan, 2001; Gao et al., 1998). Type II IFN (IFN-g),
produced by natural killer (NK) and T cells, also enhances mouse
Nos2 induction by LPS in a manner requiring STAT1 activation by
the IFN-g receptor complex (IFNGR [Meraz et al., 1996]).
Together the published work suggests that IFN receptor-acti-
vated STATs cooperate with non-IFN signals in the transcrip-
tional regulation of Nos2.
Previous analyses of the murine Nos2 promoter revealed an
IFN response region and binding sites for NF-kB (Kleinert et al.,
2003). The IFN response region contains binding sites for
STAT1 dimer (gamma IFN-activated site, GAS [Xie et al., 1993])
and interferon regulatory factors (IRF [Kamijo et al., 1994; Spink
and Evans, 1997]). IFN-g signaling leads to the formation of
STAT1 homodimers and IRF1, both of which were shown to be
essential for Nos2 induction by IFN-g/LPS (Kamijo et al., 1994;
Meraz et al., 1996). IFN-I causes formation of both STAT1 dimers
and the ISGF3 complex, which comprise a STAT1/STAT2/IRF9
heterotrimer (Darnell, 1997; Schindler et al., 2007). It is unclear
which of these complexes contributes to iNOS regulation by
IFN-I and whether IFN-I, like IFN-g, stimulate Nos2 transcription
with strong dependence on IRF1 or other IRF family members.
The analysis of signals received by the Nos2 promoter directly
from pattern recognition receptors emphasizes the role of
NF-kB. Two sites for the transcription factor were identified
(Kleinert et al., 2003; Lowenstein et al., 1993; Xie et al., 1994).
Particularly the binding element proximal to the transcription
start proved essential for the activity of the transfected promoter.
Listeria monocytogenes is a Gram-positive bacterial pathogen
replicating in the cytoplasm of mammalian host cells. It is recog-
nized by a variety of different pattern recognition receptors
including toll-like receptors and NOD-like receptors (TLR and
NLR, respectively) (Edelson and Unanue, 2002; Herskovits
et al., 2007). In murine bone marrow-derived macrophages,
a hitherto unknown cytoplasmic receptor initiates signaling to
the IFN-I genes and subsequent release of IFN-I from the infected
cells (Stetson and Medzhitov, 2006; Stockinger et al., 2004).
Exclusion of L. monocytogenes from the cytoplasm, e.g., by
mutation of its major virulence factor Listeriolysin O, completely
abrogates the ability to stimulate IFN-I production (Stockinger
et al., 2002). As with LPS, transcriptional induction of the Nos2
promoter was strongly diminished when either IFN-I productionImmunity 33, 1–10, July 23, 2010 ª2010 Elsevier Inc. 1
Figure 1. Kinetics of iNOS Induction Deter-
mined by q-PCR
(A) Exposure of bone marrow-derived macro-
phages to living L. monocytogenes (LL) or to
cotreatment with heat-killed Listeria (hkL) and
IFN-b.
(B) Bone marrow-derived macrophages were
treated with hkL, IFN-b, or a combination of both.
Error bars represent standard deviations from trip-
licate samples. The experiments were repeated at
least three times.
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this work, we now asked the question why the Nos2 gene, unlike
classical IFN-I-stimulated genes (ISGs) or NF-kB target genes,
requires input from both STATs and signals derived directly
from pattern recognition receptors for maximal transcriptional
induction. Combining an examination of transcription factor
and signaling requirements for transcriptional induction with an
analysis of transcription factor binding to the Nos2 promoter
in situ, we conclude that NF-kB enhances carboxy-terminal
domain (CTD) phosphorylation of RNA pol II, after recruitment
of the enzyme by STATs.RESULTS
Cytoplasmic and Precytoplasmic Signals Synergize
in Nos2 Induction
As discussed above, the innate immune response to L. monocy-
togenes results initially from plasma membrane and endosomal
pattern recognition during entry and from cytoplasmic sensing
after cytoplasmic escape. The Nos2 gene is paradigmatic for
a large group of genes coregulated by pattern recognition recep-
tors and IFN-I (Doyle et al., 2002; Toshchakov et al., 2002).
To test whether IFN-I synthesis was the only essential signal
for Nos2 induction derived from the cytoplasmic signaling, the
two recognition phases were separated by treating macro-
phages with heat-killed L. monocytogenes (hkL) and with IFN-b
either separately or together. Heat-killed Listeria are confinedTo be able to compare data between individual experiments, genotype-specific ex
bars represent standard deviations from triplicate samples. The mentioned expe
2 Immunity 33, 1–10, July 23, 2010 ª2010 Elsevier Inc.to phagosomes and cannot stimulate the cytoplasmic signal
required for IFN-I production. hkL and IFN-b alone were poor
inducers of iNOS mRNA synthesis (Figure 1). By contrast, both
signals together synergized to produce the full-blown iNOS
synthesis seen with viable L. monocytogenes. This result
suggests that cytoplasmic signaling can indeed be recapitulated
by providing IFN-I. In addition, it provides a valuable experi-
mental tool to separate effects of non-IFN-I and IFN-I signals
on the Nos2 promoter and to study each independently from
the other. In agreement with IFN-I synthesis preceding Nos2
transcription, the kinetics of mRNA synthesis after infection
with viable L. monocytogenes were delayed compared to the
simultaneous treatment with hkL and IFN-b.
Many genes expressed in macrophages infected with
L. monocytogenes were found in a microarray experiment to
display a pattern of regulation resembling that of the Nos2
gene. 38 genes showing the strongest synergy effect between
IFN-b alone and the additional presence of L. monocytogenes-
derived signals are shown in Figure S1 available online.Signals and Transcription Factors Required for iNOS
Regulation by L. monocytogenes
To examine transcription factor requirements for transcriptional
induction of the Nos2 gene, we used bone marrow-derived
macrophages from either wild-type or gene-targeted mice and
infected them with L. monocytogenes (Figure 2). As expected,
Nos2 expression required signaling through both the IFN andFigure 2. iNOSmRNA Induction by L.mono-
cytogenes Requires Stat1, Stat2, IRF9, and
NF-kB Signaling
(A) Bone marrow-derived macrophages of WT,
Stat1/, and Rela/ mice were infected with
living L. monocytogenes (LL) for the times indi-
cated. IFN-b was additionally present to compen-
sate for potential defects in IFN-I production. iNOS
mRNA expression was determined by q-PCR.
(B) Bone marrow-derived macrophages with
the indicated genotypes were infected with living
L. monocytogenes (LL) for 6 hr or a combination
of LL and IFN-b (Ikbkb/ + IFN-b; Rela/ +
IFNb; Irf3/ + IFN-b) for 4 hr. iNOS mRNA expres-
sion was determined by q-PCR.
pression is shown as percent induction found in wild-type macrophages. Error
riments were repeated at least three times.
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p65) genes strongly suppressed iNOS mRNA induction in in-
fected macrophages (Figure 2A). More refined analyses
confirmed the importance of the IFN-I receptor (Ifnar1/ mice)
and the NF-kB pathway (Rela/ and Ikbkb / mice, deficient
for NF-kB p65 and the IKKb kinase, respectively) and established
the importance of the ISGF3 subunits STAT1, STAT2, and IRF9
(Figure 2B). The diminished Nos2 expression observed upon
interference with NF-kB signaling was not due to reduced IFN-I
production as shown by the fact that addition of exogenous
IFN-b did not rescue this effect. Use of macrophages derived
from mice expressing STAT1 mutated at its S727 phosphoryla-
tion site (STAT1S727A) showed that phosphorylation of STAT1
at S727, important for full transcriptional induction of some
IFN-g-induced genes (Varinou et al., 2003), was not required
for Nos2 expression. This contrasts with the reduced induction
of Nos2 by IFN-g early after treatment in STAT1S727A-express-
ing macrophages (Varinou et al., 2003). In further distinction from
the IFN-g response, the decrease resulting from IRF1 deficiency
was marginal. Two additional members of the IRF family, IRF3
and IRF7, are active in L. monocytogenes-infected macro-
phages (Stockinger et al., 2009). IRF7 deficiency did not affect
Nos2 expression. IRF3 deficiency reduced Nos2 induction, but
the defect could be rescued by the addition of IFN-b, suggesting
that it resulted from reduced IFN-b synthesis, but not from
a direct effect on the Nos2 gene. The data suggest that IFN-I
participate inNos2 regulation during L. monocytogenes infection
by deploying the ISGF3 complex, but not the ancillary activity of
IRFs. The low levels of iNOS expression seen after treatment up
to 6 hr with IFN-b alone (Figure 1) were strongly reduced in mice
unable to form ISGF3 (data not shown). Interestingly, this differs
from the regulation of Nos2 mRNA during the late stage of the
IFN-I response, which has been shown to be independent of
STAT1 (Plumlee et al., 2009).
A distinguishing feature of typical IFN-I-induced genes is that
a deacetylation step is required for transcriptional induction,
which can be inhibited with the histone deacetylase (HDAC)
inhibitor trichostatin A (TSA [Nusinzon and Horvath, 2005]).
Induced synthesis ofNos2 mRNA was TSA sensitive, suggesting
that the activity of STATs on the Nos2 promoter abides by the
same rules in this regard as the transcriptional activation of clas-
sical ISGs. MAP kinase pathways downstream of pattern recog-
nition receptors (targeting ERK, JNK, and p38MAPK) were
probed by pharmacological inhibition. None of the inhibitory
drugs produced a significant reduction of L. monocytogenes-
induced Nos2 expression (data not shown). In summary, the
data from Figures 1 and 2 suggest that ISGF3 is the main signal
derived from cytoplasmic signaling, recapitulated by the addition
of exogeneous IFN-b, and that NF-kB is the major signal stimu-
lated by hkL, provided by plasma membrane and/or endosomal
pattern recognition receptors for Nos2 induction. Our further
investigations therefore concentrated on the interaction between
these two pathways.
Binding of STATs and NF-kB to Nos2 Promoter
Chromatin in Macrophages Infected
with L. monocytogenes
Association of the ISGF3 complex with Nos2 chromatin was
examined with antibodies against STAT1 and STAT2 for ChIP.Likewise, NF-kB binding was determined with antibodies to
its p50 and p65 subunits. Amplification by polymerase chain
reaction (PCR) was performed to reveal binding to the
promoter-proximal region containing the essential NF-kB site
as well as the more distal promoter containing the IFN
response region and a second potential binding site for
NF-kB (Figure 3A). Treating macrophages simultaneously with
hkL and IFN-b stimulated binding of the ISGF3 subunits
STAT1 and STAT2 with indistinguishable kinetics (Figure 3B).
The same observation was made for the NF-kB subunits p50
and p65 with the notable exception that a reduction of consti-
tutive p50 binding at the earliest time point after stimulation and
preceding the phase of increased promoter binding was repro-
ducibly observed. This finding is consistent with the reported
negative regulation of NF-kB target genes by p50 homodimers
in resting cells (Zhong et al., 2002). NF-kB association was
found exclusively with the promoter-proximal, essential site,
whereas no evidence for binding to the distal site was obtained.
As expected, STAT binding was caused by treatment with IFN-I
alone, whereas NF-kB binding occurred after exposure to hkL
(data not shown). No evidence for interdependent binding of
the two transcription factors was obtained. Consistently, infec-
tion with viable L. monocytogenes resulted in similar kinetics of
NF-kB p65 binding, but STAT1 association now required prior
IFN-I synthesis and was therefore delayed by about 2 hr
compared to direct stimulation with IFN-I (Figure 3C). Thus,
during infection, binding of NF-kB precedes that of STAT1
and STAT2. The simultaneous presence of these proteins was
further examined via a ChIP-re-ChIP procedure (Figure 3D). It-
confirmed that after both IFN-b treatment and infection with L.
monocytogenes, STAT1 could be reprecipitated from a STAT2
ChIP with the expected difference in binding kinetics (see
Figure 1).
Acetylation of Histones in Proximity to the IFN Response
Region and to the Promoter-Proximal NF-kB Site
Synergistic enhancement of transcriptional activation by ISGF3
and NF-kB might result from an interaction in the recruitment of
histone acetylases to the Nos2 promoter. Acetylation of histone
H4 at the proximal and distal promoter elements was assessed.
To correct for histone eviction, data were normalized to the
levels of total H3. Increases of histone acetylation are often
rather subtle, so we verified significance and quantified our
data by using a q-PCR protocol. All experiments were repeated
at least five times. Black bars represent amplification of the
distal promoter and white bars amplification of the proximal
promoter. This convention is maintained through all subsequent
figures.
Combined treatment of macrophages with IFN-I and hkL
produced an increase of histone acetylation at both the proximal
and distal promoter locations (Figure 4A). Treatment with IFN-I
alone led to an increase of H4 acetylation almost exclusively at
the distal IFN response region (Figure 4B). Conversely, hkL treat-
ment alone caused an increase in H4 acetylation predominantly
at the proximal NF-kB element (Figure 4C). Our findings suggest
that ISGF3 and NF-kB indeed cooperate in producing hyperace-
tylated Nos2 promoter chromatin, but that their histone acetyl
transferase (HAT)-recruiting activities show no signs of func-
tional interdependence.Immunity 33, 1–10, July 23, 2010 ª2010 Elsevier Inc. 3
Figure 3. Binding of STATs and NF-kB to
the Nos2 Promoter
(A) Schematic drawing of the IFN response region
and the NF-kB sites (NF-kB BS) in the Nos2
promoter (Kleinert et al., 2003). Binding of STATs
and NF-kB to the Nos2 promoter in response to
signals stimulated by exposure to L. monocyto-
genes.
(B) Bone marrow-derived macrophages were
stimulated with hkL and IFN-b and the cells were
processed for ChIP at the indicated time points.
Antibodies used for ChIP are shown on the left,
P.I. indicates controls performed with preimmune
sera. The precipitates were amplified with primers
flanking the proximal (NF-kB) or distal (STAT1, IRF)
promoter regions as depicted in (A) and analyzed
by gel electrophoresis.
(C) Bone marrow-derived macrophages were
infected with viable L. monocytogenes and
processed as described in (B).
(D) Bone marrow-derived macrophages were
either treated with IFN-b or infected with living
L. monocytogenes (LL) for the times indicated
and processed for ChIP-Re-ChIP.
Antibodies used for ChIP and Re-ChIP are shown
on top of the panels. The precipitates were ampli-
fied with primers flanking the distal Nos2 promoter
region and analyzed by q-PCR. Error bars repre-
sent standard deviations from triplicate samples.
The experiments were repeated at least three
times.
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Transcription Start Site
Pol II can be bound to transcription start sites in a poised state
(Adelman et al., 2009; Koch et al., 2008; Margaritis and Holstege,
2008). Alternatively, the enzyme is recruited in response to the
stimulus of gene activation (Adelman et al., 2009). To determine
which situation applies to the macrophage Nos2 gene, we
analyzed pol II association by ChIP. As shown in Figure 5A, infec-Figure 4. Histone 4 Acetylation at the Nos2 Promoter
Bone marrow-derived macrophages were treated with hkL and IFN-b (A), IFN-b a
acetyl-histone 4 (acH4) and with antibodies to histone 3 (H3). The presence of d
q-PCR. Data are expressed as increase of acH4 signals normalized to H3 sig
acetyl-histone 4 binding as a function of total histone 3 (acH4/H3). Error bars
repeated at least five times.
4 Immunity 33, 1–10, July 23, 2010 ª2010 Elsevier Inc.tion with L. monocytogenes strongly increased pol II binding,
suggesting that it occurs by regulated recruitment. Surprisingly,
treatment with IFN-I alone also stimulated binding of pol II
(Figure 5B). Association was somewhat, but not much, weaker
than after the additional presence of hkL. In contrast to IFN-I,
hkL alone did not stimulate pol II binding (Figure 5C). This result
indicates (1) that the histone acetylation caused by NF-kB is not
an absolute requirement for pol II binding and (2) that there islone (B), or hkL alone (C) as indicated. ChIP was performed with antibodies to
istal (black) or proximal (white) Nos2 promoter fragments was determined by
nals to correct for histone eviction. The histograms thus denote the ratio of
represent standard deviations from triplicate samples. All experiments were
Figure 5. Recruitment of RNA Polymerase II
to theNos2Promoter by L.monocytogenes-
Derived Signals
Bone marrow-derived macrophages from wild-
type mice (A–E) or Stat1/, Stat2/, and Irf9/
mice (D, E) were infected with living L. monocyto-
genes (LL [A, D, E]), with IFN-b alone (B), heat-
killed Listeria alone (hkL [C]), or with a combination
of IFN-b and hkL (B, C) for the times indicated. The
cells were processed for ChIP with antibodies
against pol II (A–D) or TBP (E). The precipitated
DNA was analyzed by q-PCR with primers ampli-
fying the distal (black) and proximal (white)
promoter regions. Panels (D) and (E) show
a comparison of proximal promoter fragments in
ChIP from WT (black), Stat1/ (red), Stat2/
(yellow), and Irf9/ (green) macrophages. Error
bars represent standard deviations from triplicate
samples. The experiments were repeated at least
three times.
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mode of activating theNos2 promoter. IFN and STAT-dependent
recruitment of pol II predicts that binding of TFIID and its TBP
subunit displays the same requirement. Figures 5D and 5E
indeed show that both pol II and TBP binding was completely
abrogated when Stat1/, Stat2/, or Irf9/ macrophages
were infected with L. monocytogenes.Recruitment of TFIIH-CDK7 and Phosphorylation
of the Pol II CTD
Pol II, once stably bound to the initiation site, must be phosphor-
ylated at its CTD to associate with proteins required for promoter
clearance, capping of the mRNA, and elongation (Chapman et al.,
2008; Hirose and Ohkuma, 2007). Serine 5 (S5) of the CTD amino
acid heptarepeat becomes phosphorylated first, followed by S2,
to proceed to productive elongation. With NF-kB playing only
a minor role in pol II recruitment, we wondered whether it might
play a role in distinct steps of transcriptional initiation. We inves-
tigated CTD phosphorylation at S5 by using phosphospecific
antibodies for ChIP. S5-phosphorylated pol II was precipitated
from the Nos2 initiation site only after treatment with both hkL
and IFN-I, but not after treatment with IFN-I alone (Figure 6A).
This confirms our notion that NF-kB might be involved in regu-
lating CTD phosphorylation. CTD S5 kinase activity is associated
with the general transcription factor TFIIH. TFIIH usually joins the
initiation complex only after pol II binding. It is a multiprotein tran-
scription factor containing theCTD S5kinaseCDK7 and anumber
of additional subunits including p62 (Egly, 2001). As in the case of
S5-phosphorylated pol II, CDK7 was associated with the Nos2
initiation site after stimulation with hkL and IFN-I, but not after
treatment with IFN-I alone (Figure 6B). In contrast to IFN-I, hkLImmunity 33treatment alone produced as much
CDK7 binding as the combined IFN-I-
hkL treatment (Figure 6C). The kinetics
of CDK7 binding as induced by L. mono-
cytogenes demonstrated association
with the Nos2 promoter at 2 hr postinfec-
tion (Figure 6D). At this time, NF-kB isassociated with Nos2 chromatin, but no or very little ISGF3 is
present (Figure 3C). Binding of CDK7 as well as that of TFIIH
p62 was abrogated by both NF-kB p65 and IKKb deficiency
(Figures 6E–6H). Together, these data confirm the hypothesis
that a TFIIH complex is recruited by NF-kB, providing kinase
activity for the pol II CTD at S5. Comparing the kinetics of
NF-kB and TFIIH binding in the course of infection suggested
that TFIIH remains bound at the promoter even after dissociation
of NF-kB (Figures 3, 6G, and 6H; Figure S2). We tested the possi-
bility that NF-kB, by depositing TFIIH, primes the Nos2 promoter
for subsequent ISGF3 activity, thus providing a ‘‘transcriptional
memory’’ effect. To this end, macrophages were given a 2 hr
pulse of hkL treatment, a period sufficient for CDK7 recruitment
(Figure 6D). The pulsed cells were left without further stimulation
for various intervals, followed by a 4 hr treatment with either IFN-b
alone, hkL alone, or a combination of IFN-b and hkL. The data
show that for at least 24 hr, the level achieved by IFN-b treatment
of pulsed cells exceeded the level achieved by IFN-b treatment of
unpulsed cells (Figure 6I). This result is in agreement with the
notion of a transcriptional memory or priming effect of NF-kB-re-
cruited CDK7.Pol II and CDK7 Recruitment by Interferon-Stimulated
Genes or Classical NF-kB Target Genes
The results obtained by studying Nos2 regulation raise the ques-
tion why the Nos2 gene requires both ISGF3 and NF-kB to
achieve elongation competence. They also predict that genes
induced by either IFN-I or the NF-kB pathway alone should
demonstrate promoter binding of both CDK7 and pol II after
single treatment with IFN-I or hkL. This assumption was tested
by analyzing pol II and CDK7 binding to the promoters of the, 1–10, July 23, 2010 ª2010 Elsevier Inc. 5
Figure 6. TFIIH-CDK7 Recruitment to the Nos2
Promoter and S5 Phosphorylation of the RNA Poly-
merase II CTD by L. monocytogenes-Derived Signals;
Analysis of Nos2 Promoter Priming by hkL
(A–H) Bone marrow-derived macrophages from WT mice
(A–H), Ikbkb/ mice (E, F), or Rela/ mice (G, H) were in-
fected with living L. monocytogenes (LL [D–H]), with IFN-
b alone (A, B), with hkL alone (C), or with a combination of
IFN-b and hkL (A–C) for the times indicated. The cells were
processed for ChIP with antibodies against S5-phosphory-
lated pol II (A), CDK7 (B–E, G), or the TFIIH subunit p62
(F, H). The precipitated DNA was analyzed by q-PCR with
primers amplifying the distal (black) and proximal (white)
promoter regions. Panels (E)–(H) show a comparison of prox-
imal promoter fragments in ChIP from WT (black), Ikbkb/
(red, E, F), and Rela/ (orange, G, H) macrophages.
(I) Bone marrow-derived macrophages were pretreated with
hkL for 2 hr or left without pretreatment followed by extensive
washing of the cells. The cells were then left without treatment
for different periods of time (indicated as hours gap). There-
after cells were stimulated with hkL + IFN-b, IFN-b alone, or
hkL alone for 4 hr. iNOS mRNA expression was determined
by q-PCR.
Error bars represent standard deviations from triplicate
samples. The experiments were repeated at least three times.
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by NF-kB for the production of IkBa to establish a feedback inhi-
bition loop. The data summarized in Figures 7A–7D show that
IFN-b treatment for 2 or 4 hr caused association of both pol II
and CDK7 with theMx2 but not theNfkbia promoter. Conversely,
treatment with hkL to activate the NF-kB pathway increased
association of pol II and CDK7 with the Nfkbia but not the Mx2
promoter. Both stimuli provided together did not increase
promoter binding beyond the level observed with single treat-6 Immunity 33, 1–10, July 23, 2010 ª2010 Elsevier Inc.ments. Consistent with this, transcriptional priming
by the NF-kB pathway was not observed with either
the Mx2 or the Nfkbia gene (Figures 7E and 7F). The
data are consistent with our notion that the estab-
lishment of elongation competence by cooperative
signals is a gene-specific attribute and a major
contribution to the regulation of the Nos2 promoter
by the transcription factors NF-kB and ISGF3.
DISCUSSION
NO production is a hallmark of innate immune
responses, but its influence on infected cells or
organisms varies. For some pathogens, NO is an
important clearance mechanism (Bogdan, 2001).
By contrast, L. monocytogenes stimulates macro-
phages to synthesize large quantities of NO, but
appears to be relatively insensitive to its toxic
effects under our experimental conditions
(Zwaferink et al., 2008). The main effect of NO is
to promote the death of Listeria-infected macro-
phages. Our studies of Nos2 regulation were
prompted by the findings of several labs that the
gene expression signature of cells infected with
pathogens, or exposed to their pathogen-associ-ated molecular patterns (PAMPs), results to a significant extent
from cooperative signaling by pattern recognition and IFN-I
receptors (Doyle et al., 2002; Toshchakov et al., 2002). By using
theNos2 gene as a well-studied example, we show that the need
for cooperation between the ISGF3 complex and NF-kB arises
from the inability of the former to provide CTD kinase activity
and the lack of pol II recruitment by the latter. The prevalent
mode of rendering a gene competent for transcription is to
assemble a TFIID-TFIIB-pol II complex prior to the association
Figure 7. RNA Pol II and CDK7 Recruitment to the Proximal
Promoter Regions of the IFN-Inducible Mx2 Gene and the Gene En-
coding IkB; Analysis of Mx2 and Nfkbia Promoter Priming by hkL
(A–D) Bone marrow-derived macrophages from wild-type mice were treated
with hkL + IFN-b, hkL alone, or IFN-b alone for the times indicated. The cells
were processed for ChIP with antibodies against pol II (A, C) or CDK7 (B, D).
The precipitated DNA was analyzed by q-PCR with primers amplifying the
proximal promoter regions of the Mx2 gene (A, B) and the Nfkbia gene (the
gene encoding IkBa) (C, D).
(E and F) Bone marrow-derived macrophages were pretreated with hkL for 2 hr
or left without pretreatment followed by extensive washing of the cells. The
cells were then left without treatment for different periods of time (indicated
as hours gap). Thereafter cells were stimulated with hkL + IFN-b, IFN-b alone,
or hkL alone for 4 hr. Mx2 (E) and IkBa (F) mRNA expression was determined
by q-PCR. Error bars represent standard deviations from triplicate samples.
The experiments were repeated at least three times.
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activity at the Nos2 promoter results in an unconventional tran-
scription initiation complex assembly where TFIIH binds the
promoter first to provide kinase activity for the subsequent
recruitment of pol II. Three lines of evidence led us to this conclu-
sion: (1) the kinetics of transcription factor and CDK7 binding
during L. monocytogenes infection show that TFIIH-CDK7
recruitment occurs before pol II binding, (2) IFN-I alone is able
to bring about the recruitment of pol II and hkL alone are able
to stimulate CDK7 binding, and (3) CDK7 binding is abrogated
in absence of the NF-kB pathway and TBP-pol II binding is abro-
gated in absence of ISGF3. CDK7 binding trails that of NF-kB by
about 1 hr, suggesting that a complex forms at the promoter that
is not preassembled and may require intermediate steps and
partner proteins. Similarly, pol II binding occurs roughly 1 hr after
the observed increase in STAT1 association. CDK7 remains
associated with Nos2 chromatin once NF-kB p65 leaves the
promoter (best seen in Figure S2), suggesting that the function
of NF-kB is to load the promoter with CDK7-TFIIH, but not to
maintain this association once it has been established.
To our knowledge this is the first time this mode of initiation
complex assembly is shown for a gene in the context of the
cellular genome and as a result of ISGF3-NF-kB interaction,
although several recent studies are in line with our findings (Spi-
lianakis et al., 2003). The most compelling evidence that TFIIH-
CDK7 recruitment by NF-kB may be more widely used was
provided in studies on the activation of the HIV LTR in response
to TNF (Kim et al., 2006). Contrasting the situation with Nos2, an
initiation complex including a hyperphosphorylated RNA pol II
was preassembled at the LTR, but, similar to our findings with
Nos2, elongation competence required TNF and NF-kB to
attract TFIIH-CDK7. The authors propose that NF-kB both asso-
ciates with TFIIH and stimulates release of the inhibitory CDK8
from the mediator complex. Genes induced by LPS differ con-
cerning the rate-limiting regulatory step for the onset of tran-
scription, consisting either in the release of an elongation block
to a paused polymerase or the pol II recruitment step (Adelman
et al., 2009). Whether and how NF-kB-mediated TFIIH recruit-
ment contributes in both situations is not known. Therefore it
will be of interest to determine to what extent this mechanism
contributes to the large impact of the NF-kB pathway on infec-
tion-related gene expression and in how far Nos2 represents
a paradigm valid for the many genes synergistically induced by
STATs and NF-kB. The mechanism of pol II recruitment to the
many genes regulated by NF-kB in absence of ISGF3 requires
further investigation and, conversely, the mode of TFIIH recruit-
ment to ISGF3 target genes in the absence of NF-kB remains to
be clarified. This may generally be determined by cooperative
transcription factors bound to their target promoters and/or by
differences in the preexisting chromatin structure and composi-
tion.
Our studies allow some conclusions about the mechanism of
ISGF3 action beyond the functional division of labor with
NF-kB. At the Nos2 promoter, ISGF3 stimulated binding of RNA
pol II without requiring STAT1 phosphorylation at S727 or the
helper function of IRF1. This differs from the STAT1 dimer, which
is transcriptionally more active with its transactivating domain
phosphorylated and requires IRF1 to induce the expression of
Nos2 and other genes in response to IFN-g (Kamijo et al., 1994;Immunity 33, 1–10, July 23, 2010 ª2010 Elsevier Inc. 7
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dressing IFN-g induction of the Gbp2 promoter showed that the
STAT1 dimer alone cannot recruit RNA pol II (Ramsauer et al.,
2007). This allows speculation that the STAT2 transactivating
domain may generally supersede the requirement for STAT1
S727 phosphorylation and the ancillary activity of IRF1. In accor-
dance with our findings about acetylation of the Nos2 promoter,
STAT2-dependent transcriptional initiation via mediator and
TFIID subunits correlates with the ability of the STAT2 TAD to
contact the HATs GCN5 and PCAF (Lau et al., 2003; Paulson
et al., 2002). Histone acetylation is an important regulatory step
for both NF-kB and STAT target genes (Chen and Greene,
2004; Ramsauer et al., 2007). NF-kB as well as ISGF3-dependent
acetylation of Nos2 promoter chromatin was restricted to the
nucleosomes adjacent to their binding sites. This resembles
virus-induced histone acetylation at the IFN-b promoter or the
promoter of the IFN-I-induced Ifi-56K gene that was similarly
restricted to a region around the transcription factor binding sites
and the transcription start (Parekh and Maniatis, 1999).
Reviewing our findings and corroborating studies in the
perspective of L. monocytogenes infection or pathogen infection
in general raises the question why some, but not all, ISGs are
coupled to the NF-kB pathway. IFN-I synthesis during infection
occurs in response to nucleic acid PAMPs in the cytoplasm,
when endosomal TLRs are stimulated, or when TLRs resident
at the plasma membrane travel to late endosomes in the process
of pathogen uptake (Kagan et al., 2008). With the notable excep-
tion of the cytoplasmic DNA receptor (Stetson and Medzhitov,
2006), all PRRs stimulating IFN-I synthesis will also stimulate
the NF-kB pathway, thus providing both signals necessary for
Nos2 induction. Vice versa, some PRRs capable of activating
NF-kB are not normally coupled to IFN-I synthesis. Examples
of these are TLR2, TLR5, and the NLR family receptors NOD1
and NOD2, which have been associated with IFN-I synthesis
only in a limited number of cell types or under specific circum-
stances (Barbalat et al., 2009; Pandey et al., 2009). Furthermore,
a large number of stress or inflammatory signals, most notably
those emanating from the TNF receptor family, provide NF-kB
activity without concomitant IFN-I production and signaling
(Dempsey et al., 2003). We hypothesize that such receptors
and their signals provide a TFIIH-dependent transcriptional
memory effect for Nos2 expression, independently of pathogen
uptake. Vigorous iNOS expression and NO production are
limited, however, to situations where a pathogen is engulfed
and processed by host cells, and when PAMPs appear in the
late endosome and cytoplasm. This mechanism is consistent
with our results in Figure 6 showing that the hkL-stimulated
NF-kB pathway can provide the Nos2 promoter with transcrip-
tional memory for a subsequent treatment with IFN-I. It ensures
that large amounts of NO are made only when its antipathogen
activity is needed inside cells. Continuing along these lines, the
reason why classical ISGs do not require this prime-and-trigger
mechanism may be that their products are less harmful and cells
can afford to prepare for pathogen entry without running the risk
of inflicting damage upon themselves (Zwaferink et al., 2008).
Although our study provides a mechanism for signal integration
and a potential paradigm for cooperativity between the STAT
and NF-kB pathways during infection, further experiments
must reveal the biological impact of STAT-NF-kB convergence.8 Immunity 33, 1–10, July 23, 2010 ª2010 Elsevier Inc.EXPERIMENTAL PROCEDURES
Reagents
Recombinant IFN-b was purchased from Biomedica (Nova Scotia, Canada)
and added to culture medium to a final concentration of 250 U/ml. The inhib-
itors Trichostatin A (TSA) (WAKO Biochemicals, Osaka, Japan), SP600125 for
c-JUN kinase inhibition (Sigma-Aldrich, St Louis, MO), SB203580 for
p38MAPK inhibition (Sigma-Aldrich), and U0126 for MEK inhibition (Calbio-
chem, Nottingham, UK) were used in a final concentration of 150 nM,
25 nM, 4 nM, and 10 nM, respectively.Bacteria and Infection
The Listeria monocytogenes strain LO28 was cultured in brain heart infusion
broth overnight at 37C. Infection of cells at MOI 10 was performed as
described (Stockinger et al., 2002). Heat-killed Listeria (hkL) were generated
by incubation of an overnight culture of LO28 in a waterbath at 70C for 20 min.Mice and Cells
Animal experiments were discussed and approved by the University of Veter-
inary Medicine, Vienna, institutional ethics committee and carried out in
accordance with protocols approved by the Austrian law (GZ 680 205/67-
BrGt/2003). Mice (WT C57BL/6, Ifnar1/ [Muller et al., 1994], Stat1/ [Durbin
et al., 1996], STAT1S727A [Varinou et al., 2003], Stat2/ [Park et al., 2000],
Irf1/ [Reis et al., 1994], Irf3/ [Sato et al., 2000], Irf7/ [Honda et al.,
2005], Irf9/ [Harada et al., 1996], and IkbkbD and RelaD [Greten et al.,
2007]) were sacrificed for bone marrow between 7 and 10 weeks of age. All
animals were in a C57BL/6 genetic background. The mice were housed under
specific-pathogen-free conditions. Poly I:C-mediated deletion of IKKb and
NF-kB p65 in bone marrow cells was performed as described (Greten et al.,
2007). Bone marrow-derived macrophages (BMDM) were obtained by culture
of bone marrow in L-cell-derived colony-stimulating factor 1 as described
previously (Baccarini et al., 1985).RNA Preperation and qRT-PCR
RNA preparation was performed with NucleoSpin RNA II Kit purchased from
Macherey-Nagel (Du¨ren, Germany) according to the manufacturer’s protocol.
Quantitative real-time PCR was performed on Mastercycler ep realplex S,
purchased from Eppendorf (Vienna, Austria). Primer for iNOS mRNA
expression and qRT-PCR were described previously (Stockinger et al.,
2004). Primer for MX2 and IkBa mRNA expression were as follows: MX2 fwd
50-CCAGTTCCTCTCAGTCCCAAGATT-30; MX2 rev 50-TACTGGATGATCAA
GGGAACGTGG-30; IkBa fwd 50-GCAATTTCTGGCTGGTGGG-30; IkBa rev
50-GATCCGCCAGGTGAAGGG-30.Chromatin Immunoprecipitation and Re-ChIP
Chromatin immunoprecipitation (ChIPs) were performed according to the
protocol described in Nissen and Yamamoto (2000). Antibodies used were
described recently (anti-STAT1C [Kovarik et al., 1998], anti-STAT2 [Park
et al., 2000]), purchased from Santa Cruz (Santa Cruz, CA) and used at
a 1:20 dilution (anti-NF-kB p65, anti-NF-kB p50, anti-RNA Pol II, anti-CDK7,
and anti-p62-TFIIH) purchased from Bethyl (Montogomery, TX) and used in
a dilution of 1:100 (anti-pS5 CTD Pol II), purchased from Abcam (Cambridge-
shire, UK) and used in a dilution of 1:100 (anti-histone 3 and anti-TBP), or
purchased from Upstate and used in a dilution of 1:100 (anti-acetyl histone
4). ChIP data were normalized to input and, in case of histone acetylation,
further normalized to total H3 and to the untreated sample to correct for
histone eviction. In the re-ChIP experiments, the immunecomplexes were
eluted by adding 10 mM DTT and incubation for 30 min at 37C. The samples
were diluted 40-fold in RIPA-buffer and reimmunoprecipitated.
Primers used for PCR and q-PCR of the Nos2 promoter were as follows:
iNOS dis fwd 50-CCAACTATTGAGGCCACACAC-30; iNOS dis rev 50-GCT
TCCAATAAAGCATTCACA-30; iNOS prox fwd 50-GTCCCAGTTTTGAAGTG
ACTACG-30; iNOS prox rev 50-GTTGTGACCCTGGCAGCAG-30; Mx2 prox
fwd 50-ACCCAGCCAAGGCCCCCTTA-30; Mx2 prox rev 50-GCAGCTGCCAG
GGCTCAGAC; IkBa prox fwd 30-GGACCCCAAACCAAAATCG-50; IkBa prox
rev 30-TCAGGCGCGGGGAATTTCC-50.
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Macrophages were infected with an overnight culture of L. monocytogenes for
8 hr (MOI10) or treated 4 hr with IFN-b. RNA was extracted with Trizol and
QIAGEN RNeasy Kit according to the manufacturers’ protocol. 1 mg of RNA
per sample was used for cDNA synthesis. cDNA syntheses and array-hybrid-
izations were performed according to the manufacturers’ protocol (Amer-
sham-BioSciences; GE Healthcare).
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Supplemental Information includes two figures and can be found with this
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Figure S1. Microarray analysis of genes induced in 
macrophages by IFN-β treatment or infection with 
Listeria monocytogenes. Infection produces the IFN-β 
signal as well as additional signals from pattern 
recognition receptors. IFN-β -induced genes were 
further examined for increased expression in Listeria-
infected cells. The 38 genes showing the highest 
increase of Listeria-induced expression over IFN-β 
treatment alone are shown. First column: gene symbol; 
second column: gray-scale indicating induction after 
IFN-β treatment; third column: gray-scale indicating 
induction after Listeria treatment; fourth column: ratio of 
induction after Listeria infection to induction after IFN-β 
treatment. The gray-scale intensity corresponds to 
values equally spaced on the log-scale from white 
(lowest induction of absolute ratio of 1.40) to black 









Figure S2. TFIIH-p62 remains at the Nos2 promoter after binding of NF-κB-p65 decreases. 
Bone marrow-derived macrophages from wild-type mice (black bars) or Rela-/- mice (red bars) 
were infected with living L. monocytogenes (LL) for 4hr or 6hr. The cells were processed for 
ChIP using antibodies against TFIIH-p62 (left panel) or NF-κB-p65 (right panel). The 
precipitated DNA was analyzed by q-PCR with primers amplifying the proximal Nos2 promoter 
region. Error bars represent standard deviations from triplicate samples. The experiment was 
repeated at least three times. 
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Additional experiments addressing the mechanism of 
gene induction in macrophages after infection with 
Listeria monocytogenes 
iNOS and IL1ra mRNA expression underlies the same 
transcriptional initiation mechanism 
Our microarray experiment revealed 37 genes resembling Nos2 with regard to the 
stimulus requirements, for full transcriptional expression. To determine whether the 
mechanism characterized for Nos2 gene regulation applies also to the additional genes 
identified in the microarray, mRNA expression profiles of DUSP1, DUSP2, and IL1ra 
were analyzed by qPCR. In keeping with the microarray, all genes displayed a 
synergistic enhancement of mRNA expression by hkL and IFNβ. Particularly the 
expression pattern of the gene encoding the IL1 receptor antagonist (Il1ra) was highly 
similar to that of Nos2 (Figure 17A-C).  
CDK7 and Pol II recruitment to the Nos2 promoter was found to depend on hkL and 
IFNβ derived signals, respectively (Farlik et al., 2010). Based on these findings we 
wanted to know whether the mechanism observed at the Nos2 promoter also applied at 
the IL1ra gene. In support of the findings with Nos2, ChIP assay analysis revealed that 
both CDK7 and Pol II recruitment to the Il1ra proximal promoter depended on hkL and 
IFNβ, respectively (Figure 17D,E). Furthermore, the priming effect on the 
transcriptional activation of the Nos2 gene, caused by NFκB-mediated deposition of 
TFIIH-CDK7, also applied for the Il1ra gene (Figure 17F). The level achieved by IFNβ 
treatment of hkL pulsed cells exceeded the level achieved by IFNβ treatment of 
unpulsed cells for at least 8hrs. The transcriptional memory effect in case of Il1ra was 
less stable than with Nos2, where the hkL pulse enhanced  IFNβ treatment for at least 
24hrs (Farlik et al., 2010).  
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Taken together our results indicate, that the regulation of Il1ra and, possibly, other 
genes co-regulated by STAT1 and NFκB, follows the same mechanism as Nos2 
regulation, under our conditions, with some differences in the binding kinetics of the 
crucial components to the Il1ra promoter. hkL treatment causes the recruitment of 
CDK7-TFIIH to the Nos2 promoter within 2hrs, whereas CDK7 binding at the Il1ra 
promoter was observed only after 4 hrs. Vice versa, Pol II recruitment to the Il1ra gene 
occurred earlier than binding to the Nos2 promoter. Consistently, Pol II precedes the 
binding of CDK7 at the Il1ra promoter after cotreatment with IFNβ and hkL. 
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Figure 17: Gene regulation by heat-killed Listeria (hkL) and IFNb). (A-C). mRNA 
expression of IL1ra (A), DUSP1 (B), and DUSP2 (C) was determined by qPCR. (D,E) 
Bone marrow derived macrophages from WT mice were treated with hkL alone, IFNβ 
alone or a combination of both for the times indicated. Macrophages were processed for 
ChIP with antibodies against CDK7 (D), or Pol II (E). The precipitated DNA was 
analyzed by qPCR with primers amplifying the proximal promoter region of the Il1ra 
gene. (F) Analysis of Il1ra promoter priming by hkL.  Bone marrow-derived 
macrophages were pretreated with hkL for 2 hr or left without pretreatment, followed by 
extensive washing of the cells. The cells were then left without treatment for different 
periods of time (indicated as hours gap). Thereafter cells were stimulated with 
hkL+IFNβ, IFN-β alone, or hkL alone for 4 hr. IL1ra mRNA expression was 
determined by q-PCR. 
Recruitment of RNA POLII and ISGF3 to the Nos2 promoter, 
correlation with the H3K4me3 chromatin mark 
Since type I IFN induced recruitment of ISGF3 to the distal Nos2 gene promoter was 
shown to be required for subsequent RNA Pol II recruitment (Farlik et al., 2010), we 
addressed the question whether Pol II recruitment is mediated by a direct interaction 
between ISGF3 and Pol II. Therefore we performed detailed binding analysis of Pol II 
and ISGF3 by ChIP and compared their binding kinetics. IFNβ treatment resulted in the 
recruitment of Pol II enzyme within 2-3 hrs (Figure 18A). This finding was supported 
by the data generated with a ChIP against phosphorylated Ser5 at RNA Pol II CTD, 
which revealed small amounts of initiated Pol II enzyme at the proximal Nos2 promoter 
after 2 hrs of treatment with hkL and IFNβ (Figure 18B). Differences in the output of 
the ChIPs monitoring RNA Pol II and phS5 Pol II CTD binding are likely to be due to 
different sensitivity of the respective antibodies, the latter being able to bind to more 
than one phosphorylated serine/epitope on the same Pol II molecule. Nevertheless, a 
contribution of NFκB, provided by the hkL co-treatment, resulting in faster recruitment 
of Pol II to the Nos2 promoter, can at this point not be excluded. As expected, the 
binding of Pol II was delayed by about 2hrs after infection with Listeria monocytogenes, 
and appeared at the proximal Nos2 promoter 4hrs after infection (Figure 18C).  
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Recruitment of Pol II after infection with Listeria monocytogenes appears to occur 
concomitant with the association of ISGF3 revealed by ChIP-reChIP analysis (compare 
Figure 18C and Figure 18D right panel), suggesting that Pol II might indeed be 
recruited via direct interaction with ISGF3. Of note, ISGF3 recruitment to the distal 
Nos2 promoter after exposure to IFNβ takes place within 0,5 to 1 hr (Figure 18D left 
panel)(Farlik et al., 2010), and precedes Pol II recruitment by more than 1 hour 
(compare Figure 18D left panel and Figure 18 A and B). This finding suggests that Pol 
II requires the recruitment of a co-factor in order to bind the Nos2 promoter. 
Furthermore, this result points to a contribution of NFκB in Pol II recruitment, since 
ISGF3 is able to recruit the Pol II enzyme faster when NFκB is active. NFκB is 
activated in response to hkL and recruited to the proximal Nos2 promoter prior to Pol II 
recruitment after 1hr of treatment (Farlik et al., 2010). 
The tri-methylation of H3K4 is a hallmark of active genes and a marker for recent 
transcriptional activity. It is closely correlated with the step of transcriptional initiation 
since the recruitment of the H3K4 methylase, SET1, has been shown, in yeast, to 
depend on the phosphorylation of Pol II CTD at Ser5 (Ng et al., 2003b). However, 
recent studies in mammalian cells indicate that H3K4me3 can occur independent of Pol 
II phosphorylation and can even serve to bind factors of the Pol II PIC as a possible 
prerequisite for Pol II binding (Vermeulen et al., 2007; Wang et al., 2009).  
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We wondered whether the recruitment of a H3K4 methylase to the Nos2 promoter could 
be the rate-limiting step for efficient recruitment of RNA-Pol II. Therefore we 
monitored the H3K4me3 pattern by ChIP assay analysis after treatment of WT bone 
marrow derived macrophages with IFNβ alone and the combination of IFNβ and hkL. 
The H3K4me3 level was indeed increased upon treatment with IFNβ alone, but could 
be slightly enhanced upon co-treatment with hkL, a picture similar to the recruitment 
pattern observed for Pol II, which was similarly enhanced upon co-treatment with hkL 
(compare Figure 18E with 18A). Moreover, enrichment of H3K4me3 at the proximal 
Nos2 promoter directly follows the recruitment of ISGF3 (compare Figure 18E with 
Figure 18D left panel). Additionally, we tested whether H3K4me3 is a feature unique 
for IFNβ treatment, or whether the proximal Nos2 promoter is also enriched for the 
H3K4me3 mark in response to hkL treatment. Again we performed ChIP assay analysis 
after treatment of the cells for 4 hrs with hkL or IFNβ alone, or a combination of both. 
In all three tested situations the proximal Nos2 promoter showed an enrichment of 
H3K4me3, with slightly enhanced values when both stimuli where present 
simultaneously (Figure 18F). 
Together our results indicate that the ISGF3 mediated recruitment of a yet still unknown 
H3K4 methylase might be required for the subsequent, stable recruitment of RNA Pol II 
to the Nos2 promoter. Further experiments adressing the mechanism behind Pol II 
recruitment and H3K4me3 introduction in reponse to IFNβ, need to be performed in 
future studies. Furthermore, our data suggest that in response to an infection with 
Listeria monocytogenes, NFκB can assist in the recruitment of Pol II by introducing the 
H3K4me3 mark prior to recruitment of ISGF3, thereby enabeling a faster recruitment of 
RNA Pol II. Also this hypothesis has to be strenghened by additional experiments to 
display the interdependency of Pol II and H3K4me3 on both ISGF3 and NFκB 
transcription factors. Still the existing data clearly indicate that H3K4me3 in bone 
marrow derived macrophages, is introduced to Nos2 promoter chromatin independent of 
RNA Pol II phosphorylation on Ser5 as shown after treatment with IFNβ, and can even 
take place in the absence of RNA Pol II, after treatment with hkL alone. 
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Figure 18: RNA PolII and ISGF3 recruitment to the Nos2 promoter.. (A-F) Bone 
marrow derived macrophages were treated with IFNβ alone, heat-killed Listeria (hkL) 
alone or the combination of hkL and IFNβ for the times indicated (A,B,D,F). In panelsC 
and D) the cells were infected with living Listeria monocytogenes (LL).  ChIP was 
performed with antibodies against Pol II (A,C), phosphoS5 RNA PolII CTD (B), and 
H3K4me3 (E,F). In panel D ChIP-reChIP was performed with antbodies against STAT1 
and STAT2 as indicated . . The precipitates were amplified with primers flanking the 
distal or proximal Nos2 promoter and analyzed by qPCR. Data are expressed as % of 
Input (A-D). Data of H3K4me3 ChIP (E, F) are normalized to total H3 to correct for 
histone eviction and expressed as relative enrichment compared to untreated cells. 
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CDK7 and CDK9 recruitment to the Nos2 promoter, link to the 
H3S10phK14ac chromatin mark 
Based on the recent findings in Farlik et al. 2010 and  Figure 19A,B showing that 
CDK7/TFIIH recruitment to the Nos2 promoter and phosphorylation of the pol II CTD 
at S5 requires the presence of NFκB, we next asked the question whether NFκB is 
necessary also for the recruitment of CDK9/p-TEFb to the Nos2 promoter. CDK9 
activity is required for the phosphorylation of RNA Pol II at Ser2, which in turn leads to 
the release of the NELF mediated elongation block. To test this hypothesis, we 
performed ChIP assay analysis with extracts from WT bone marrow derived 
macrophages and monitored CDK9 recruitment after treatment with either hkL or IFNβ 
alone or a combination of both. As with CDK7 we observed a clear dependency of 
CDK9 recruitment on the presence of hkL, whereas IFNβ alone was not able to recruit 
detectable amounts of CDK9 to the Nos2 promoter (Figure 19C). Thus, NFκB serves to 
recruit both CDK7/TFIIH and CDK9/p-TEFb to the proximal Nos2 promoter. 
Next we examined the  molecular mechanism for CDK7/TFIIH retention at the Nos2 
gene promoter, a prerequisite for the maintainance of transcriptional memory (Farlik et 
al., 2010). Recent findings show that CDK9/p-TEFb recruitment can be mediated via 
BRD4 to the promoter of actively transcribed genes. BRD4 recruitment depends on the 
formation of a nucleosomal recognition code, comprised of H3K9acS10ph/H4K16ac 
(Zippo et al., 2009). This report further highlights that H4K16ac, required for BRD4 
association, is mediated by the recruitment of the HAT MOF, which itself is bound to 
14-3-3 proteins. 14-3-3 proteins were shown to recognize a phosphoacetylated motif on 
histone H3 either including Ser10 or Ser28 (Winter et al., 2008; Zippo et al., 2009). 
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Since our data clearly demonstrate that CDK9 recruitment follows the same rules as 
CDK7 recruitment in our system, we asked the question whether the same or a similar 
mechanism as the one described by Zippo et al. applies to CDK7/TFIIH recruitment and 
positioning in the context of iNOS regulation. At least some NFκB-responsive genes 
rely on the activity of IKKα as a H3S10 kinase (Yamamoto et al., 2003). To test 
whether the histones at the Nos2 promoter are enriched for the phosphoacetylation 
motiv H3S10phK14ac, we performed ChIP assays with a phosphoacetylation specific 
antibody. Surprisingly, we could detect an enrichment for this mark predominantly at 
the distal promoter following treatment with hkL and IFNβ, displaying kinetics of 
enrichment similar to the recruitment of NFκB and ISGF3 under these conditions. By 
contrast only a marginal increase of this mark was detected at the proximal Nos2 
promoter, the site of NFκB recruitment (Figure 19D)(Farlik et al., 2010).  
Since NFκB is recruited exclusively to the proximal promoter region, we hypothesized, 
that the distally bound ISGF3 complex might have an impact on the introduction of this 
mark. To test this, we examined the phosphoacetylation pattern after treatment with 
either hkL alone, IFNβ alone, or a combination of both. Interestingly, only hkL 
treatment, hence the NFkB signal, was able to enrich the distal Nos2 promoter for the 
presence of the phosphoacetylation mark (Figure 19E). The hkL-mediated introduction 
of this mark to the distal promoter chromatin  appears counterintuitive to both the NFkB 
site in the proximal promoter and the idea of CDK9 recruitment to the site of Pol II 
pausing. To further examine the pattern of H3S10phK14ac we asked whether the lack of 
signal-dependent increase results from a high constitutive presence of this mark at the 
proximal promoter. We therefore normalized the data of the uninduced sample for the 
H3S10phK14ac mark at the proximal Nos2 promoter to the data generated for the distal 
promoter. In line with our hypothesis, we detected an up to seven fold enrichment of the 
mark at the proximal promoter, compared to the distal region (Figure 19F).  
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The up to seven fold difference in the uninduced sample suggests that even after the 
signal-dependent enrichment of H3S10phK14ac in the distal region, absolute levels of 
this mark still remain higher at the proximal Nos2 promoter. Since the enrichment of the 
H3S10phK14ac mark in the distal region is dependent on signalling by hkL, a possible 
explanation for the observed increase at the distal region could be provided by hkL-
dependent reorganization of nucleosomes. In line with this assumption, an alternative 
mechanistic explanation to the link between H3S10phK14ac, the binding of 14-3-3 
proteins and the recruitment of HATs like MOF (Zippo et al.), is provided by the group 
of James Davie (Drobic et al., 2010). These authors linked H3S10ph-mediated 14-3-3 
binding at the promoters of PRGs to the recruitment of BRG1. BRG1 mediated 
mobilisation of nucleosomes has been shown in many recent studies to be a feature of 
ISGs, necessary for long range interactions between the promoter and enhancer regions 
(Zhang and Boothby, 2006; Ni and Bremner, 2007; Ni et al., 2008). To test whether 
chromatin remodeling and the sliding of nucleosomes from the proximal to the distal 
promoter could be an explanation for the enriched H3S10phK14ac mark at the distal 
promoter, we analyzed H3 levels after treatment with hkL by ChIP. Interestingly, both 
promoter regions showed a strong reduction of total H3, very early after stimulation, in 
both regions. However, the drop in H3 levels at the proximal promoter has been 
reproducibly shown to remain low throughout the stimulation with hkL, whereas the 
level of H3 at the distal region increases, concomitant with the binding of NFκB and the 
observed increase in H3S10phK14ac at this region of the Nos2 promoter (compare 
black bars in Figure 19G with black bars in Figure 19D). 
Taken together these results show that both CDK7/TFIIH and CDK9/p-TEFb are 
recruited in response to hkL, independent of the recruitment of Pol II. The 
H3S10phK14ac mark was shown to be present already in untreated cells at the proximal 
region, but increases dependent on hkL derived signals at the distal region of the Nos2 
gene promoter. Chromatin remodelling at the distal Nos2 promoter region appears to 
follow the same pattern as the enrichment of distal  H3S10phK14ac and proximal NFκB 
binding, pointing to a possible link between these events. 
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Figure 19: CDK7 and CDK9 recruitment to the Nos2 promoter after treatment with 
IFNβ and/or hkL (heat killed Listeria). (A-G) WT bone marrow derived macrophages 
were treated with IFNβ alone, hkL alone or the combination of hkL and IFNβ for the 
times indicated. The cells were processed for ChIP (A-G) with antibodies against CDK7 
(A,B), CDK9 (C), H3S10phK14ac (D-F), and H3 (G). The precipitates were amplified 
with primers flanking the distal or proximal Nos2 promoter and analyzed by qPCR. 
Data are expressed as % of Input (A-C,G). Data of H3S10phK14ac ChIP are expressed 
as relative enrichment, compared to untreated cells and further normalized to total H3 to 
correct for histone eviction (D,E). The data obtained for the proximal promoter were 
further normalized to the values obtained for the distal Nos2 promoter region to 
investigate the basal presence of the H3S10phK14ac mark (F). 
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NFκB-deficient macrophages retain IFN-β production and low 
levels of Stat1-dependent Nos2 expression during infection 
with Listeria monocytogenes 
Recently we identified ISGF3 and NFκB as the main transcription factors involved in 
iNOS regulation upon infection with Listeria monocytogenes (Farlik et al., 2010). 
Detailed analysis of iNOS mRNA expression after infection revealed that iNOS mRNA 
expression in bone marrow derived macrophages isolated from Stat1 -/- mice was 
hardly detectable. In contrast, Rela -/- BMDMs retain some iNOS mRNA expression 
(Figure 20A). Since iNOS has been shown to rely on NFκB and ISGF3 activity, the 
remaining iNOS expression in Rela -/- macrophages might be due to type I IFN 
signaling resulting from endogenous production of IFNβ upon infection with Listeria 
monocytogenes. Intriguingly, expression of IFNβ has been shown to depend on the 
formation of an enhanceosome comprised of AP1, IRF3, IRF7, and NFκB (Panne et al., 
2007). To test our hypothesis we monitored IFNβ mRNA expression in L. 
monocytogenes infected WT, Stat1 -/-, and Rela -/- BMDMs by qPCR analysis. 
Unexpectedly, we could detect IFNβ mRNA expression in Rela-/- macrophages that 
appears to be even higher than in WT or Stat1-/- macrophages (Figure 20B). This 
suggests that NFkB-independent production of type I IFNs and subsequent ISGF3 
activation are responsible for the residual Nos2 expression in infected macrophages.  
While NFκB is the major signal for Nos2 induction stimulated by hkL through pattern 
recognition receptors (Farlik et al., 2010), additional transcription factors may 
contribute to the regulation of iNOS expression. One example is HIF-1α (hypoxia 
induced factor) that regulates iNOS expression in response to hypoxic stress in concert 
with NFκB (Lu et al., 2006). The group of Samuel Leibovich recently demonstrated a 
function for HIF-1α downstream of TLR-4 signaling (Ramanathan et al., 2009). Since 
NFκB activation in the early phase of Listeria infection is TLR-dependent we examined 
HIF-1α expression upon treament with hkL or infection with living Listeria. qPCR 
analysis of macrophages treated with hkL and IFNβ, hkL alone, LPS and IFNγ or 
infected with living Listeria revealed that HIF-1α is indeed expressed in all situations 
albeit at low levels compared to antimicrobial genes such as iNOS or IFNβ (Figure 
20C). 
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Additionally to NFκB, iNOS expression depends on the activation of STATs and the 
subsequent formation of the ISGF3 complex. Crucial for STAT1 activation is the 
phosphorylation on Y701, although there is an increasing amount of evidence that non-
tyrosine phosphorylated STAT1 still exerts some functions (Cheon and Stark, 2009). To 
test whether the phosphorylation at Y701 of STAT1 is required for iNOS mRNA 
expression, macrophages were obtained from mice expressing  a STAT1Y701F mutant. 
qPCR analysis of iNOS mRNA from infected macrophages shows that iNOS mRNA 
expression in STAT1Y701F macrophages is reduced to the level found in Stat1 -/- 
macrophages after 6hrs of infection. 
Together our results indicate that the expression of IFNβ mRNA, after infection with 
Listeria monocytogenes does not require the presence of the p65 subunit of NFκB. 
Moreover we could show that HIF-1α is expressed under infection conditions as well as 
in response to hkL and IFNβ. Whether HIF-1α plays a role in the regulation of iNOS 
mRNA expression remains to be determined. Analysis of the STAT1Y701F mutant 
reveals that STAT1 phosphorylation at Y701 is required for ISGF3 mediated iNOS 
expression in the early phase of infection.   
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Figure 20: Kinetics of iNOS, IFNβ and HIF1α mRNA expression, after infection with 
Listeria monocytogenes, determined by qPCR analysis. Bone marrow derived 
macrophages from WT, STAT1Y701F, Stat1 -/- (A) WT, Stat1 -/-, and Rela -/- (B,C) 
and WT (D) mice, were infected with LL (living Listeria) (A-D), or treated with hkL 
(heat killed Listeria), a combination of hkL and IFNβ, or a combination of LPS and 
IFNγ (D) for the times indicated. iNOS (A,B), IFNβ (C), and HIF1α (D) mRNA 
expression was determined by q-PCR after normalization to GAPDH levels. 
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Discussion 
The induction of gene expression is a complex process involving transcription factor 
recruitment and the introduction of chromatin modifications which together orchestrate 
the recruitment of a transcription-competent RNA Pol II enzyme. PRGs rely mainly on 
one stimulus and class I transcription factors for the regulation of their expression. 
However, beside the de novo recruitment of transcription factors in response to a certain 
stimulus, a hallmark of PRGs is the initial presence of factors like SP2 and chromatin 
marks, like H3K4me3, which render the promoter poised for activation, prior to 
stimulation. Moreover, RNA Pol II itself is present in a paused state at the promoters of 
most PRGs, ahead of stimulation, leading to basal gene expression and the generation of 
unmature transcripts. The stimulus-dependent regulation of PRGs lies in the 
transcription factor mediated recruitment of P-TEFb, which is required to release RNA 
Pol II from the NELF mediated elongation block, and to induce Ser2 phosphorylation-
dependent maturation of the mRNA (Medzhitov and Horng, 2009). 
Until recently, it was thought that the need for CDK7-TFIIH mediated initiation, and the 
requirement of CDK9-P-TEFb for the release from the NELF mediated elongation 
block, resulted from the monitoring function of these two checkpoints of transcription 
for the recruitment of capping enzymes and factors of the spliceosome to the nascent 
transcript. Taken together our results and the results from the groups of Papamatheakis 
(Spilianakis et al., 2003) and Medzhitov (Hargreaves et al., 2009) indicate that CDK7-
TFIIH and/or CDK9 P-TEFb recruitment additionally serve to restrict and actively 
regulate the onset of productive transcription.  
Here we have shown that at least for some SRGs not only the recruitment of RNA Pol II 
is a limiting step to induce gene expression, but also the recruitment of co-factors 
follows strict rules and results from the division of labor between different transcription 
factors. According to our findings this hypothesis is valid for transcription factors that 
are activated within a single pathway, such as STAT1 and IRF1, but also those activated 
through different signaling pathways, like NFκB and ISGF3. Collectively these proteins 
converge at the promoters of a subset of infection-induced genes to introduce active 
chromatin, to assemble the PIC – Pol II complex, and engage the Pol II enzyme in 
active transcription.  
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Using IFNγ as a potent inducer of ISGs we could show that the formation of active 
chromatin was largly mediated by the promoter presence of STAT1, which in turn 
proved responsible for the recruitment of CPB/p300 to the Gbp2 promoter. However, 
STAT binding was not sufficient to induce gene expression, due to it’s failure to recruit 
RNA-Pol II. Interestingly, IRF1, which has been shown in numerous studies to act in 
concert with STAT1 to induce IFNγ target gene expression, was found to be able to 
recruit Pol II even in the absence of STAT1 (Ramsauer et al., 2007). Addressing the 
role of IRFs in the regulation of the IFNγ-driven Gbp2 gene, we uncovered a new role 
for IRF7 in the regulation of IFNγ-responsive, ISRE-containing genes. Our finding that 
IRF7 participates in IFNγ signalling is consistent with recent findings that IRF7 
expression is detected after IFNγ administration to various cells of different organisms, 
ranging from a monocyte/macrophage cell line of rainbow trouts, to murine astrocytes 
and human fetal microglial cells or NIH3T3 cells (Holland et al., 2008; Saha et al., 
2010).  
We could reproducibly show that MEFs induce IRF7 expression in response to IFNγ, 
and identified a novel GAS in the 5’flanking region of the Irf7 gene. The IRF7 GAS 
bound STAT1 after treatment with IFNγ, and was conserved in the human Irf7 gene 
promoter. We were able to demonstrate that, due to the role of IRF7 as a class II 
transcription factor, late but not initial gene expression of IFNγ target genes in MEFs 
depended on the presence of IRF7. As expected, IRF7 activity, was confined to ISRE 
driven genes. Our data are supported by recent results from the group of Tenoever, 
showing that ISRE sites in the promoters of ISGs can be a targeted by IRF7 and induce 
an antiviral response in absence of ISGF3 (Schmid et al., 2010).  
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Both IRF7 and IRF1 were able  to stimulate GBP2 expression individually when 
transfected into WT or Stat1 -/- MEFs. The added value of having both present 
simultaneously lay in a synergistic induction of the Gbp2 promoter. Unlike IRF1, IRF7 
activity on the Gbp2 promoter depended on the presence of the kinases TBK1 and/or 
IKKε. Absence of both kinases reduced expression of the ISRE-driven genes Gbp2 and 
Tap1 to an equal extent as the disruption of the Irf7 gene. This led us to conclude that 
IRF7 needs to be phosphorylated to drive ISG expression. This notion was further 
supported by the finding that IRF7 was unable to stimulate the expression of the Gbp2 
promoter-luciferase construct in Tbk1 and Ikbke double-deficient MEFs. Contrasting the 
data with Gbp2, SOCS1 expression was reduced in Irf7 -/- MEFs but still fully 
responsive to IFNγ in Tbk1/Ikbke -/- MEFs. Hence, IRF7 presence is required for full 
expression of ISRE-driven genes in response to IFNγ, but its phosphorylation is 
required only for a subset of IFNγ-inducible genes. We speculate that IRF7 function at 
the promoters of ISRE driven genes may require phosphorylated IRF7 to recruit co-
factors and/or to introduce activating chromatin marks. These prerequisites for 
transcriptional activation may be implemented at promoters of SOCS1-like genes 
independently of IRF7 recruitment, either by other IFN-regulated factors, or present 
ahead of stimulation. In support for the first hypothesis the Socs1 promoter does contain 
a bonafide IRF binding site at an enhancer but no IRF binding site was found directly at 
the promoter. Therefore, one can conclude that promoter rearrangements leading to 
SOCS1 expression is likely to be regulated by promoter bound STAT1 homodimers, 
and the contribution of IRF7 might be to orchestrate events required to maintain and 
support productive trancription of SOCS1 mRNA.  
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Since treatment with IFNγ in Stat1-/- MEFs did not further enhance the transcriptional 
activity of IRF7 we were able to conclude that TBK1/IKKε are not activated 
downstream of the IFNGR. Concomitant with the finding that IRF7-mediated GBP2 
expression was absent in Tbk1/Ikbke -/- MEFs, but present after transfection of IRF7 in 
Stat1-/- MEFs, which still express the two kinases, we were attracted to the idea that 
constitutive activity of TBK1/IKKε might suffice to bring about the necessary IRF7 
phosphorylation. Support for this hypothesis was obtained by 2D PAGE analysis 
suggesting the presence of at least one IRF7 phosphoisoform in WT, but not in 
Tbk1/Ikbke -/- MEFs. This is, to our knowledge, the first report of a constitutive activity 
of the TBK1/IKKε kinase modul with a clear biological impact not only on the pattern 
recognition pathways through which the kinases are usually activated, but on an 
independent pathway. This adds a new line of understanding the mechanisms of 
crosstalk between pathways regulating innate immunity. 
The IRF7 regulatory region contains eight serines as possible targets for TBK1/IKKε. 
Detailed functional analysis by the lab of David Levy revealed that a series of IRF7 
phosphoisoforms is generated upon viral infection and the resulting activation of the 
two kinases (Caillaud et al., 2005). Since only one isoform could be detected in our 
system, we were interested to find the serine residue or the combination of serine 
residues phosphorylated by constitutively active TBK1/IKKε. Analysis of several 
different IRF7 mutants revealed that a combination of phosphorylated serines is 
required for IRF7 transcriptional activity on ISRE driven genes like Gbp2. Especially 
S425 - S426 and S437 - S438 proved essential in our system and were of particular 
interest. The serine to alanine mutation of both renders IRF7 inactive. An aspartate 
mutant of all serines of the regulatory domain except S425 and S426 was active in the 
absence of TBK/IKKε and this activity could be enhanced upon selective introduction 
of TBK1 to a greater extent than that of WT IRF7. In contrast, transfection of the same 
mutant into Stat1 -/- MEFs expressing both TBK1 and IKKε resulted in GBP2 
expression levels comparable to those initiated by WT IRF7. This phenomenon can best 
be explained by a negative effect of IKKε in Stat1 -/- MEFs, due to either competition 
for required adaptor proteins, as proposed by the group of John Hiscott (Paz et al., 
2009), or by a direct inhibitory phosphorylation of IRF7 by IKKε (Caillaud et al., 2005). 
In favour of the latter assumption, Ser425 was shown to be phosphorylated in vitro by 
IKKε.  
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Cotransfection of IKKε together with TBK1 clearly established a repressive effect of 
IKKε on the transcriptional activity of IRF7. This effect was observed with every 
mutant analysed, including the phosphomimetic M15 mutant mentioned above. This 
indicates that IKKε indeed serves to exert negative control over the transcriptional 
activation of IRF7 by TBK1. This interpretation is in line with our observation that the 
inducibility of the Gbp2 reporter was generally lower in Stat1 -/- MEFs than in 
Tbk1/Ikbke -/- MEFs (compare Figures 15B,D with Figures 15 C,E). In accordance with 
the data shown in Caillaud et al., our result that the inherent ability of the M15 mutant, 
which has all serines, except S425 and S426, mutated to aspartate, to activate the Gbp2 
promoter was suppressed by IKKε in absence of TBK1, suggests that the antagonistic 
effect of IKKε is due to phosphorylation of Ser425 rather than competition for binding 
sites in a signaling complex. For the first time our report clearly demonstrates a non-
redundant, antagonistic role of IKKε on TBK1, which is required to limit the effect of 
TBK1 on IRF7 activation and possibly directs IRF7 specificity towards target gene 
recognition. Whether this antagonistic effect still occurs when TBK1 and IKKε are 
activated by PAMP signalling will be subject to future studies.  
IRF1 is expressed very early in the response to IFNγ and binds the Gbp2 promoter 
within 1 hour after the onset of signaling. Compared to IRF1, IRF7 binding kinetics to 
the Gbp2 promoter confirmed a function later in GBP2 expression, since IRF1 precedes 
IRF7 at the Gbp2 promoter. This is in line with the effects on Gbp2 mRNA expression 
observed in Irf7 -/- MEFs. The difference in recruitment kinetics suggests that IRF1 
binds the Gbp2 promoter independent of IRF7. Similar to IRF1, IRF7 binds both the 
distal and proximal Gbp2 promoter. Sequential ChIP analysis revealed that the promoter 
regions are simultaneously occupied by both IRF1 and IRF7, which therefore have to 
share the same ISRE site. The transfection experiments show that IRF7 can regulate 
GBP2 expression independently of IRF1, which suggests that IRF7 binding to the Gbp2 
promoter does not require previous promoter association by IRF1. Surprisingly, IRF7 
leaves the proximal Gbp2 promoter after 4 hrs of IFNγ treatment, whereas it remains 
bound at the distal region, indicating that IRF7 presence at the proximal promoter is not 
required for the maintenance of Gbp2 transcription. 
Discussion 
  Page 88
This sequential mode of transcription factor assembly at the Gbp2 promoter, starting 
with STAT1, which introduces H4 acetylation by the recruitment of CBP/p300, 
followed by IRF1, which could be linked to the recruitment of RNA Pol II, and finally 
IRF7, gives rise to a number of questions addressing the function of IRF7 at the 
promoter of IFNγ target genes. One possible function for IRF7 would be to assist IRF1 
in the subsequent recruitment of Pol II, to enable sustained target gene expression. 
Whether, this results from direct association of IRF7 with RNA Pol II, leading to the 
recruitment of more RNA Pol II, or from the recruitment of GTFs, such as TFIID, is 
subject to ongoing experiments. A further possible function for IRF7 could be the 
introduction of activating chromatin marks, which in turn would lead to the stable 
association of GTFs or the RNA Pol II itself. Finally, IRF7 might mediate the 
recruitment of factors needed to efficiently engage RNA Pol II into active transcription. 
In this situation CDK7-TFIIH or CDK9-P-TEFb, which are both required to generate 
mature, full length transcripts would be potential IRF7 targets. Whether STAT1, IRF1 
or IRF7 is the factor responsible for CDK7-TFIIH recruitment remains to be solved. 
Which of the above mentioned possibilities resembles the actual situation at the Gbp2 
promoter will be revealed by future experiments. Interesting to note at this point is that 
the input of IRF7 to transcriptional initiation of the Gbp2 promoter, but not its nuclear 
translocation or the recruitment to target promoters, requires TBK1-mediated 
phosphorylation. This is demonstrated by the TBK1-independent effect of IRF7 on 
SOCS1 expression and points to a difference in the mode of transcriptional activation 
by IRF7 when comparing the Gbp2 or Tap1 promoters with the Socs1 promoter.  
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In addition to these mechanistic statements our data allow some conclusions about the 
consequences of IFNγ-induced IRF7 expression and its role in the regulation of IFNγ– 
responsive genes. Most cells in an organism do not express IRF7 constitutively, 
consistent with its classification as a class II transcription factor. A notable exception 
from this rule is a subset of DCs, pDCs (plasmacytoid dendritc cells), often refered to as 
IPCs (interferon producing cells) due to their capability to produce high amounts of type 
I IFNs very soon after their exposure to a pathogen. A hallmark of pDCs, which is 
linked to their ability to produce type I IFNs very rapidly, is the constitutive expression 
of IRF7, the ‘master regulator’ of type I IFN production. Since type I IFNs are mainly 
produced in response to intracellular pathogens, pDCs play a fundamental role in the 
defence against various viral infections (Honda et al., 2005; McCullough et al., 2009). 
Our results, together with recent work by others, indicates that IRF7 is expressed in a 
variety of cell types upon IFNγ treatment, and may participate in the induction of an 
antiviral state independently of type I IFN (Holland et al., 2008; Saha et al., 2010; 
Schmid et al., 2010). By elevating the basal levels of IRF7 in non-pDCs IFNγ may play 
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After IFNγ treatment STAT1 was shown to recruit CBP/p300 and to stimulate the 
hyperacetylation of histone 4 (H4). Likewise, the ISGF3 complex proved essential for 
the enrichment of acetylated histone H4 at the Nos2 promoter in the context of a 
response to type I IFNs. Interestingly, increased acetylation was confined to distal Nos2 
promoter regions adjacent to the ISRE consensus, whereas acetylation of the proximal 
Nos2 promoter required the binding of NFκB to its proximal consensus binding 
sequence. H4 acetylation at promoters closely correlates with transcriptional activation, 
and several H4 lysine residues, including K5/8/12 and 16, have been linked to the 
sequential binding of BRD4 and CDK9, which are required for the onset of 
transcription (Hargreaves et al., 2009; Zippo et al., 2009). Given that IFNβ-induced 
histone acetylation at the Nos2 promoter is limited to the distal region, one can 
speculate that the absence of activating histone modifications at the proximal Nos2 
promoter might be responsible for the inability of ISGF3 to recruit CDK7-TFIIH and 
CDK9 - P-TEFb, to the site of RNA Pol II recruitment in order to induce transcription. 
In further support for this hypothesis, the binding of CDK9 was also shown to be 
dependent on hkL derived signals. Whether or not the binding and retention of CDK7 
and CDK9 to the proximal Nos2 promoter is mediated by BRD4 in the context of 
Listeria monocytogenes infection will be subject to future investigations. 
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Continuing on the idea of promoter proximal H4 acetylation as a prerequisite for CDK7 
and CDK9 deposition, one has to ask why classical ISGs, like Gbp2 or Mx2 are 
expressed upon IFN treatment without the need for NFκB assistance in recruiting 
CDK7/9. One possible explanation is that the promoter of classical ISGs is preloaded 
with factors required for CDK7/9 recruitment and/or RNA Pol II itself. This notion is in 
line with the above-mentioned findings of the groups of Papamatheakis and Medzhitov 
(Spilianakis et al., 2003; Hargreaves et al., 2009). A second possibility is given by the 
idea that the structure and composition of the promoter itself, i.e. different or differently 
positioned transcription factor binding sites, determine whether a gene responds to 
STATs alone or whether it requires the information input from a second signalling 
pathway as shown for iNOS. Interesting to note, at this point, is that, in contrast to Nos2, 
STATs bind the promoters of most classical ISGs very close to the transcriptional start 
site. Even in the case of IFNγ-driven Gbp2 and Irf7 expression STAT1 was bound to 
ISRE sites close to the TSS, most likely as part of an unconventional, ISGF3-like 
complex formed by STAT1 homodimers together with IRF9 (Ramsauer et al., 2007). 
STAT1 binding at the Gbp2 promoter was shown to be required for H4 acetylation but 
is not able to stimulate the recruitment of RNA Pol II. 
In contrast to IFNγ driven Gbp2 expression, type I IFN mediated ISGF3 activation and 
subsequent iNOS expression did not depend on the phosphorylation of STAT1 at 
Ser727. In case of IFNγ-induced Gbp2 expression STAT1 Ser727 phosphorylation was 
required for the recruitment of CBP/p300. This finding suggests that the TAD of 
STAT2 might be used to facilitate contact to HATs, as described for GCN5 and PCAF 
(Paulson et al., 2002; Lau et al., 2003). Another difference between IFNγ and type I IFN 
mediated gene induction is the differential requirement for IRFs to initiate gene 
expression. IFNγ-regulated gene expression was found to rely on both IRF1 and IRF7, 
whereas Nos2 expression after infection with Listeria monocytogenes, was unaltered in 
macrophages deficient for IRF1 or IRF7. This invites the speculation that STAT1 
homodimers require serine 727 phosphorylation to contact HATs and need the 
assistance of IRF1 to recruit the RNA Pol II enzyme, whereas the TAD of STAT2, 
embedded in the ISGF3 complex, seems to perform both functions.  
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Despite the fact that ISGF3 fails to induce H4 acetylation at the proximal Nos2 
promoter, it efficiently introduces the H3K4me3 mark at the site of RNA Pol II 
recruitment, independent of the Pol II phosphorylation status. Together with the 
observation that ISGF3 is responsible for mediating the recruitment of TBP and RNA 
Pol II, this suggests that direct contact of the distally bound ISGF3 with the proximal 
Nos2 promoter has to occur. This interaction might be enabled by DNA bending, a 
mechanism shown to contribute  to the regulation of the CIIta promoter. Specifically, 
BRG1 dependent CIIta remodelling requires DNA bending to allow for long-range 
interactions in cis (Ni et al., 2008). Still the question remains, why the introduction of 
H3K4me3 at the proximal Nos2 promoter is mediated by ISGF3, but H4 acetylation 
stays confined to the distal promoter. One possible explanation could be that HAT 
recruitment is directly mediated by ISGF3 and occurs very locally as shown for the Ifnβ 
promoter and the Ifi56K gene (Parekh and Maniatis, 1999), whereas the introduction of 
H3K4me3 at the proximal promoter might be a result of ISGF3 mediated H2Bub, which 
has been shown in recent reports to lead to RNA Pol II independent binding of SET 
domain containing proteins (Dover et al., 2002; Kim et al., 2009; Nakanishi et al., 2009). 
This mechanism would also explain the delayed kinetics of H3K4me3 enrichment 
compared to ISGF3 recruitment in response to IFNβ. Beside ISGF3, NFκB has also 
been shown to introduce the H3K4me3 mark after treatment with hkL alone, which 
therefore occurs completely independent of RNA Pol II recruitment. To our knowledge 
this is the first report demonstrating this in primary cells. Identifying the responsible 
H3K4 methylase at the Nos2 promoter will be of immediate future interest, since the 
only report showing H3K4 tri-methylation independent of Pol II phosphorylation was 
performed in MEFs and resulted in the conclusion that this might be a feature unique for 
TATA less genes (Wang et al., 2009).  Contrasting this notion, Nos2 is clearly a TATA-
containing gene. The consequences of H3K4me3 are of further interest since this mark 
has recently been found to be recognized by TAF proteins of the TFIID complex 
(Vermeulen et al., 2007). Whether or not the introduction of this mark can assist in, or is 
required for the deposition of TFIID and RNA Pol II at the Nos2 promoter remains to be 
determined.  
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Phosphoacetylation of histone H3 at the iNOS promoter presents another task for future 
studies. Unexpectedly, the H3S10phK14ac mark was present at very high levels at the 
proximal Nos2 promoter already before treatment and did not significantly increase 
upon treatment with hkL. IKKα has been shown in numerous studies to be able to serve 
as a H3S10 kinase in response to activation of the NFκB p50/p65 heterodimer (Anest et 
al., 2003; Yamamoto et al., 2003). However, we found the proximal NFκB site of the 
Nos2 promoter to be occupied by p50 homodimers in unstimulated cells. p50 
homodimers repress transcription by blocking the accessibility for the NFκB binding 
site and by the binding of HDAC repressor complexes. In more recent studies IKKα 
was shown to function not only as H3S10 kinase, but also to derepress genes from p50 
homodimer–HDAC mediated repression (Hoberg et al., 2006; Gloire et al., 2007). The 
question whether or not basal H3S10 phosphorylation levels at the Nos2 promoter are 
mediated by IKKα, and whether p50 homodimers play a role in targeting IKKα to the 
Nos2 promoter in uninduced cells, to render the promoter poised for activation, will be 
addressed in future studies. Furthermore, recent data of the group of James Davie link 
the H3 phosphoacetylation mark to the association of 14-3-3 proteins, enabeling the 
binding of BRG1 to remodel chromatin (Drobic et al., 2010). Since hkL treatment 
induces rapid chromatin remodeling at the whole Nos2 promoter, the same or a similar 
mechanism requiring BRG1 function might apply. A second possible function of this 
mark is provided by the recent finding that 14-3-3 proteins, after binding the 
phosphoacetylation mark, serve to bind HATs such as MOF, which in turn acetylate 
histone H4 at lysine 16. This mark can further be recognised by BRD4, which was 
shown to mediate CDK9 recruitment to gene promoters of PRGs (Zippo et al., 2009).  
The recently identified mechanism of gene induction by NFκB shows that NFκB 
mediated CDK7-TFIIH recruitment and deposition is required to maintain 
transcriptional memory. Gene induction by NFκB alone did not take place due to its 
inability to recruit RNA-Pol II. Moreover, a group of interferon responsive genes was 
identified by microarray analysis, which was upregulated during infection with Listeria 
monocytogenes following an expression pattern similar to iNOS (Farlik et al., 2010). 
The question whether this mechanism is specific for the identified IFN responsive genes, 
or whether NFκB recruits and stably deposits CDK7 and CDK9 to NFκB target gene 
promoters at many genomic loci without rendering the genes transcriptionally active, 
will be examined using A ChIP-sequencing approach. 
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It is important at this point to note that the observed deposition of both CDK7 and 
CDK9 by NFκB independently of Pol II binding, is a novel finding that challenges the 
current view of gene regulation in many ways. Our data in (Farlik et al., 2010) show 
that this mechanism introduces transcriptional memory with a built-in integrator 
function that allows the separation of the NFκB and ISGF3 activating signals over time 
(Levy, 2010). CDK7 is required for transcriptional initiation and the recruitment of 
capping factors to the nascent transcript. On the other hand CDK9, and subsequent Ser2 
phosphorylation at the RNA Pol II CTD, functions to recruit factors of the spliceosome 
and in the release of the NELF mediated elongation block, thereby enabeling RNA Pol 
II to proceed to productive elongation. Deposition of both, CDK7 and CDK9, now 
raises the question, whether the maturation of iNOS mRNA occurs faster when NFκB is 
active and recruited to the Nos2 promoter before ISGF3. Comparing the expression of 
iNOS pre-mRNA transcripts and mature mRNA after infection will allow us to gain 
insight into the communication between NFκB and the factors governing the mRNA 
maturation process.  
Several observations concerning the role of NFκB in Listeria-infected macrophages are 
worthy of mention. We identified the p65 subunit of NFκB as the most important factor 
in the regulation of Nos2 gene expression downstream of hkL-induced signaling. This 
result was obtained by the use of mice after conditional deletion of p65. Reportedly, p65 
is an essential component of the IFNβ enhanceosome (Panne et al., 2007), hence we 
expected to lose expression of IFNβ in bone marrow derived macrophages of these mice. 
Surprisingly, macrophages after infection with Listeria monocytogenes expressed 
significant amounts of iNOS mRNA even in the absence of exogenous IFNβ. Consistent 
with this, the Nos2 expression remaining in p65-depleted macrophages resulted from 
residual production of endogenous IFNβ and ISGF3 activation. These findings support 
the conclusion  that at least in context of Listeria infection, p65 is dispensable for a 
functional IFNβ enhanceosome. Although this finding contrasts the results of Panne et 
al., recent data from the labs of Ruslan Medzhitov and Amer Beg agree with the idea, 
that NFκB can be dispensible for IFNβ expression (Stetson and Medzhitov, 2006; Wang 
et al., 2010). 
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Separating L. monocytogenes signalling into signals provided by hkL and IFN-I has 
proven to be a successful experimental approach throughout this study and will be 
similarly useful to address some of the questions raised above. On the one hand, 
pretreatment by hkL for a prolonged period of time might allow us to study NFκB 
dependent effects on the expression and maturation of iNOS mRNA. On the other hand 
pretreatment with IFNβ before the addition of hkL will be helpful in determining 
whether IFNβ and its recruitment of ISGF3 to the Nos2 promoter, is able to stably 
deposit RNA Pol II at the Nos2 promoter, similar to what was shown for NFκB and 
CDK7/9. This poses an interesting problem because during viral infection IFNβ may 
impinge on tissue, surrounding an infected cell, prior to the second signal required for 
iNOS expression, hence a memory effect produced by Pol II deposition would be 
required. This mechanism would convert a SRG suddenly into a PRG, where Nos2 
mRNA is expressed as soon as the IFN-I-primed cell encounters a PAMP that activates 
NFκB and recruits CDK7 and CDK9 to the Nos2 promoter. This scenario is highly 
reminiscent of the mode of transcriptional induction shown for PRGs after LPS 
treatment by the group of Medzhitov. In further agreement with the Medzhitov model, 
IFNβ  restructures the Nos2 promoter in a manner characteristic for LPS-induced PRGs, 
including the recruitment of Pol II and the presence of H3K4me3 (Hargreaves et al., 
2009). IFNβ has also been shown to induce moderate levels of Nos2 mRNA on its own. 
Whether this mRNA is mature or unprocessed due to the lack of CDK7 and CDK9 and 
therefore unstable, according to Hargreaves and Medzhitov another hallmark of PRGs, 
has yet to be deciphered.  
In an entire organism, paracrine stimulation by IFNβ is very often a result of viral 
infections such as that of the airways by influenza. Elevated serum levels of IFNβ 
would therefore cause the proposed Nos2 conversion to a “part-time PRG” in 
responding cells. The second signal, leading to NFκB activation, can be, but must not be 
provided by the same pathogen that caused the production of type I IFNs, and can also 
be the result of, for example, TNFα secretion and signaling in response to infections. As 
shown in numerous studies, secondary infections, which very often occur in the wake of 
influenza infection can cause severe damage in an organism due to an overreaction of 
the already highly active immune system (Jamieson et al., 2010). Part of this damage 
might be caused by the products of iNOS and/or similarly regulated genes. 
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Materials 
Additional reagents not decribed in references Farlik et al (Farlik et al., 2010), or 
Ramsauer et al. (Ramsauer et al., 2007) were as follows:  
Antibodies 
Monoclonal antibody to H3K4me3 was purchased from Millipore (Billerica, MA, USA) 
(Cat. No.: 04-745) and used for ChIP in a dilution of 1:100.  
 
Monoclonal antibody to H3S10phK14ac was purchased from Upstate Biotechnology 
(Lake Placid, NY, USA) and used for ChIP in a dilution of 1:100. 
 
Monoclonal antibody to IFNAR1 was described recently (Sheehan et al., 2006) and 
used in a dilution of 1:1000 
 
Polyclonal antibody specific for IRF7 was generated in the Lab by immunisation of a 
rabbit with a peptide containing aminoacids 207-452 of the IRF7 protein fused to GST 
and used for ChIP at a dilution of 1:20; and 1:100 for Western blot.  
  
Secondary antibody for WB analyses by Odyssey Infrared Imaging System of Li-Cor 
Biosciences to mouse IgG (Cat. Nr. 610-132-121) and rabbit IgG (Cat. Nr. 611-132-122) 
were purchased by Rockland.  
Primer 
Mouse  IL1ra - Forward: GCTCATTGCTGGGTACTTACAA 
   Reverse: CCAGACTTGGCACAAGACAGG 
Mouse  Dusp1 - Forward: GGATATGAAGCGTTTTCGGCT 
Reverse: GGATTCTGCACTGTCAGGCA 
Mouse  Dusp2 - Forward: GATTCAGAGCCACCGGGTAC 
Reverse: AGCTTCCCCCAGGAGTCAGT 
Mouse  IRF7 - Forward: CTGGAGCCATGGGTATGCA 
Reverse: AAGCACAAGCCGAGACTGCT 
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Mouse IRF1 – Forward: CCGAAGACCTTATGAAGCTCTTTG 
Reverse: GCAAGTATCCCTTGCCATCG 
 
Mouse SOCS1 – Forward: ACTCCGTGACTACCTGAGTTCCTT 
Reverse: GCATCTCACCCTCCACAACCACT 
Mouse HIF1α – Forward: TCACCAGACAGAGCAGGAAA 
Reverse: CTTGAAAAAGGGAGCCATCA 
Mouse TAP1 – Forward: CTGGCAACCAGCTACGGGT 
Reverse: TGAGAATGAGGATGTGGTGGG 
Mouse IFNβ was used as described previousely (Stockinger et al., 2004) 
ChIP mouse IRF7 enhancer – Forward: TCGAACTCAGAAATCTGCCTGC 
Reverse: TCAAATCCCAGCAACCACAAGG 
ChIP mouse IRF7 promoter – Forward: GGTCGGGTGTAGTTTGAGGA 
Reverse: GCCAAGGTGGCTGTAGATGT 
ChIP mouse IL1ra promoter – Forward: CACGCCTCTGGAAGCTGGGC 
Reverse: AGGAGCACCCAGGCAGTGTC 
Cells 
Irf3 -/-, Irf7 -/-, were derived from recently published mice (Sato et al., 2000; Honda et 
al., 2005). Tbk1-Ikbke -/- MEFs were kindly provided by Akira S. and generated as 
described in (Hemmi et al., 2004). MEFs were cultured in DMEM containing 10% FCS. 
ChIP buffers 
ProtA- beads: Amersham (Nr:17-0780-01) 
   1.5g beads in 7,5ml TE  
   200 µg/ml Hering sperm 
   1mg/ml BSA 
   0.05%NaAz 
Lysis buffer:  50mM HEPES-KOH 
   1mM EDTA 
   0.5mM EGTA 
   140mM NaCl 
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   10% glycerol 
   0.5% NP-40 
   0.25% Triton X-100 
   (+protease inhibitor cocktail, +PMSF) 
 
Wash buffer:  10mM Tris.HCl pH8 
   1mM EDTA 
   0.5mM EGTA 
   200mM NaCl 
   (+protease inhibitor cocktail, +PMSF) 
 
RIPA buffer:  10mM Tris.HCl pH8 
   1mM EDTA 
   0.5mM EGTA 
   140mM NaCl 
   5% glycerol 
   0.1% sodium deoxycholate 
   0.1% SDS 
   1% Triton X-100 
   (+protease inhibitor cocktail, +PMSF) 
 
Proteinase K buffer: 10mM Tris-HCl pH8 
   1mM EDTA 
   100mM NaCl 
   0.5% SDS 
   add 200µg/ml proteinase K 
 
TE:   10mM Tris-HCl pH8 
   1mM EDTA 
 
PMSF: if required add to final concentration of 1mM 
protease inhibitor cocktail: complete EDTA-free tablets (Roche Nr:11873580001) 
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Nuclear extraction buffers 
Buffer A: 10 mM HEPES (pH 7.9) 
10 mM KCl 
0.1 mM EDTA 
0.1 mM EGTA 
1 mM DTT  
(+PMSF, + proteinase inhibitors) 
 
Buffer C: 20 mM HEPES (pH 7.9) 
0.4 M NaCl  
1 mM EDTA 
1 mM EGTA 
1 mM DTT 
(+PMSF, + proteinase inhibitors) 
2D-PAGE-buffers and strip 
Rehydration Buffer: 8M UREA (12g for 25ml) 
2% CHAPS (0,5g for 25ml) 
125µl (for 25ml) IPG buffer (optional, or add 2µl fresh before 
sample loading) 
Bromphenolblue (a few grains) 
ddH2O to 25ml  
store in 1ml aliquots at -20°C  
just before use add 18µl of 1M DTT per 1ml rehydration buffer 
 
SDS equilibration buffer: 1,5M Tris pH 8,8   endconc. 50mM   (6,7ml) 
UREA         6M       (72,07g) 
(87% v/v) Glycerol                30%     (69ml) 
SDS         2%        (4g) 
Bromphenolblue       a few grains 
ddH2O            ad 200ml 
store 10ml aliquots at -20°C 
Materials 
  Page 100
just before use add 650µl 1M DTT per 10ml buffer 
 
Agarose sealing solution: SDS electrophoresis buffer 
0,5% Agarose 
Bromphenolblue    a few grains 
 
Strips used were purchased from Amersham: Immobiline Dry Strip pH 4-7 (18cm). 
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Methods 
Additional reagents not decribed in references Farlik et al (Farlik et al., 2010), or 
Ramsauer et al. (Ramsauer et al., 2007) were as follows: 
Transfection and Luciferase detection 
The day before transfection 2x105 MEFs were seeded in each well of a 6 well plate, 
tissue culture treated, in the presence of 2ml DMEM + 10% FCS. 
For transfection Turbofect of Fermentas was used according to manufacturers 
instructions. The medium containing transfection reagent and DNA was exchanged 
4hours after transfection by fresh medium, DMEM + 10% FCS. 24 hours after 
transfection cells were lysed and luciferase was measured using the Dual Luciferase 
Reporter Assay System of Promega (Madison, WI, USA; Cat. Nr. E1910), according to 
the manufacturers protocol.   
RLUs of the Firefly and Renilla Luciferase were measured with the FB 12 Luminometer 
– Berthold Detection Systems (Bad Wildbad, Germany). 
Protein A Bead preperation for ChIP 
Beads used: Protein A Sepharose CL-4B 17-0780-01; GE-Healthcare 
 
- Wash/dissolve Beads in Falcon 50ml with 20ml sterile H2O by shaking gently 
- Put Beads on ice and let the Beads settle down by there own (or in urgent needs 
centrifuge at 4°C 1000rpm 3min.) 
- Transfer supernatant to a new 50ml Falcon (on ice) 
- Add another 20ml of sterile H2O and shake gently 
- Let the Beads settle down again on ice (or centrifuge again – see above) 
- Collect the supernatant 
- Add 10ml of TE (sterile filtered) and dissolve by shaking gently 
- Let the Beads settle down again on ice (or centrifuge again – see above) 
- Discard supernatant of both falcons (including the one with the collected supernatants) 
and dissolve the Beads in an equal amount (according to the amount of Beads) of fresh 
TE 
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- Aliquot the Beads TE mix to 1,5ml reaction tubes (~ 1ml per tube = 0,5ml Beads + 
0,5ml TE) 
- Centrifuge the aliquots at 3000rpm, 1min at 4°C 
- Discard supernatant and keep tubes on ice! 
Prepair the following Master Mix (for 100µl of Beads): 
2µl Salmon Sperm DNA 
10µl BSA (10% in H2O) 
5µl NaAzid (5%) 
83µl TE 
 
- Add 500µl of mastermix to each reaction tube and incubate the tubes 30min (better 
over night!) at 4°C on a rotating wheel (20rpm)  
- Store the Beads at 4°C (expires within 4-5 months) 
ChIP and Re-ChIP Procedure 
ChIPs were performed according to the protocol described by Nissen and Yamamoto 
(Nissen and Yamamoto, 2000) with minor corrections. 
- In case of MEFs use a 80% confluent 15cm tissue culture dish. For BMDMs 1.2-1.5 x 
107 macrophages per dish are seeded the day before treatment. 
- Treat the cells 
- Crosslink cells 10min at 37°C with FA: add 540µl FA (33%) directly to 20ml medium  
- add 125mM Glycin to stop crosslinking: add 1ml of 2,5M Glycin to 20ml medium and 
incubate for 5min at RT 
- suck off medium  
- wash with ice cold 1xPBS 
- scrape cells in 5 to 10 ml ice cold 1x PBS 
- centrifuge 600g for 10min at4°C 
- lyse the cells 10min 4°C (wheel) with 5ml ice cold lysis buffer (+Pille, +PMSF)  
- centrifuge 600g for 5min at 4°C 
- wash cells 10min 4°C (wheel) with 10ml ice cold Wash Buffer (+Pille, +PMSF) 
- centrifuge 600g for 5min at 4°C 
- resuspend in 1,5ml ice cold RIPA buffer 
Here extracts can be stored for 3-5 days at 4°C. 
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- Sonication for MEFs 90% duty cycle/ 40% output (7x-15sec) on ice (fragment size 
200-800bp); for macrophages use 90% duty cycle/50% output (10-15x15sec) on ice; for 
other cells these settings have to be individually optimised  
- Centrifuge 16000g for 15min at 4°C and transfer supernatant in new tube 
> extracts can be stored at -80°C after shockfreezing in liquid nitrogen for several 
months 
- Save 40µl (10% of the amount you plan to use for the IP) as Input at 4°C 
- OD260/280 measurement of a 1:50 dilution of the extract (if necessary adjust DNA 
concentration to an equal amount in all samples with RIPA containing PMSF+Pille) 
- preclear samples with 40µl protein A sepharose beads (60min.) 
- Centrifuge 5´ 2000rpm at 4°C  
- transfer extract to 1,5ml tubes and add antibodies (one of them has to be control 
antibody for background – e.g. rabbit 0 serum) – antibodies of interest concentration 
depending on the reactivity of the antibody 
- incubate samples over night on the rotating wheel at 4°C 
- add 40µl beads and incubate the samples on the rotating wheel at 4°C for 1 hour 
- centrifuge beads at 2000rpm for 3min at 4°C  
- suck off supernatant and wash with 500µl RIPA  
- incubate the samples on the rotating wheel at 4°C for 5 min 
- repeat washing step 4 times with RIPA buffer + PMSF 
- include Input again in the following steps! 
- add 200µl protease K buffer + 4µl protease K (20mg/ml) 
- incubate 2-3 hours at 55°C on the rotating block at 900rpm 
- transfer tubes to 65°C over night for reverse crosslinking 
- centrifuge beads at 2000rpm for 5min at RT 
> possibility to store the samples at -20°C 
- DNA – extraction: add 200µl phenol/chloroform/isoamylalkohol and centrifuge 15min 
at 14000rpm, RT (opt. Phase lock Tubes 1,5ml heavy – Eppendorf) 
- transfer aqueous phase to a new tube and add 500µl Ethanol, 40µl NH4oAc, 20µg 
Glycogen to each sample 
- vortex samples  
- precipitate DNA at -20°C (2 hours) over night or at -80°C for 45min 
- centrifuge at 14000rpm for 15min at 4°C  
- discard supernatant 
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- wash 1x with 500µl 70% EtOH (ice cold) 
- discard supernatant and airdry the pellet for 15min at RT 
- dissolve the pellet in 40-200µl TE and incubate samples at 55°C for 5min 
- start analysis of DNA by PCR or qPCR, ChIP on Chip or ChIP Sequencing analysis 
 
For Re-ChIP the immunecomplexes were eluted by adding 10 mM DTT and incubation 
for 30 min at 37°C. The samples were diluted 40-fold in RIPA-buffer (containing PMSF 
and proteinase inhibitors) and reimmunoprecipitated. 
Nuclear extraction 
Nuclear extracts were performed as described in Chan et al. (Chan et al., 2010). 
- Use in case of MEFs a 80% dense 10cm dish  
- add 2 ml of buffer A directly to the plate 
- leave 15 min on ice 
- add 125 µL of 10 % NP-40 
- scrape the cells off 
- vortex vigorously for 10 s 
- centrifuge 30sec at 4 ᵒC at 500 g 
- supernatant is cytoplasmic (collect it) 
- wash the pellet once again in buffer A without NP-40 (it may need two washings) 
- resuspend pellet in 80 µL of buffer C (in case of 2D-gels one might need to decrease 
the volume to 20µl) 
- incubate 15 min on ice with agitation  
- centrifuge 5 min at 4 ᵒC at maximum rpm 
- collect the supernatant (nuclear fraction) 
- prepare proteins for loading 
2D – PAGE 
After prepairing the nuclear extract to enrich for nuclear proteins and reduce 
concentration of detergent, 20µl of nuclear extract are taken up in 280µl rehydration 
buffer (freshly add 2µl IPG buffer with the pH corresponding to the IPG strips used in 
the next steps). 
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- incubate the nuclear extract together with the rehydration buffer at 95°C for 10 
min. and load everything to the IPG – Strip, which is placed gelside down into 
the strip holder. 
- Cover the strip with IPG Dry Strip Cover Fluid (Amersham) 
- Attach the lid and place the holder into the IPGphor machine (plus = pH1 -  
minus = pH12) 
- Program for the first dimension used was as follows: 200V (15min.); 300V 
(30min.); 400V (over night); 800V (1hr) 
- Remove strip from holder and place it into 10ml equilibration buffer (freshly 
add DTT) into a glass tube (with the gel side open to the tube) and shake it 15 
minutes at room temperature 
- After equilibration place the strip by plastic side on the back to the larger gel 
glass plate, washed by electrophoresis buffer and move it down to touck the 
SDS gel 
- Overlay the strip with agarose sealing solution (avoid bubbles) and run the gel 
(90 – 100 mA). 
- After the gel is finished the proteins are blotted to a nitrocellulose membrane 
(blotting time can last up to 3-4 hrs) and further detected by Western blot.  
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